bromocriptine has been researched along with ergoline in 662 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 453 (68.43) | 18.7374 |
| 1990's | 74 (11.18) | 18.2507 |
| 2000's | 67 (10.12) | 29.6817 |
| 2010's | 64 (9.67) | 24.3611 |
| 2020's | 4 (0.60) | 2.80 |
| Authors | Studies |
|---|---|
| Birkenhäger, JC; Lamberts, SW | 3 |
| Fahn, S; Hutt, C; Prasad, AL; Snider, SR; Stein, B | 1 |
| Acharya, S; Saran, BM | 1 |
| Goldstein, M; Hata, F; Lew, JY; Ohashi, T | 1 |
| Adler, H; Calne, DB; Kennedy, S; Silbergeld, EK | 1 |
| Frantz, AG; Kleinberg, DL | 1 |
| Battista, AF; Fuxe, K; Goldstein, M; Lew, JY; Lieberman, A; Nakamura, S | 1 |
| Angrist, B; Lieberman, A; Serby, M | 2 |
| Hungerbühler, JP; Regli, F | 1 |
| Blackburn, KJ; Bremner, RM; Davey, MJ; Greengrass, PM; Morville, M | 1 |
| Calne, DB; Eisler, T; Neophytides, A; Nutt, JG; Teychenne, PF; Williams, AC | 1 |
| Besser, GM; Jones, A; Lowry, PJ; Thorner, MO; Yeo, T | 1 |
| Estey, E; Goldstein, M; Goodgold, A; Gopinathan, G; Kupersmith, M; Lieberman, AN | 1 |
| Da Prada, M; Keller, HH | 1 |
| Horowski, R | 1 |
| Parkes, JD | 1 |
| Agnati, LF; Coyle, JT; Fuxe, K; Hökfelt, T; Schwarcz, R | 1 |
| Danzeisen, M; Gygax, P; Meier-Ruge, W; Wiernsperger, N | 1 |
| Sethy, VH | 1 |
| Heuson, JC; Rozencweig, M | 1 |
| Cassar, J; Edwards, R; Kohner, EM; Mashiter, K | 1 |
| Lees, AJ; Shaw, KM; Stern, GM | 1 |
| Davis, RH; Griffiths, K; Groom, G; Hibbard, BM; Walker, S | 1 |
| Al-Dujaili, EA; Besser, GM; Edwards, CR; Hanker, JP; Miall, PA; Thorner, MO | 1 |
| Debono, AG; Donaldson, I; Marsden, CD; Parkes, JD | 1 |
| Duns, A; Gomez-Pan, A; Goolamali, SK; Hall, R; Sachdev, Y; Tunbridge, WM; Weightman, DR | 1 |
| Hayes, S; Lees, AJ; Ross, EJ; Shaw, KM; Stern, GM; Thompson, BD | 1 |
| Barrett, A; Hobbs, JR; Morgan, L | 1 |
| Hirvonen, E; Ranta, T; Seppälä, M | 4 |
| Teasdale, G | 1 |
| Benedek-Jaszmann, LJ; Hearn-Sturtevant, MD | 1 |
| Besser, GM; Thorner, MO; Wass, JA | 1 |
| Farrar, DJ; Pryor, JS | 1 |
| Kaye, SB; Ross, EJ; Shaw, KM | 1 |
| Bennink, HJ; Haspels, AA; Snuiverink, H | 1 |
| Franks, S; Hull, MG; Jacobs, HS; Nabarro, JD; Steele, SJ | 1 |
| Calne, DB; Gielen, AC; Gillespie, MM; Kartzinel, R; Perlow, M; Sadowsky, DA; TEYCHENNE, P | 1 |
| Crockford, PM; Morrish, DW | 1 |
| Besser, GM; Chiodini, PG; Liuzzi, A; Mason, AS; Morris, D; Thorner, MO; Wass, JA | 1 |
| del Pozo, E; Maclay, WP | 1 |
| Hagen, C; Hummer, L; Madsen, S; Olgaard, K | 2 |
| Davis, JC; Hipkin, LJ; O'Mullane, NM; Walker, BA | 1 |
| Horky, K; Marek, J | 1 |
| Saidi, K; Sharif, F; Wenn, RV | 1 |
| Cowan, GO | 1 |
| Bennink, HJ; van der Steeg, HJ | 1 |
| Martin, P; Roulier, R; Serment, G | 1 |
| Fraser, IS; Shearman, RP | 1 |
| Adams, E; Beard, M; Holley, A; Mashiter, K | 1 |
| Jürgensen, O; Taubert, HD | 1 |
| Higuchi, M; Kolloch, R; Krück, F; Stumpe, KO; Vetter, H | 1 |
| Brosens, IA | 1 |
| Cionini, R; Maneschi, F; Navalesi, R; Rolla, M | 1 |
| Cooke, ID; Lachman, E; Singer, A | 1 |
| Szabo, S | 1 |
| Blackstock, J; Dick, JP; George, RJ; Marsden, CD; Parkes, JD; Schachter, M | 1 |
| Anlezark, G; Meldrum, B | 1 |
| Asper, H; Bürki, HR; Ruch, W; Züger, PE | 1 |
| Botalla, L; Chiodini, PG; Colussi, G; De Stefano, L; Gräf, KJ; Horowski, R; Liuzzi, A; Oppizzi, G; Verde, G | 1 |
| Calne, DB; Hunt, RD; Kartzinel, R | 1 |
| Caraceni, T; Cocchi, D; Müller, EE; Panerai, AE; Paratl, EA | 1 |
| Calne, DB; Carter, AC; Chase, TN; Kartzinel, R; Perlow, MD; Shoulson, I | 1 |
| Albiazzati, MG; Frattola, L; Spano, PF; Trabucchi, M | 1 |
| Horrobin, DF; Mahajan, KK; Robinson, CJ | 1 |
| Flaks, A; Hamilton, JM; Maguire, S; Saluja, PG | 1 |
| Martin, RJ; Meier, AH; Wheeland, RA | 1 |
| Benker, G; Hackenberg, K; Hamburger, B; Reinwein, D | 1 |
| Calne, DB; Kartzinel, R; Shoulson, I | 3 |
| Benker, G; Günnewig, H; Hackenberg, K; Hamburger, B; Reinwein, D; Zäh, W | 1 |
| Frattola, L; Spano, PF; Tonon, GC; Trabucchi, M | 1 |
| Kennedy, AL; Montgomery, DA | 1 |
| Andreoli, VM; Frattola, L; Spano, PF; Trabucchi, M | 1 |
| Gullino, PM | 1 |
| Saiani, L; Spano, PF; Tonon, GC; Trabucchi, M | 1 |
| Castegnaro, E; Pontiroli, AE; Pozza, G; Vettaro, MP; Viberti, GC | 1 |
| Coppen, A; Ghose, K | 1 |
| Durand, JP; Gautier, JC | 1 |
| Bricaire, H; Strauch, G | 1 |
| Hammond, CB; Handwerger, S; Wiebe, RH | 1 |
| Asfour, M; Fossati, P; Hedouin-Quincampoix, M; L'Hermite, M | 1 |
| Bolton, AE; Colhoun, EM; Willmott, MP | 1 |
| O'Donoghue, RF | 1 |
| Etreby, MF; Gräf, KJ; Horowski, R | 1 |
| Cabezas, A; Canales, ES; Forsbach, G; Guzman, V; Soria, J; Zárate, A | 1 |
| Hardt, W; Michel, E; Nevinny-Stickel, J; Schmidt-Gollwitzer, K; Schmidt-Gollwitzer, M | 1 |
| Andersen, AN; Larsen, JF; Nielsen, J; Steenstrup, OR; Svendstrup, B | 1 |
| Godwin-Austen, RB; Smith, NJ | 1 |
| Estey, E; Goldstein, M; Gopinathan, G; Kupersmith, M; Lieberman, A | 1 |
| Dirks, H; Köbberling, J; McIntosh, C; Schwinn, G | 1 |
| Davajan, V; Kletzky, OA; March, CM | 1 |
| Caccamo, A; Crosignani, PG; Lombroso, GC; Peracchi, M; Reschini, E; Trojsi, L | 1 |
| Belforte, L; Camanni, F; Chiodini, PG; Liuzzi, A; Massara, F; Molinatti, GM; Müller, EE; Silvestrini, F | 1 |
| Canales, ES; Fonseca, E; Lasso, P; Murrieta, S; Soria, J; Zárate, A | 1 |
| Harrower, AD; Nairn, IM; Strong, JA; Yap, PL | 1 |
| Felt, V; Hainer, V; Krejcík, L; Nedvídková, J | 1 |
| Devinoy, E; Houdebine, LM | 1 |
| Ishibashi, M; Kosaka, K; Yamaji, T | 1 |
| Felt, V; Nedvdková, J | 1 |
| Bowie, M; Boyar, RM; Budinger, JM; Hellman, L; Mountain, IM; Rosenberg, BJ; Stock, CC; Teller, MN | 1 |
| Fell, LR; Findlay, JK; Hooley, RD | 1 |
| Bagnoli, P; Zocchi, G | 1 |
| Battaini, F; Hofmann, M; Spano, P; Tonon, G; Trabucchi, M | 1 |
| Loeffler, LJ; Schran, HF; Schwarz, HJ; Talbot, KC | 1 |
| Caldara, R; Crosignani, PG; Faglia, G; Ferrari, C; Mattei, A; Moriondo, P; Travaglini, P | 1 |
| Dogliotti, L; Mussa, A; Sandrucci, S | 1 |
| Kellams, JJ; Lemberger, L; Rowe, H; Small, JG | 1 |
| Jaton, AL; Loew, DM; Vigouret, JM | 2 |
| Bürki, HR; Jaton, AL; Loew, DM; Vigouret, JM; Züger, PE | 1 |
| Klawans, HL; Nausieda, PA; Weiner, WJ | 1 |
| Briner, U; Doepfner, W; Flückiger, E; Kovacs, E; Marbach, P; Wagner, HR | 1 |
| Birkenhäger, JC; Kwa, HG; Lamberts, SW; Seldenrath, HJ | 1 |
| Abe, H; Chihara, K; Furumoto, M; Kato, Y; Maeda, K | 1 |
| Mroueh, AM; Siler-Khodr, TM | 2 |
| Hainer, V; Krejcík, L; Tvaroh, F; Urbánek, J | 1 |
| Bricaire, H; Mahoudeau, JA; Strauch, G; Valcke, JC | 1 |
| Elithorn, A; Jakobovits, A; James, IM; Morgan, MY; Sherlock, S | 1 |
| Brown, JB; Burger, HG; Evans, JH; Healy, D; Pepperell, RJ; Smith, MA | 1 |
| Dolphin, AC; Jenner, P; Marsden, CD; Sawaya, MC | 1 |
| Lachelin, GC; Leblanc, H; Yen, SS | 1 |
| Medina, D | 1 |
| Hassett, CC; Lambrecht, LK; Welsch, CW | 1 |
| Cassar, J; Joplin, GF; Mashiter, K | 1 |
| Adams, C; Brooks, CL; Hassett, CC; Lambrecht, LK; Welsch, CW | 1 |
| Besser, GM; Jones, AE; Mason, AS; Morris, DV; Rees, LH; Thorner, MO; Wass, JA | 1 |
| Monteiro, JC; Palmer, BV | 1 |
| Advis, JP; Alvarez, EO; Hancke, JL | 1 |
| Hughes, LE; Mansel, RE; Preece, PE | 1 |
| Fahn, S; Hutt, CS; Snider, SR | 1 |
| Boissier, JR; Chermat, R; Puech, AJ; Simon, P | 1 |
| Andersen, AN | 1 |
| Briand, P; Daehnfeldt, JL; Thorpe, SM | 1 |
| Craig, A; Harrower, AD; Nairn, IM; Strong, JA; Walton, HJ; Yap, PL | 1 |
| Pfeiffer, RF; Silbergeld, EK | 1 |
| Di Carlo, F; Dogliotti, L; Mussa, A | 1 |
| Corbey, RS; Cruysberg, JR; Rolland, R | 1 |
| Shapiro, AG | 1 |
| Lipper, S | 1 |
| Jotkowitz, S | 1 |
| Birkenhäger, JC; de Lange, SA; Lamberts, SW | 1 |
| Distiller, LA; Joffe, BI; Seftel, HC | 1 |
| Di Chiara, G; Gessa, GL; Porceddu, ML; Vargiu, L | 1 |
| Bright, MI; Brown, JB; Burger, HG; Evans, JH; Healy, D; Pepperell, RJ; Smith, MA | 1 |
| Courot, M; Garnier, D; Pelletier, J; Ravault, JP; Terqui, M | 1 |
| Hosoki, H | 1 |
| Agnoli, A; Carolei, A; Masturzo, P; Meco, G; Polleri, A; Rolandi, E | 1 |
| Hogh, J | 1 |
| Delitala, G | 1 |
| Anlezark, GM; Horton, RW; Meldrum, BS | 1 |
| Loizzo, A; Longo, VG | 1 |
| Calne, DB | 2 |
| Bern, SM; Calne, DB; McInturff, D; Pfeiffer, RF; Teychenne, PF | 1 |
| Bertazzoni, A; Caldara, R; Crosignani, PG; Ferrari, C; Mattei, A; Polloni, G; Rampini, P; Romussi, M; Telloli, P | 1 |
| Carminati, R; Cocchi, D; Locatelli, V; Müller, EE | 1 |
| Abildgaard, U; Meling, AB; Nilsen, PA | 1 |
| Gerlach, J | 1 |
| Lees, A; Shaw, KM; Stern, GM | 1 |
| Benedek-Jaszmann, LJ; Sternthal, V | 1 |
| Walker, S | 2 |
| Kunz, F; Lörincz, P; Ludin, HP; Ringwald, E | 1 |
| Dirks, H; Köbberling, J; Schwinn, G | 2 |
| Benker, G; Günnewig, H; Hackenberg, K; Reinwein, D; Werner, U; Zäh, W | 1 |
| Gala, RR; Jaques, S | 1 |
| Alagna, S; Delitala, G; Devilla, L; Masala, A; Rovasio, PP | 1 |
| Calne, DB; Pfeiffer, RF; Teychenne, PF | 1 |
| Dickey, RP; Stone, SC | 1 |
| Chetri, G; Dammacco, A; Dammacco, F; Gagliardi, F; Rigillo, N; Tafaro, E | 1 |
| Johnson, AM; Loew, DM; Vigouret, JM | 1 |
| Clemens, R; Naftolin, F; Pallotta, J; Spark, RF | 1 |
| Calne, DB; Kartznel, R | 1 |
| Cassar, J; Joplin, GF; Mashiter, K; Sullivan, G | 1 |
| Vaisurb, S | 1 |
| Billeter, E; Flückiger, E; Wagner, HR | 1 |
| Hirvonen, E; Laatikainen, T; Ranta, T; Seppälä, M; Unnérus, HA | 1 |
| Botalla, L; Chiodini, PG; Cremascoli, G; Liuzzi, A; Muller, EE; Oppizzi, G; Silvestrini, F; Verde, G | 1 |
| Hirvonen, E; Ranta, T; Seppälä, M; Unnérus, HA | 1 |
| Horrobin, DF; James, MF; Karmali, RA; Robinson, CJ | 1 |
| Knowles, PA | 1 |
| Bories, F; Bousser, MG; Conard, J; Samama, M | 1 |
| Besser, GM; Thorner, MO | 2 |
| Cooke, I; Foley, M; Jenkins, A; Kennedy, G; Lenton, E; McNeilly, A; Millar, D; Obiekwe, B; Parsons, J; Preston, E | 1 |
| Stempel, LE | 1 |
| Farrar, DJ; Osborne, JL | 1 |
| Kullander, S | 1 |
| Brown, WB; Driver, PM; Forbes, JM; Jones, R | 1 |
| Hockaday, JM; Hockaday, TD; Peet, KM | 1 |
| Chandler, JA; Danutra, V; Griffiths, K; Harper, ME | 1 |
| McLellan, DL | 1 |
| Dolecek, R | 1 |
| Canales, ES; Forsbach, G; Soria, J; Zárate, A | 1 |
| Salocks, CB; Sinha, YN; VanderLaan, WP | 1 |
| Browne, AD; Darragh, A; del Pozo, E; O'Kelly, DA | 1 |
| Estey, E; Goldstein, M; Kupersmith, M; Lieberman, A | 1 |
| Naftolin, F; Tolis, G | 1 |
| Del Pozo, E; Geiger, W; Künzig, HJ; Lancranjan, I; Lose, KH; Schulz, KD | 1 |
| Alagna, S; Delitala, G; Devilla, L; Lotti, G; Masala, A | 1 |
| Nagasawa, H; Yanai, R | 1 |
| Welsch, CW | 2 |
| Agnoli, A; Carolei, A; Casacchia, M; Meco, G; Ruggieri, S; Zamponi, A | 1 |
| Cararach, V; Davi, E; Martin-Comin, J; Pujol-Amat, P; Robyn, C | 1 |
| Dipalma, JR | 1 |
| del Pozo, E; Ohnhaus, EE | 1 |
| Martin, FI; Perry-Keene, DA; Warne, GL | 1 |
| Gomez-Pan, A; Hirst, BH; Labib, LA; Reed, JD | 1 |
| Debono, AG; Marsden, CD; Parkes, JD | 1 |
| Altwein, JE; Helmerich, D | 1 |
| Balestreri, R; Barban, G; Bertolini, S; Castello, C; Elicio, N; Jacopino, GE; Pistocchi, G | 1 |
| Barreca, T; Gallamini, A; Gianrossi, R; Nizzo, MC; Queirolo, A | 1 |
| Gallamini, A; Gianrossi, R; Murialdo, G; Nizzo, MC; Peirano, L | 1 |
| Lionel, ND | 1 |
| Barrett, A; Hobbs, JR; Morgan, L; Raggatt, PR | 1 |
| Aljinovic, A; Gunti, J; Pusterla, E | 1 |
| Bories, F; Bousser, MG; Castaigne, P; Laplane, D | 1 |
| Sathanandan, M; Visvanathan, T | 1 |
| Calne, DB; Kartzinel, R; Perlow, M; Pfeiffer, R; Teychenne, PF | 1 |
| Blair, CM; Fraser, TR; Gordon, H; Kjeld, JM; Nader, S; Tooley, M | 1 |
| Begg, G; Paul, M; Shuman, L; Utian, WH; Vinik, AI | 1 |
| Coustenoble, G; Engelmann, P; Gueris, D; Morin, P | 1 |
| Canales, ES; de la Peña, RO; González-Colindres, J; Levinson, G; Zárate, A | 1 |
| Davis, JC; Diver, MH; Hipkin, LJ; Summers, VK | 1 |
| Jacobi, J; Lloyd, HM; Meares, JD | 1 |
| Calne, DB; Claveria, LE; Reid, JL | 1 |
| Horrobin, DF; Karmali, RA | 3 |
| Camanni, F; Isaia, GC; Massara, F; Molinatti, GM | 1 |
| Boss, RS; Gala, RR | 1 |
| Gorins, A; Netter, A; Netter, AL | 1 |
| Friesen, HG; Pinter, EJ; Tolis, G | 1 |
| Kühn, ER; Vandoren, GE | 1 |
| Alagna, S; Delitala, G; Devilla, L; Masala, A | 1 |
| Archer, DF; Josimovich, JB; Lloyd, SJ | 1 |
| Lequin, RM; Roland, R; Schellekens, LA | 1 |
| Boyd, AE; Reighlin, S | 1 |
| Okumura, T; Seki, K; Seki, M | 1 |
| Geiger, W; Künzig, HJ; Lose, KH; Schulz, KD | 1 |
| Besser, GM; Dacie, J; Jones, A; Jones, AE; Thorner, MO | 1 |
| Ben-David, M; Polishuk, WZ; Spitz, J; Yarkoni, S | 1 |
| Duns, A; Gomez-Pan, A; Hall, R; Sachdev, Y; Tunbridge, WM | 1 |
| Dony, JM; Rolland, R | 1 |
| Camanni, F; Fassio, V; Massara, F; Molinatti, GM; Müller, EE | 1 |
| Kuhn, NJ; Rodway, RG | 1 |
| Peaker, M; Taylor, JC | 1 |
| Del Pozo, E; Geiger, W; Künzig, HJ; Lose, KH; Schulz, KD | 1 |
| Handforth, A; Sourkes, TL | 1 |
| del Pozo, E | 1 |
| Coulam, CB; Hammond, CB | 1 |
| Davidson, H; Horrobin, DF; James, MF; Mahajan, KK; Manku, MS; Robinson, CJ | 1 |
| Schneider, D | 1 |
| Kanis, JA; Ledingham, JG; Nairn, IM; Oliver, DO; Walton, RJ | 1 |
| Andre, JM; Jacquier, A; Kissel, P | 1 |
| Dorr, C; Sathananthan, K | 1 |
| Canales, ES; Fonesca, E; González, J; Levinson, G; Soria, J; Zárate, A | 1 |
| Hollister, AM; Malven, PV; Morningstar, JE | 1 |
| Allan, NC; Harrower, AD; Yap, PL | 1 |
| Cao, Y; Eberwine, J; Kitai, ST; Stefani, A; Surmeier, DJ; Wilson, CJ | 1 |
| Chang, JP; Peter, RE; Wong, AO | 1 |
| Demedts, M; Dom, R; Frans, E | 1 |
| Muscat, R; Papp, M; Willner, P | 1 |
| Samini, M; Shokravi, S; Zarrindast, MR | 1 |
| Pawlikowski, M; Pisarek, H; Stepien, H | 1 |
| Pisarek, H; Stepien, H | 1 |
| Crosignani, P; D'Alberton, A; de Vincentiis, S; Ferrari, C; Mattei, AM; Paracchi, A | 1 |
| Kruk, ZL; Millar, J; Stamford, JA | 1 |
| Amenta, F; Collier, WL; Ricci, A; Rossodivita, I | 1 |
| Horn, PT; Kohli, JD | 1 |
| Demichel, P; Moran, A; Roquebert, J; Sauvage, MF | 1 |
| Nikulina, EM; Popova, NK; Skrinskaya, JA | 1 |
| Hosseini-Nia, T; Owji, AA; Zarrindast, MR | 1 |
| Minaian, A; Zarrindast, MR | 1 |
| Eliassi, A; Zarrindast, MR | 1 |
| Georgiev, V; Kambourova, T; Petkova, B | 1 |
| Davis, A; Jenner, P; Marsden, CD | 1 |
| Amenta, F; Cavallotti, C; Collier, WL; De Michele, M; Ricci, A | 1 |
| Iuvone, PM; Zawilska, J | 1 |
| Barone, D; Benedetti, MS; Dostert, P; Efthymiopoulos, C; Peretti, G; Roncucci, R | 1 |
| Casazza, S; D'Alberton, A; de Vincentiis, S; Fadin, M; Giorda, G; Motta, T | 1 |
| Corrales Hernández, JJ; García Díez, LC; Terroba, C | 1 |
| Dominoni, P; Ferrari, L; Gianola, D; Gualteroni, L; Montini, M; Pagani, G; Pagani, MD; Sileo, F; Stroppa, S; Tengattini, F | 1 |
| Balabolkin, MI; Gerasimov, GA; Gorokhova, TR; Liubimov, AV | 1 |
| Gessa, GL; Olianas, MC; Onali, P | 1 |
| Brown, A; Dali, H; Neumeyer, JL; Pihan, G; Szabo, S | 1 |
| Beaulieu, M; Felder, R; Kebabian, JW | 1 |
| Dieguez, C; Hall, R; Lewis, BM; Lewis, M; Scanlon, MF | 1 |
| Camanni, F; Ciccarelli, E; Giordano, G; Giusti, M; Miola, C; Potenzoni, F; Sghedoni, D | 1 |
| Balabolkin, MI; Gerasimov, GA; Gorokhova, TR; Snigireva, RIa | 1 |
| Al-Sereiti, MR; Turner, P | 1 |
| Uilenbroek, JT | 1 |
| Edwards, SR; Jackson, DM; Ross, SB | 1 |
| Chiodini, PG; Dallabonzana, D; Liuzzi, A; Oppizzi, G; Verde, GG | 1 |
| Harvey, NS | 1 |
| Barton, AC; Demarest, KT; Moore, KE | 1 |
| Chagraoui, A; Protais, P; Vasse, M | 1 |
| Battaglia, G; Creese, I; Hess, EJ; Norman, AB | 1 |
| Ohno, Y; Sasa, M; Takaori, S | 1 |
| Cubeddu, LX; Hoffmann, IS; Talmaciu, RK | 1 |
| Robertson, GS; Robertson, HA | 1 |
| Bidzinski, A; Consolo, S; Forloni, G; Fusi, R; Ladinsky, H | 1 |
| Millington, WR; Mueller, GP; O'Donohue, TL | 1 |
| Beninger, RJ; Dickson, PR; Hoffman, DC | 1 |
| Feuerstein, TJ; Hertting, G; Jackisch, R; Moll, S | 1 |
| Corenblum, B | 1 |
| Kletzky, OA; Shangold, GA | 1 |
| Borenstein, R; Kletzky, OA; Mileikowsky, GN | 1 |
| Burchill, SA; Thody, AJ | 1 |
| Rinne, UK | 2 |
| De Pasqua, A; Di Micco, R; Pontiroli, AE; Sartani, A; Zanardi, E | 1 |
| Besser, M; Ciccarelli, E; Grossman, A; Touzel, R | 1 |
| Svensson, L | 1 |
| Churg, A; Fleetham, JA; McElvaney, NG; Wilcox, PG | 1 |
| Baroldi, P; Cavioni, V; Crosignani, PG; Ferrari, C; Galparoli, C; Gerevini, G; Mattei, AM; Paracchi, A; Romano, C; Spellecchia, D | 1 |
| Lang, AE | 1 |
| Bohnet, HG; De Moll, H; Kato, K | 1 |
| Cancio, E; Cocchi, D; Dall'Ara, A; Devesa, J; Di Salle, E; Lima, L; Müller, EE | 1 |
| Benedetti, M; Bernardi, G; Calabresi, P; Mercuri, NB | 1 |
| Crosignani, PG; Ferrari, C | 1 |
| Caballero, A; Caballero-Asensi, A; Caballero-Díaz, JL; Mena, P | 1 |
| Heinlein, W; Horowski, R; Schatz, H; Stracke, H | 1 |
| Ståhle, L; Ungerstedt, U | 1 |
| Claudi, F; Cristalli, G; Martelli, S; Massi, M; Perlini, V; Venturi, F | 1 |
| Booth, NH; Hatch, RC; Jernigan, AD; Lipham, LB; Robbins, JD | 1 |
| Klawans, HL; Paleologos, N | 1 |
| Golda, V; Petr, R; Rozsíval, V; Suba, P | 1 |
| Ahmed, SR; Shalet, SM | 1 |
| Barbieri, C; Boghen, M; Caldara, R; Codecasa, F; Dubini, A; Ferrari, C; Mucci, M; Paracchi, A; Romano, C | 1 |
| Caselitz, J; Lüdecke, DK; Saeger, W; Schottke, H | 1 |
| Giannetti, LM; Manfellotto, G; Tessitore, A | 1 |
| Casey, DE | 1 |
| Jankovic, J | 1 |
| Bratty, PJ; Burton, K; Calne, DB; Larsen, TA; Martin, WR; Robinson, RG; Schulzer, M | 1 |
| Goldstein, M; Lieberman, AN | 1 |
| Buvat, J; Dewailly, D; Fossati, P; Fourlinnie, JC; Lemaitre, G; Mazzuca, M; Thomas, P; Wemeau, JL | 1 |
| Belchetz, PE; Casson, IF; Hipkin, LJ; Walker, BA | 1 |
| Pepperell, RJ | 1 |
| Agid, Y; Dubois, B | 1 |
| Horvath, E; Kovacs, KT; Laws, ER; Randall, RV; Scheithauer, BW; Whitaker, MD | 1 |
| Glantz, RH; Goetz, CG; Klawans, HL; Tanner, CM | 1 |
| Baas, H; Fischer, PA; Japp, G; Schneider, E | 2 |
| Chiodini, P; Cozzi, R; Dallabonzana, D; Liuzzi, A; Luccarelli, G; Oppizzi, G; Verde, GG | 1 |
| Adams, CB; Besser, GM; Charlesworth, M; Doniach, I; Grossman, A; Ross, R; Wass, JA | 1 |
| Chiodini, PG; Dallabonzana, D; Dorow, R; Horowski, R; Liuzzi, A; Oppizzi, G; Verde, G | 1 |
| Brabant, G; Brennecke, I; Friedrich, H; Herrmann, H; Hesch, RD; von zur Mühlen, A; Wagner, TO | 1 |
| Zaccheo, T | 1 |
| Mattox, JH | 1 |
| Luquin, MR; Martínez Lage, JM; Obeso, JA | 1 |
| Acosta Delgado, D; Astorga Jiménez, R; García-Luna, PP; Leal Cerro, A; Santos Español, C; Villamil, F | 1 |
| Bamji, AN; Calne, DB; Greenacre, JK; Leigh, PN; Teychenne, PF | 1 |
| Bartke, A | 1 |
| Burton, K; Calne, DB | 1 |
| Jewelewicz, R; Vande Wiele, RL | 1 |
| Calne, DB; Plotkin, CN; Rosin, AJ; Teychenne, PF | 1 |
| Buylaert, WA; Green, AR; Heal, DJ | 1 |
| Goldfine, ID; Vigneri, R | 1 |
| Chase, TN; Tamminga, CA | 1 |
| Everett, JW | 1 |
| Crabtree, RE; Lemberger, L | 1 |
| Calne, DB; Eisler, T; Gopinathan, G; Williams, A | 1 |
| Agnati, LF; Andersson, K; Fredholm, B; Fuxe, K; Hall, H; Köhler, C; Ogren, SO | 1 |
| Carruba, MO; Mantegazza, P; Müller, EE; Ricciardi, S | 1 |
| Gianutsos, G; Moore, KE | 1 |
| Hruska, RE; Silbergeld, EK | 1 |
| Bo, P; Maurelli, M; Nappi, G; Savoldi, F | 1 |
| Dhahir, P; Lemberger, L; Rubin, A | 1 |
| Butt, WR; Franks, S; Horrocks, PM; London, DR; Lynch, SS | 1 |
| Vesely, DL | 1 |
| Ross, ED; Stewart, RM | 1 |
| Enna, SJ; Lake, CR; Teychenné, PF; Ziegler, MG | 1 |
| Bergmann, F | 1 |
| Duvoisin, RC; Heikkila, RE; Manzino, L | 1 |
| Kanto, J | 1 |
| Gianutsos, G; Palmeri, JL | 1 |
| Reichlin, S; Szabo, S | 1 |
| Ferrer, JM; Mora, F; Sanguinetti, AM; Vives, F | 1 |
| de Belleroche, J; Gardiner, IM | 1 |
| Novak, PJ; Tadepalli, AS | 1 |
| Burke, JA; Chang, FW; Potter, DE | 1 |
| Arnerić, SP; Chow, SA; Fischer, LJ; Long, JP | 1 |
| Bendesky, RJ; Martin, GE | 1 |
| Cook, DB; Hall, K; Johnston, DG; Kendall-Taylor, P; Patrick, D; Watson, M | 1 |
| Goldberg, LI | 1 |
| Esplugues, J; Morales-Olivas, FJ; Palop, V; Rubio, E | 1 |
| Kopecká, J; Marek, J | 1 |
| Jellinger, K | 1 |
| Biesemeyer, H; Ludin, HP; Ringwald, E | 1 |
| Király, I; Van Ree, JM | 1 |
| Beckman, J; Burton, K; Calne, DB; Martin, WR | 1 |
| Fingerová, H; Gazárek, F; Stehlíková, J; Talas, M; Zenísek, L | 2 |
| Kobilková, J; Kucera, E; Marek, J; Srámková, J; Zivný, J | 1 |
| Markstein, R | 1 |
| Kolena, J; Seböková, E | 1 |
| Locatelli, V; Panerai, AE; Penalva, A; Petraglia, F | 1 |
| McPherson, GA | 1 |
| Blackwell, RE; Bradley, EL; Chang, RJ; DeVane, GW; Duvall, ER; Kline, LB; Vitek, JJ | 1 |
| Burns, RS; Calne, DB; LeWitt, PA | 1 |
| Calne, DB; Dambrosia, JM; Foster, N; Larsen, TA; LeWitt, PA; Newman, RP; Raphaelson, MI; Ward, CD | 1 |
| Borges, JL; Boyett, RL; Elton, RL; Evans, WS; Kaiser, DL; MacLeod, RM; Rogol, AD; Schran, HF; Thorner, MO | 1 |
| Frau, MI; Gessa, GL; Meloni, M; Rossetti, ZL; Tissari, AH | 1 |
| Blackwell, RE; Bradley, EL; Rodgers-Neame, NT | 1 |
| Besser, GM; Cookson, JC; Drury, PL; Price, PA; Turner, TH; Wass, JA | 1 |
| Da Prada, M; Haefely, WE; Keller, HH; Kettler, R; Pieri, L | 1 |
| Finer, N; Herbert, LC; Hicks, BH | 1 |
| Draganova, S; Georgiev, V; Getova, D; Lazarova, M; Markovska, V; Petkov, V; Petkova, B; Roussinov, K; Shopova, S | 1 |
| Abate, F; Baviera, G; Bellinvia, G; La Spada, R; Leonardi, R; Oliva, A | 1 |
| Ruckebusch, Y | 1 |
| Klÿn, JG; Lamberts, SW; Oosterom, R | 1 |
| Luquin, MR; Obeso, JA | 1 |
| Login, IS | 1 |
| Falsetti, L; Loda, G; Pontiroli, AE; Roggia, A; Scagliola, T; Schimberni, M; Turla, R | 1 |
| de Vries, JB; Feenstra, MG; Goedemoed, JH; Horn, AS; Rollema, H; Sumners, C | 1 |
| Fischer, PA; Hubener, K; Schneider, E | 2 |
| Caraceni, T; Carella, F; Giovannini, P; Grassi, MP; Parati, E; Scigliano, G | 2 |
| Benco, R; Caldara, R; Crosignani, PG; Ferrari, C; Mattei, AM; Picciotti, MC; Ragni, G; Rampini, P | 1 |
| Borghi, G; Chiodini, P; Dallabonzana, D; Liuzzi, A; Oppizzi, G; Silvestrini, F; Spelta, B; Tonon, C | 1 |
| Brincat, S; Lang, AE; Marsden, CD; Parkes, JD; Quinn, N | 1 |
| Caldara, R; Farrari, C; Rampini, P; Telloli, P | 1 |
| Noonan, JJ; Rose, DP | 1 |
| Hruska, RE; Silbergeld, EK; Weir, RL | 1 |
| Ambrosi, B; Bochicchio, D; Faglia, G; Moriondo, P; Nava, C; Nissim, M; Travaglini, P | 1 |
| Felt, V; Nedvídková, J | 1 |
| Gopinathan, G; Hiesiger, E; Leibowitz, M; Lieberman, AN; Neophytides, A; Walker, R | 1 |
| Ford, J; Jackson, JA; Jankovic, J | 1 |
| Goldstein, M; Goodgold, A; Gopinathan, G; Leibowitz, M; Lieberman, AN; Neophytides, A; Pact, V; Walker, R | 1 |
| Lang, AE; Marsden, CD; Parkes, JD; Quinn, NP; Toone, B | 1 |
| Maurer, RA | 1 |
| Mann, M; Michael, SD; Svare, B | 1 |
| Harrison, DJ; McNeilly, AS; Russell, JA | 1 |
| Ausková, M; Bílek, J; Krejcí, P; Madej, A; Rezábek, K; Stupnicki, R | 1 |
| Mann, MA; Michael, SD; Svare, B | 1 |
| Kikuyama, S; Seki, T | 1 |
| De Cecco, L; Horowski, R; Maganza, C; Morano, S; Pedretti, E; Ragni, N; Semino, F; Venturini, PL | 1 |
| Baccolo, M; Vecchione, A | 1 |
| Calne, DB; Teräväinen, H | 1 |
| Calne, DB; Dambrosia, JM; Durso, R; Gopinathan, G; LeWitt, PA; Sanes, JN; Ward, CD | 1 |
| Marek, J; Schreiberová, O; Schüllerová, M; Srámková, J; Stĕpán, J | 1 |
| Buonaccorsi, S; Pellicciotta, G; Pontiroli, AE; Scapin, F; Tronconi, G | 1 |
| Albarrán, FJ; Caballero, A; Mena, P; Molina, CE; Palomo, A | 1 |
| Fuller, RW; Perry, KW | 1 |
| Ahlenius, S; Engel, J; Larsson, K; Svensson, L | 1 |
| Johnels, B | 1 |
| Callaghan, JT; Crabtree, R; Lemberger, L | 1 |
| Calne, DB; Dambrosia, JM; Evarts, EV; Gopinathan, G; Sanes, JN; Stuart, WK; Teräväinen, H; Ward, CD | 1 |
| Cardinali, S; Russo, S | 1 |
| Benco, R; Crosignani, PG; Dellabonzana, D; Ferrari, C; Liuzzi, A; Mattei, A; Rampini, P; Scarduelli, C; Spelta, B | 1 |
| Fernández Pardal, MM; Leiguarda, RC; Micheli, F | 1 |
| Besser, GM; Delitala, G; Grossman, A; Hathway, NR; Yeo, T | 1 |
| Reynolds, GP; Riederer, P | 1 |
| Agnati, LF; Andersson, K; Fuxe, K; Hökfelt, T; Köhler, C; Kuonen, D; Ogren, SO | 1 |
| Camerman, A; Camerman, N | 1 |
| Borghi, G; Chiodini, P; Cozzi, R; Dallabonzana, D; Horowski, R; Liuzzi, A; Luccarelli, G; Oppizzi, G; Rainer, E; Silvestrini, F; Spelta, B; Verde, G | 1 |
| Albertazzi, E; Bartolotti, A; Turci, M | 1 |
| Rolland, R; Van Dam, LJ | 1 |
| Marsden, CD; Parkes, JD; Schachter, M; Sheehy, MP | 1 |
| Arvigo, M; Barreca, A; Cariola, G; Foppiani, L; Giordano, G; Minuto, F; Ponzani, P | 1 |
| Arita, K; Eguchi, K; Ito, A; Kawamoto, K; Kurisu, K; Uozumi, T | 2 |
| Ahlenius, S; Alster, P; Hillegaart, V; Uvnäs-Moberg, K | 2 |
| Bryson, HM; Fitton, A; Rains, CP | 1 |
| Riva di Sanseverino, L; Sabatino, P; Tonani, R | 1 |
| Bosc, M; Leclere, J; Pascal-Vigneron, V; Weryha, G | 1 |
| Levavi-Sivan, B; Ofir, M; Yaron, Z | 1 |
| Mark, MH; Sage, JI | 1 |
| Hoffman, DC; Wise, RA | 1 |
| Shibata, S; Tanaka, T; Watanabe, S; Yamamoto, Y | 1 |
| Kitai, ST; Surmeier, DJ | 1 |
| Cestari, R; Lojacono, L; Missale, C; Missale, G; Raddino, R; Sigala, S; Spano, PF | 1 |
| Fraser, RB; Jones, TH | 1 |
| Ferrari, CI; Ismail, I; Piscitelli, G; Polli, A; Scanlon, MF; Webster, J | 1 |
| Serri, O | 1 |
| Gomez, A; Gonzalez, M; Motles, E; Tetas, M | 1 |
| Aranyi, A; Bihari, M; Brlik, J; Csehi, A; Kassai, A; Szántay, C | 1 |
| Delaforge, M; Mansuy, D; Peyronneau, MA; Renaud, JP; Riviere, R | 1 |
| Boulton, AA; Juorio, AV; Paterson, IA; Zhu, MY | 1 |
| Kamijo, N; Nagao, T; Ono, H | 1 |
| Casy, AF | 2 |
| Colombo, N; D'Alberton, A; de Vincentiis, S; Marchini, M; Motta, T | 1 |
| Crosignani, PG; Ferrari, C; Piscitelli, G | 1 |
| Arai, N; Fukuyama, J; Isaji, M; Kuno, S; Miyata, H; Mizuta, E | 1 |
| Delgrange, E; Donckier, J; Maiter, D | 1 |
| Webster, J | 1 |
| Catz, T; Inzelberg, R; Kippervasser, S; Korczyn, AD; Nisipeanu, P; Orlov, E; Rabey, JM; Schechtman, E | 1 |
| Deroche, V; Koob, GF; Weiss, F; Weissenborn, R | 1 |
| Arai, N; Isaji, M; Itoh, F; Kojima, M; Miyagi, M; Taya, F; Ujiie, A | 1 |
| Cerbone, G; Cirillo, S; Colao, A; Di Sarno, A; Ferone, D; Lombardi, G; Marzullo, P; Merola, B; Sarnacchiaro, F | 1 |
| Korczyn, AD; Nisipeanu, P | 1 |
| Marsden, CD | 1 |
| Colao, A; Di Sarno, A; Di Somma, C; Facciolli, G; Klain, M; Landi, ML; Lombardi, G; Panza, N; Pivonello, R; Salvatore, M | 1 |
| Conner, P; Fried, G | 1 |
| Colao, A; De Rosa, M; Di Sarno, A; Ferone, D; Landi, ML; Lombardi, G; Merola, B; Paesano, L; Zarrilli, S | 1 |
| Crabbé, J; Delgrange, E; Donckier, J | 1 |
| Kuno, S; Mizuta, E; Yoshida, O; Yoshimura, N | 1 |
| Chervin, A; Fideleff, HL; Gurucharri, C; Holland, ME; Sinai, I | 1 |
| Ichihara, K; Kamei, H; Mizukoshi, K; Nagasaka, M; Okumura, K | 1 |
| Inada, Y; Kojima, M; Komatsu, H; Miyata, H; Moro, M; Torii, R | 1 |
| Abs, R; Beckers, A; Coremans, P; Lamberigts, G; Mahler, C; Maiter, D; Mockel, J; Petrossians, P; Raftopoulos, C; Stevenaert, A; van den Bruel, A; Vandeweghe, M; Velkeniers, B; Verhelst, J; Verlooy, J | 1 |
| Larson, BT; Rowell, PP | 1 |
| Montastruc, JL; Rascol, O; Senard, JM | 1 |
| Atkin, SL; Foy, PM; Hadden, DR; Leong, KS; MacFarlane, IA; Swift, AC | 1 |
| Colao, A; Di Sarno, A; Di Somma, C; Klain, M; Loche, S; Lombardi, G; Pietrosante, M; Pivonello, R; Salvatore, M | 1 |
| Brannan, T; Prikhojan, A; Yahr, MD | 1 |
| Tollin, SR | 1 |
| De Santis, L; Doldi, N; Ferrari, A; Papaleo, E | 1 |
| Agostini, S; Billeci, D; Conte, N; De Menis, E; Marton, E; Tramontin, P; Visentin, A | 1 |
| Clarke, CE; Deane, KD | 1 |
| de la Sota, RL; Gobello, C; Goya, RG | 1 |
| Atkinson, AB; Bell, PM; Courtney, CH; Ellis, PK; Hadden, DR; Leslie, H; McCance, DR; Sheridan, B | 1 |
| Diroma, C; Fraddosio, A; Iliceto, G; Lamberti, S; Moramarco, A; Palagano, G; Zenzola, A | 1 |
| Arikan, E; Hatemi, H; Sabuncu, T; Tasan, E | 1 |
| Cappabianca, P; Colao, A; Di Salle, F; Di Sarno, A; Di Somma, C; Faggiano, A; Landi, ML; Lombardi, G; Pivonello, R; Rossi, FW | 1 |
| Colao, A; di Sarno, A; di Somma, C; Lombardi, G; Pivonello, R | 1 |
| Liu, C; Tyrrell, JB | 1 |
| Freed, DJ; Gillam, MP; Middler, S; Molitch, ME | 1 |
| Gekht, AB | 1 |
| Mah, PM; Webster, J | 1 |
| Cavallero, D; Fazzuoli, L; Giusti, M; Valenti, S | 1 |
| Goadsby, PJ; Levy, MJ; Matharu, MS | 1 |
| Fujinami, A; Kuno, S; Matsui, H; Mizuta, I; Ohta, K; Ohta, M | 1 |
| Bankowski, BJ; Zacur, HA | 1 |
| Broglia, G; Castex, G; Corrada, Y; Gobello, C | 1 |
| Ball, SG; Hall, K; James, RA; Kendall-Taylor, P; Pearce, SH; Quinton, R; Sibal, L; Ugwu, P | 1 |
| Molitch, ME | 4 |
| Braucks, GR; Gadelha, MR; Naliato, EC; Tabet, AL; Violante, AH | 1 |
| Chang, JY; Kattah, JC; Orth, EH; Talkad, AV; Xu, MY | 1 |
| Hotta, M; Kamo, T; Kawakami, M; Nemoto, S; Oshima, J; Shimojo, S; Shiraishi, M; Sugihara, H; Takahashi, Y; Yasaki, S | 1 |
| Couldwell, WT; Liu, JK | 1 |
| Grosset, D; Grosset, K; Macphee, G; Needleman, F | 1 |
| Baran, AS; Rack, MJ; Richert, AC; Roffwarg, HP | 1 |
| Basu, S; Chaudhuri, KR; Dhawan, V; Jackson, G; Odin, P | 1 |
| Trifonov, I | 1 |
| Casulari, LA; Mello, PA; Naves, LA; Papadia, C; Pereira Neto, A | 1 |
| Brooks, PL; Vella, ET; Wynne-Edwards, KE | 1 |
| Newell-Price, J; Ross, R; Selvarajah, D; Webster, J | 1 |
| Goetz, CG; Poewe, W; Rascol, O; Sampaio, C | 1 |
| Abs, R; Verhelst, J | 1 |
| Goadsby, PJ; Levy, MJ; Matharu, MS; Meeran, K; Powell, M | 1 |
| Howell, DL; Hudgins, RJ; Mazewski, CM; Meacham, LR; Wasilewski, K | 1 |
| Biswas, M; Davies, JS; Evans, LM; Jadon, D; McEwan, P; Rees, DA; Scanlon, MF; Smith, J | 1 |
| Crosignani, PG | 1 |
| Góth, MI; Iván, G; Nagy, GM; Oláh, M; Szigeti-Csúcs, N | 1 |
| Bronstein, MD | 2 |
| Boulos, PT; Hamilton, DK; Laws, ER; Vance, ML | 1 |
| Barlier, A; Jaquet, P | 1 |
| Colao, A; De Leo, M; Di Sarno, A; Guerra, E; Lombardi, G; Mentone, A | 1 |
| Burger, E; Härtter, S; Kvernmo, T | 1 |
| Mascarell, S; Sarne, DH | 1 |
| Tokhunts, KA | 1 |
| Colao, A; Di Somma, C; Lombardi, G; Pivonello, R; Savastano, S; Tauchmanovà, L | 1 |
| Chuang, E; Molitch, ME | 1 |
| Greenman, Y | 1 |
| Horikawa, F; Kawabata, Y; Miki, N; Miyake, H; Ono, M; Ueno, Y | 1 |
| Casanueva, FF; Giustina, A; Mancini, T | 1 |
| Caldas, D; Cesar de Oliveira Naliato, E; Colao, A; Dutra Violante, AH; Fontes, R; Gomes de Souza, R; Guerra, E; Lamounier Filho, A; Rezende Loureiro, C; Schrank, Y; Sebastian, A; Vaisman, M | 1 |
| Daida, H; Hatano, T; Hattori, N; Iwama, Y; Komine-Kobayashi, M; Mizuno, Y; Mochizuki, H; Nakayama, T; Sakai, M; Urabe, T; Yamashiro, K | 1 |
| Acharya, SV; Bandgar, TR; Gopal, RA; Joshi, SR; Menon, PS; Shah, NS | 1 |
| Doi, K; Isono, T; Kawamura, T; Kitagawa, N; Kuno, S; Masaki, M; Mizuta, E; Oeda, T; Sawada, H; Taniguchi, S; Yaku, H; Yamamoto, K; Yutani, C | 1 |
| Andersohn, F; Garbe, E | 1 |
| Martin, NM; Meeran, K; Tan, T | 1 |
| Fujioka, S; Iwamoto, K; Kawamura, M; Nakajima, M; Ohno, H | 1 |
| Pullan, PT | 1 |
| Bahuleyan, B; Easwer, HV; Krishna, K; Menon, G; Nair, S; Rao, BR | 1 |
| Ajitkumar, G; Ghosh, KN; Mercy, KA; Praseeda, R; Sreekumaran, T | 1 |
| Albuquerque, JL; Azevedo, MF; Boguszewski, CL; Bronstein, MD; Casulari, LA; de Oliveira, AR; Dos Santos Faria, M; Gadelha, MR; Montenegro, RM; Musolino, NR; Naves, LA; Pinho Barbosa, FR; Ramos, AJ; Serfaty, FM; Vilar, L | 1 |
| Atis, A; Aydin, Y; Goker, N; Kaleli, S; Uludağ, S | 1 |
| Amano, K; Hori, T; Izumi, S; Kawamata, T; Makino, R; Miki, N; Okada, Y; Ono, M; Seki, T; Takano, K | 1 |
| Klibanski, A | 1 |
| Bahceci, M; Sismanoglu, A; Ulug, U | 1 |
| Babakhani, L; Fereshtehnejad, SM; Mojthahedi, K; Motazedian, S | 1 |
| Barbosa, FR; Domingues, RC; dos Santos Silva, CM; Fontes, R; Gadelha, MR; Lima, GA; Warszawski, L | 1 |
| Burger, P; Menucci, M; Quiñones-Hinojosa, A; Salvatori, R | 1 |
| Freudenmann, RW; Gahr, M; Kölle, MA | 1 |
| Boguszewski, CL; dos Santos Nunes, V; El Dib, R; Nogueira, CR | 1 |
| Adamidou, F; Anagnostis, P; Efstathiadou, Z; Karathanassi, E; Kita, M; Polyzos, SA | 1 |
| Azevedo, M; Boguszewski, CL; de Souza, AM; dos Santos, CM; Marini, LC; Sakamoto, KS | 1 |
| Bernard, N; Descotes, J; Gillet, A; Gouraud, A; Mirkou, A; Suchovsky, D; Vial, T | 1 |
| Abad, A; Aller, J; Batista, E; Doltra, A; García-Pavía, P; Halperin, I; Lucas, T; Mirelis, JG; Mora, M; Puig-Domingo, M; Santos, AE; Sitges, M; Varela, C | 1 |
| Elenkova, A; Kalinov, K; Shabani, R; Zacharieva, S | 1 |
| Berardini, A; Biagini, E; Graziosi, M; Pazzi, C; Rapezzi, C; Rosmini, S | 1 |
| Bilge, A; Kurtulmus, N; Yarman, S | 1 |
| Kumar, JB; Luthra, PM | 1 |
| Deukmedjian, AR; Hann, S; Morrison, AD; Shah, V; Vale, FL | 1 |
| Bancroft, T; Burton, T; Le Nestour, E; Neary, M | 1 |
| Ahtiainen, P; Calandra, RS; Di Giorgio, NP; Gonzalez, B; Huhtaniemi, IT; Poutanen, M; Ratner, LD; Rulli, SB | 1 |
| Alkabbani, A; Doshi, K; Hamrahian, A; Hatipoglu, B; Kennedy, L; Makin, V; Mon, SY; Olansky, L; Thorton, JN; Weil, R | 1 |
| Abaci, A; Altincik, A; Bober, E; Buyukgebiz, A; Can, S; Catli, G; Demir, K | 1 |
| Hashida, H; Hattori, N; Iijima, M; Kano, O; Kubo, S; Matsumura, M; Murakami, H; Nanri, K; Okuma, Y; Suzuki, M; Suzuki, Y; Tomimitsu, H; Utsumi, H | 1 |
| Agúndez, JA; Alonso-Navarro, H; García-Martín, E; Jiménez-Jiménez, FJ | 1 |
| Góth, M | 1 |
| Cuevas, JL; Fernández, V; González, O; Rojas, D; Torche, E; Wohllk, N | 1 |
| Hisanaga, R; Nakamura, M; Nomoto, S; Sato, T | 1 |
| Descamps, P; Jeanneteau, P; Mercier, MB; Parot-Schinkel, E; Sentilhes, L | 1 |
| Barkan, A; Benbassat, C; Bronstein, MD; Shapiro, J; Shimon, I; Tsvetov, G | 1 |
| Figueroa-Núñez, C; González, E; Gutierrez, M; Hernán Martínez, J; Mangual-García, M; Mansilla-Letelier, P; Miranda, Mde L; Palermo-Garofalo, C; Sánchez, A; Santiago, M; Torres, O; Trinidad, R | 1 |
| Bonadei, I; Curnis, A; D'Aloia, A; Metra, M; Piovanelli, B; Rovetta, R; Vizzardi, E | 1 |
| Beketić-Orešković, L; Ježek, D; Kasum, M; Orešković, S; Pekez, M; Stanić, P; Vrčić, H | 1 |
| Krysiak, R; Okopien, B | 1 |
| Aydogan, U; Cengiz, M; Ercan, CM; Ergun, A; Ide, T; Kayaalp, O; Keskin, U; Yumusak, N | 1 |
| Akbaba, G; Arduc, A; Aydin, Y; Berker, D; Gokay, F; Guler, S; Isik, S; Kucukler, FK; Ozuguz, U; Tutuncu, Y | 1 |
| Elenkova, A; Gerenova, J; Hristozov, K; Kalinov, K; Kamenov, Z; Kirilov, G; Marinov, M; Natchev, E; Orbetzova, M; Tcharaktchiev, D; Tsinlikov, I; Vandeva, S; Yaneva, M; Zacharieva, S | 1 |
| Cámara Gómez, R; Del Olmo García, M; Merino Torres, JF; Querol Ripoll, R; Simal Julián, JA | 1 |
| Couldwell, WT; Eloy, JA; Liu, JK; Wong, A | 1 |
| Krysiak, R; Okopien, B; Okrzesik, J | 1 |
| Couldwell, WT; Eloy, JA; Hajart, AF; Jethwa, PR; Liu, JK; Patel, TD | 1 |
| Lamos, EM; Levitt, DL; Munir, KM | 1 |
| Dogansen, SC; Selcukbiricik, OS; Tanrikulu, S; Yarman, S | 1 |
| Alfieri, A; Ballarino, MC; Boero, L; Chervin, A; Danilowicz, K; Diez, S; Fainstein Day, P; García-Basavilbaso, N; Glerean, M; Guitelman, M; Katz, D; Loto, MG; Mallea-Gil, MS; Manavela, M; Martinez, M; Miragaya, K; Moncet, D; Rogozinski, AS; Servidio, M; Stalldecker, G; Vitale, M | 1 |
| Bronstein, MD; Espinosa, E; Glezer, A; Greenman, Y; Mendoza, V; Mercado, M; Popovic, V; Shimon, I; Sosa, E; Tirosh, A | 1 |
| Cooper, O; Gertych, A; Greenman, Y; Jonas-Kimchi, T; Melmed, S; Ram, Z; Robenshtok, E; Sagiv, N; Shimon, I; Stern, N; Yaish, I; Yuan, X | 1 |
| Blankley, G; Galbally, M; Power, J; Snellen, M | 1 |
| Chapman, IM; De Sousa, SM; Falhammar, H; Torpy, DJ | 1 |
| Atkinson, JL; Donegan, D; Erickson, B; Erickson, D; Jentoft, M; Meyer, F; Natt, N; Nippoldt, TB | 1 |
| Andereggen, L; Andres, RH; Beck, J; Christ, E; El-Koussy, M; Frey, J; Seiler, RW | 1 |
| Hart, RJ; Mourad, S; Tang, H; Zhai, SD | 1 |
| Dhanjal, MK; Knight, M; Lambert, K; McCance, DR; Rees, K; Seed, PT; Williamson, C | 1 |
| Beckers, A; Bonneville, JF; Brue, T; Castinetti, F; Cuny, T; Dufour, H; Eroukhmanoff, J; Potorac, I; Tejedor, I; Touraine, P; Weryha, G | 1 |
| Carvalho, D; Souteiro, P; Teixeira, M | 1 |
| Araujo, B; Belo, S; Carvalho, D | 1 |
| Ji, MJ; Kim, JH; Kim, SY; Kim, YH; Lee, JH; Paek, SH; Shin, CS | 1 |
| Cha, HJ; Kim, JH; Kim, SW; Kim, YH; Lee, JH; Lee, SY; Paek, SH; Shin, CS | 1 |
| Čehić, E; Franulić, D; Grgić, F; Kasum, M; Lila, A; Orešković, S; Vujić, G | 1 |
| Bilbao, I; Egaña, N; García, C; Olaizola, I | 1 |
| Arlt, W; Ayuk, J; Fountas, A; Gittoes, N; Karavitaki, N; Santharam, S; Tampourlou, M; Toogood, A | 1 |
| Hart, RJ; Mourad, SM; Tang, H; Wang, A; Zhai, SD | 1 |
| Arastu, MI; Curiale, AM; Lipton, BA; Longo, S; Nanda, S; Tessier, S | 1 |
| Cescato, VAS; Cunha-Neto, MBC; Glezer, A; Musolino, NRC; Pinheiro, FMM; Silva, GO; Stumpf, MAM | 1 |
| Attanasio, R; Basile, M; Bozzao, A; Cappabianca, P; Caputo, M; Cozzi, R; Cruciani, F; De Menis, E; Doglietto, F; Esposito, F; Ferrante, E; Ferraù, F; Grimaldi, F; Iatì, G; Lania, AG; Laureti, S; Lello, S; Locatelli, D; Maffei, P; Mazzatenta, D; Minniti, G; Mitrova, Z; Paoletta, A; Papini, E; Peri, A; Persichetti, A; Poggi, M; Rudà, R; Ruini, C; Samperi, I; Saulle, R; Scoppola, A; Settanni, F; Silvani, A; Simona Auriemma, R; Tortora, F; Vecchi, S; Veronese, N | 1 |
57 review(s) available for bromocriptine and ergoline
| Article | Year |
|---|---|
[Considerations in the drug treatment of parkinsonism (author's transl)].
Topics: Amantadine; Apomorphine; Bromocriptine; Dopamine; Ergolines; Extrapyramidal Tracts; Female; Humans; Levodopa; Male; Monoamine Oxidase Inhibitors; Neurotransmitter Agents; Parkinson Disease; Phosphodiesterase Inhibitors; Piribedil; Tremor | 1978 |
Bromocriptine in the treatment of parkinsonism.
Topics: Apomorphine; Bromocriptine; Catecholamines; Drug Interactions; Ergolines; Humans; Kinetics; Motor Activity; Movement Disorders; Parkinson Disease; Piribedil; Receptors, Drug; Stereotyped Behavior | 1979 |
Comparative effects of a series of prolactin inhibitors, 17beta-estradiol and 2alpha-methyldihydrotestosterone propionate, on growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Acetonitriles; Androstanols; Animals; Breast Neoplasms; Bromocriptine; Drug Evaluation, Preclinical; Ergolines; Ergot Alkaloids; Estradiol; Female; Humans; Lisuride; Mammary Neoplasms, Experimental; Prolactin; Rats; Urea | 1977 |
[Drug treatment of male infertility].
Topics: Androgens; Bromocriptine; Ergolines; Estrogen Antagonists; Glucocorticoids; Gonadotropin-Releasing Hormone; Gonadotropins; Humans; Immunosuppressive Agents; Infertility, Male; Kallikreins; Male; Pentoxifylline; Prostaglandin Antagonists; Testolactone; Testosterone | 1990 |
Medical treatment of pituitary adenomas: effects on tumor growth.
Topics: Adenoma; Adrenocorticotropic Hormone; Bromocriptine; Dihydroergotoxine; Dopamine; Drug Administration Schedule; Ergolines; Growth Hormone; Levodopa; Lisuride; Metergoline; Methysergide; Pergolide; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1985 |
Psychiatric disorders in parkinsonism: 2. Organic cerebral states and drug reactions.
Topics: Amantadine; Antiparkinson Agents; Atrophy; Brain; Bromocriptine; Cognition; Dementia; Dreams; Drug Interactions; Ergolines; Humans; Levodopa; Libido; Memory; Parasympatholytics; Parkinson Disease; Receptors, Dopamine; Sexual Behavior; Substance-Related Disorders; Visual Perception | 1986 |
Update on dopamine agonists in Parkinson's disease: "beyond bromocriptine".
Topics: Antiparkinson Agents; Bromocriptine; Dopamine; Ergolines; Humans; Parkinson Disease; Piperazines | 1987 |
Medical treatment of hyperprolactinaemic disorders.
Topics: Acromegaly; Bromocriptine; Delayed-Action Preparations; Dopamine; Ergolines; Female; Humans; Hyperprolactinemia; Lisuride; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Psychoses, Substance-Induced; Tamoxifen | 1986 |
Long-term use of dopamine agonists in Parkinson's disease.
Topics: Bromocriptine; Corpus Striatum; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Movement Disorders; Parkinson Disease; Pergolide; Receptors, Dopamine; Time Factors | 1985 |
Bromocriptine in Parkinson disease.
Topics: Aged; Animals; Bromocriptine; Drug Administration Schedule; Ergolines; Humans; Levodopa; Lisuride; Middle Aged; Parkinson Disease; Pergolide; Time Factors | 1985 |
Pharmacologic therapy of patients with pituitary tumors secreting prolactin, growth hormone and adrenocorticotropin.
Topics: Adrenergic alpha-Antagonists; Adrenocorticotropic Hormone; Amenorrhea; Antineoplastic Agents; Bromocriptine; Cyproheptadine; Ergolines; Estrogens; Female; Galactorrhea; Growth Hormone; Humans; Hypothalamus; Levodopa; Pituitary Gland; Pituitary Neoplasms; Pregnancy; Prolactin | 1980 |
Clinical pharmacokinetics of ergotamine, dihydroergotamine, ergotoxine, bromocriptine, methysergide, and lergotrile.
Topics: Absorption; Animals; Bromocriptine; Dihydroergotamine; Ergolines; Ergot Alkaloids; Ergotamine; Half-Life; Humans; Kinetics; Methysergide | 1983 |
Dopamine receptors and hypertension. Physiologic and pharmacologic implications.
Topics: Animals; Benzazepines; Blood Pressure; Bromocriptine; Domperidone; Dopamine; Ergolines; Fenoldopam; Humans; Hypertension; Levodopa; Quinpirole; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Vasoconstriction; Vasodilation | 1984 |
The pharmacology of Parkinson's disease: basic aspects and recent advances.
Topics: Animals; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Brain; Bromocriptine; Carbidopa; Corpus Striatum; Dopamine; Ergolines; Humans; Kidney; Kinetics; Levodopa; Lisuride; Liver; Methyldopa; Norepinephrine; Parkinson Disease; Pergolide; Receptors, Dopamine; Selegiline; Serotonin; Stereotyped Behavior; Substantia Nigra; Tyramine | 1984 |
New drugs for hyperprolactinaemia.
Topics: Aminoquinolines; Bromocriptine; Cabergoline; Clinical Trials as Topic; Ergolines; Hormone Antagonists; Humans; Hyperprolactinemia | 1995 |
Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation.
Topics: Administration, Oral; Antineoplastic Agents; Biological Availability; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Female; Humans; Hyperprolactinemia; Lactation; Prolactin; Tissue Distribution | 1995 |
D1 and D2 dopamine receptor modulation of sodium and potassium currents in rat neostriatal neurons.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Bromocriptine; Dopamine Agents; Embryo, Mammalian; Ergolines; In Vitro Techniques; Neostriatum; Neurons; Potassium Channels; Quinpirole; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Sodium Channels | 1993 |
Cabergoline: a new drug for the treatment of hyperprolactinaemia.
Topics: Bromocriptine; Cabergoline; Clinical Trials as Topic; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Ergolines; Female; Humans; Hyperprolactinemia; Lactation; Postpartum Period; Randomized Controlled Trials as Topic | 1995 |
A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation.
Topics: Aminoquinolines; Animals; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Lactation; Male; Pregnancy | 1996 |
Newer therapies for Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Humans; Indoles; Parkinson Disease | 1996 |
Clinical experience with cabergoline in patients with advanced Parkinson's disease treated with levodopa.
Topics: Antiparkinson Agents; Bromocriptine; Cabergoline; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Randomized Controlled Trials as Topic | 1998 |
Hyperprolactinemia; etiology, diagnosis and treatment alternatives.
Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Pergolide; Prolactin; Receptors, Prolactin | 1998 |
Treatment of Parkinson's disease should begin with a dopamine agonist.
Topics: Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Humans; Indoles; Levodopa; Lisuride; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine D2; Thiazoles | 1999 |
CSF rhinorrhoea following treatment with dopamine agonists for massive invasive prolactinomas.
Topics: Adult; Bromocriptine; Cabergoline; Cerebrospinal Fluid Rhinorrhea; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Tomography, X-Ray Computed | 2000 |
Cabergoline versus bromocriptine for levodopa-induced complications in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Dyskinesia, Drug-Induced; Ergolines; Humans; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic | 2001 |
Dopamine receptor agonists for treating prolactinomas.
Topics: Aminoquinolines; Animals; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Ergolines; Ergot Alkaloids; Female; Humans; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma | 2002 |
DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.
Topics: Benzophenones; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Therapy, Combination; Enzyme Inhibitors; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Nitrophenols; Parkinson Disease; Pergolide; Randomized Controlled Trials as Topic; Tolcapone | 2002 |
[Use of dopamine agonists in the treatment of Parkinson's disease].
Topics: Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Controlled Clinical Trials as Topic; Dopamine Agonists; Ergolines; Humans; Indoles; Lisuride; Parkinson Disease; Pergolide; Piribedil; Placebos; Pramipexole; Serotonin Receptor Agonists; Thiazoles; Time Factors | 2002 |
Hyperprolactinemia: etiology, diagnosis, and management.
Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Humans; Hyperprolactinemia; Neurosurgical Procedures; Prevalence | 2002 |
Dopamine agonist therapy for hyperprolactinemia.
Topics: Aminoquinolines; Benzothiazoles; Bromocriptine; Cabergoline; Clinical Trials as Topic; Dopamine Agonists; Ergolines; Ergoloid Mesylates; Female; Humans; Hyperprolactinemia; Indoles; Pergolide; Pramipexole; Thiazoles | 2003 |
Dopamine resistance of prolactinomas.
Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance; Ergolines; Humans; Pituitary Neoplasms; Prolactinoma | 2003 |
Contemporary management of prolactinomas.
Topics: Bromocriptine; Cabergoline; Contraindications; Diagnosis, Differential; Ergolines; Female; Humans; Hypophysectomy; Magnetic Resonance Imaging; Male; Pituitary Diseases; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma; Radiosurgery; Remission Induction | 2004 |
[Prolactinoma and pregnancy].
Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma | 2004 |
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone | 2005 |
Hyperprolactinemia: pathophysiology and management.
Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Estrogens; Female; Humans; Hyperprolactinemia; Male; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma; Radiotherapy; Surgical Procedures, Operative | 2003 |
Current treatment issues in female hyperprolactinaemia.
Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms; Pregnancy; Prolactinoma | 2006 |
Treatment of pituitary tumors: dopamine agonists.
Topics: Adenoma; Bromocriptine; Cabergoline; Dopamine; Dopamine Agonists; Ergolines; Humans; Pituitary Neoplasms; Receptors, Dopamine | 2005 |
Prolactinomas and pregnancy.
Topics: Aminoquinolines; Bromocriptine; Cabergoline; Child; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma | 2005 |
Pharmacologic resistance in prolactinoma patients.
Topics: Bromocriptine; Cabergoline; Cell Proliferation; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Resistance; Ergolines; Estrogens; Female; Humans; Male; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma; Receptors, Dopamine D2 | 2005 |
Quinagolide--a valuable treatment option for hyperprolactinaemia.
Topics: Administration, Oral; Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Male; Patient Compliance | 2006 |
Drug insight: Cabergoline and bromocriptine in the treatment of hyperprolactinemia in men and women.
Topics: Adenoma; Antineoplastic Agents; Bromocriptine; Cabergoline; Ergolines; Female; Humans; Hyperprolactinemia; Male; Prolactin; Prolactinoma; Sex Characteristics | 2006 |
A review of the receptor-binding and pharmacokinetic properties of dopamine agonists.
Topics: Animals; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Interactions; Dyskinesia, Drug-Induced; Ergolines; Heart Valve Diseases; Humans; Indoles; Pergolide; Pulmonary Fibrosis; Receptors, Dopamine | 2006 |
Hyperprolactinemia and prolactinomas.
Topics: Bromocriptine; Dopamine Agonists; Ergolines; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactinoma | 2008 |
Clinical practice. Prolactinomas.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma; Visual Fields | 2010 |
Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: a systematic review of randomized controlled trials and meta-analysis.
Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Humans; Hyperprolactinemia; Randomized Controlled Trials as Topic | 2011 |
Prolactinoma in pregnancy.
Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Fetus; Humans; Hyperprolactinemia; Infertility, Female; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma | 2011 |
Plausible improvements for selective targeting of dopamine receptors in therapy of Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Apomorphine; Bromocriptine; Dopamine Agonists; Drug Delivery Systems; Ergolines; Humans; Parkinson Disease; Receptors, Dopamine | 2012 |
Anti-Parkinson's disease drugs and pharmacogenetic considerations.
Topics: Aryl Hydrocarbon Hydroxylases; Benzothiazoles; Benztropine; Bromocriptine; Cabergoline; Catechols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Ergolines; Genetic Markers; Humans; Indans; Indoles; Levodopa; Lisuride; Nitriles; Parkinson Disease; Pergolide; Pharmacogenetics; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Reproducibility of Results; Selegiline | 2013 |
[Drug therapy for acromegaly].
Topics: Acromegaly; Aminoquinolines; Antineoplastic Agents, Hormonal; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Administration Schedule; Drug Therapy, Combination; Ergolines; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Interdisciplinary Communication; Membrane Proteins; Octreotide; Patient Care Team; Peptides, Cyclic; Pituitary Neoplasms; Somatostatin | 2013 |
Dopamine agonists in prevention of ovarian hyperstimulation syndrome.
Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction | 2014 |
Update on prolactinomas. Part 2: Treatment and management strategies.
Topics: Bromocriptine; Cabergoline; Disease Management; Dopamine Agonists; Drug Administration Schedule; Drug Resistance, Neoplasm; Ergolines; Female; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neuroendoscopy; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma; Radiosurgery; Sphenoid Sinus | 2015 |
A review of dopamine agonist therapy in type 2 diabetes and effects on cardio-metabolic parameters.
Topics: Animals; Biomarkers; Blood Glucose; Bromocriptine; Cabergoline; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Dopamine Agonists; Ergolines; Humans; Hypoglycemic Agents; Risk Factors; Treatment Outcome | 2016 |
Pharmacological lactation suppression with D2 receptor agonists and risk of postpartum psychosis: A systematic review.
Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Lactation; Psychoses, Substance-Induced; Receptors, Dopamine D2; Risk Factors | 2016 |
Dopamine agonists for preventing ovarian hyperstimulation syndrome.
Topics: Abortion, Spontaneous; Administration, Oral; Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Ovarian Hyperstimulation Syndrome; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Reproductive Techniques, Assisted | 2016 |
Current Medical Strategies in the Prevention of Ovarian Hyperstimulation Syndrome
Topics: Aminoquinolines; Bromocriptine; Buserelin; Cabergoline; Chorionic Gonadotropin; Dopamine Agonists; Ergolines; Estradiol; Estrogens; Female; Fertility Agents, Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Oocyte Retrieval; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy Rate; Progesterone; Progestins; Triptorelin Pamoate | 2017 |
Dopamine agonists for preventing ovarian hyperstimulation syndrome.
Topics: Abortion, Spontaneous; Administration, Oral; Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Fertilization in Vitro; Humans; Live Birth; Ovarian Hyperstimulation Syndrome; Placebos; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Sperm Injections, Intracytoplasmic | 2021 |
How to manage intolerance to dopamine agonist in patients with prolactinoma.
Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactinoma | 2023 |
82 trial(s) available for bromocriptine and ergoline
| Article | Year |
|---|---|
Editorial: Bromocriptine.
Topics: Acromegaly; Bromocriptine; Clinical Trials as Topic; Ergolines; Female; Galactorrhea; Humans; Lactation; Parkinson Disease; Pregnancy | 1975 |
Letter: Bromocriptine in parkinsonism.
Topics: Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Humans; Parkinson Disease | 1975 |
Controlled trial of bromocriptine, quinoestrol, and placebo in suppression of puerperal lactation.
Topics: Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Female; Humans; Lactation; Milk, Human; Norpregnatrienes; Placebos; Pregnancy; Prolactin; Quinestrol; Time Factors | 1975 |
Inhibition of the plasma-aldosterone response to frusemide by bromocriptine.
Topics: Aldosterone; Bromocriptine; Dopamine; Ergolines; Furosemide; Humans; Injections, Intravenous; Mineralocorticoid Receptor Antagonists; Potassium; Renin; Sodium | 1975 |
Letter: Bromocriptine in parkinsonism.
Topics: Bromocriptine; Drug Evaluation; Ergolines; Humans; Levodopa; Parkinson Disease | 1975 |
Bromocriptine therapy in acromegaly.
Topics: 11-Hydroxycorticosteroids; Acromegaly; Administration, Oral; Adult; Aged; Blood Glucose; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Female; Follicle Stimulating Hormone; Growth Hormone; Humans; Luteinizing Hormone; Male; Middle Aged; Pituitary Function Tests; Thyrotropin; Thyrotropin-Releasing Hormone; Time Factors | 1975 |
Premenstrual tension and functional infertility. Aetiology and treatment.
Topics: Adult; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Female; Humans; Infertility, Female; Menstruation; Placebos; Premenstrual Syndrome; Prolactin | 1976 |
The effect of bromocriptine in patients with benign prostatic hypertrophy.
Topics: Aged; Bromocriptine; Clinical Trials as Topic; Ergolines; Humans; Male; Middle Aged; Placebos; Prostatic Hyperplasia; Urinary Tract; Urination; Urination Disorders | 1976 |
Bromocriptine and levodopa (with or without carbidopa) in parkinsonism.
Topics: Aged; Bromocriptine; Carbidopa; Clinical Trials as Topic; Disability Evaluation; Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation; Ergolines; Female; Follow-Up Studies; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos; Time Factors | 1976 |
Lisuride in Parkinson's disease.
Topics: Administration, Oral; Antiparkinson Agents; Bromocriptine; Clinical Trials as Topic; Drug Therapy, Combination; Ergolines; Humans; Lisuride; Parkinson Disease | 1979 |
Bromocriptine in Huntington chorea.
Topics: Adult; Bromocriptine; Dose-Response Relationship, Drug; Ergolines; Female; Humans; Huntington Disease; Male; Middle Aged | 1976 |
Treatment of Huntington's chorea with bromocriptine.
Topics: Adult; Aged; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Female; Gait; Humans; Huntington Disease; Male; Middle Aged; Placebos; Spatial Behavior; Speech | 1977 |
Studies with bromocriptine: III. Concomitant administration of caffeine to patients with idiopathic parkinsonism.
Topics: Bromocriptine; Caffeine; Clinical Trials as Topic; Drug Synergism; Drug Therapy, Combination; Ergolines; Female; Humans; Male; Middle Aged; Parkinson Disease; Phosphodiesterase Inhibitors | 1976 |
An ergot derivative in the treatment of Parkinson's disease.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Bromocriptine; Clinical Trials as Topic; Ergolines; Humans; Levodopa; Parkinson Disease | 1976 |
Stimulatory effect of the dopa-decarboxylase inhibitor Ro 4-4602 on prolactin release; inhibition by l-dopa, metergoline, methysergide and 2-Br-alpha-ergocryptine.
Topics: Administration, Oral; Adolescent; Adult; Benserazide; Bromocriptine; Clinical Trials as Topic; Drug Interactions; Ergolines; Female; Humans; Hydrazines; Levodopa; Male; Metergoline; Methysergide; Middle Aged; Pituitary Gland; Pituitary Gland, Anterior; Prolactin; Secretory Rate; Stimulation, Chemical; Time Factors | 1977 |
Bromocriptine and premenstrual syndrome: controlled study.
Topics: Adult; Bromocriptine; Clinical Trials as Topic; Ergolines; Female; Humans; Premenstrual Syndrome | 1977 |
[Treatment of parkinsonian syndromes by bromocriptin].
Topics: Aged; Amantadine; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Female; Humans; Hypotension; Levodopa; Male; Movement Disorders; Nausea; Parkinson Disease, Secondary | 1977 |
The suppression of puerperal lactation with bromocryptine.
Topics: Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Estradiol; Female; Follicle Stimulating Hormone; Humans; Lactalbumin; Lactation; Placebos; Postpartum Period; Pregnancy | 1977 |
The suppression of puerperal lactation with bromocriptine.
Topics: Bromocriptine; Clinical Trials as Topic; Ergolines; Female; Humans; Lactation; Norpregnatrienes; Postpartum Period; Pregnancy; Quinestrol | 1977 |
[The effect of several sexual steroids, 2-bromo-ergokryptin and lisurid-hydrogenmaleate an the postpartum concentration of serum prolactin and lactation (author's transl)].
Topics: Bromocriptine; Clinical Trials as Topic; Ergolines; Estrogens; Female; Humans; Lactation; Nandrolone; Placebos; Postpartum Period; Pregnancy; Prolactin; Quinestrol; Serotonin Antagonists; Testosterone | 1977 |
Effect of bromocriptine on the premenstrual syndrome. A double-blind clinical trial.
Topics: Adolescent; Adult; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Ergolines; Estradiol; Female; Humans; Middle Aged; Premenstrual Syndrome; Progesterone; Prolactin | 1977 |
Comparison of the effects of bromocriptine and levodopa in Parkinson's disease.
Topics: Aged; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Humans; Individuality; Levodopa; Male; Middle Aged; Parkinson Disease | 1977 |
Treatment of Parkinson's disease with lergotrile mesylate.
Topics: Acetonitriles; Antiparkinson Agents; Bromocriptine; Carbidopa; Carboxy-Lyases; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Parkinson Disease | 1977 |
Inhibition of prolactin release by serotonin antagonists in hyperprolactinemic subjects.
Topics: Adult; Bromocriptine; Ergolines; Female; Humans; Male; Metergoline; Methysergide; Pituitary Diseases; Prolactin | 1978 |
Study of the suppression of lactation and the influence on blood clotting with bromocriptine (CB 154) (Parlodel): a double blind comparison with diethylstilboestrol.
Topics: Blood Coagulation; Bromocriptine; Clinical Trials as Topic; Depression, Chemical; Diethylstilbestrol; Drug Evaluation; Ergolines; Female; Humans; Lactation; Postpartum Period; Pregnancy | 1976 |
Effect of CB 154 (2-bromo-alpha-ergocryptine) on paralysis agitans compared with Madopar in a double-blind, cross-over trial.
Topics: Aged; Azides; Benserazide; Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Combinations; Ergolines; Female; Humans; Hydrazines; Hyperkinesis; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Psychoses, Substance-Induced | 1976 |
Letter: Bromocriptine and spasmodic torticollis.
Topics: Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Ergolines; Humans; Male; Middle Aged; Placebos; Torticollis | 1976 |
Late suppression of lactation with bromocriptine.
Topics: Breast; Bromocriptine; Clinical Trials as Topic; Depression, Chemical; Ergolines; Female; Humans; Lactation; Placebos; Pregnancy | 1976 |
Studies with bromocriptine. Part 2. Double-blind comparison with levodopa in idiopathic parkinsonism.
Topics: Aged; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Tremor | 1976 |
A comparison of 2 bromo alpha ergocryptine, quinoestrol and placebo in suppression of puerperal lactation [proceedings].
Topics: Bromocriptine; Clinical Trials as Topic; Depression, Chemical; Drug Evaluation; Ergolines; Female; Humans; Lactation; Norpregnatrienes; Placebos; Postpartum Period; Pregnancy; Prolactin; Quinestrol | 1975 |
[Clinical experience with bromocriptine, a central dopaminergic stimulator].
Topics: Aged; Amantadine; Bromocriptine; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Dose-Response Relationship, Drug; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos; Trihexyphenidyl | 1976 |
[Treatment of acromegaly with bromocriptine (CB 154)].
Topics: Acromegaly; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Humans | 1976 |
[Drug therapy of acromegaly using bromocriptine: results after a 1-year therapy].
Topics: Acromegaly; Adult; Aged; Bromocriptine; Clinical Trials as Topic; Ergolines; Female; Humans; Male; Middle Aged; Time Factors | 1976 |
The treatment of puerperal lactation with bromocriptine.
Topics: Bromocriptine; Ergolines; Female; Humans; Lactation; Placebos; Postpartum Period; Pregnancy; Prolactin | 1976 |
The use of bromocriptine in the treatment of the unstable bladder.
Topics: Adolescent; Adult; Aged; Bromocriptine; Ergolines; Female; Humans; Male; Middle Aged; Urinary Bladder; Urination Disorders | 1976 |
Effect of bromocriptine and chlorotrianisene on inhibition of lactation and serum prolactin. A comparative double-blind study.
Topics: Bromocriptine; Chlorotrianisene; Clinical Trials as Topic; Ergolines; Female; Humans; Lactation; Pregnancy; Prolactin | 1975 |
Suppression of puerperal lactation using 2 brom-ergocryptine.
Topics: Bromocriptine; Clinical Trials as Topic; Ergolines; Female; Humans; Lactation; Pregnancy; Quinestrol; Volition | 1975 |
[Letter: Inhibition of lactation by an antiprolactin substance, CB 154].
Topics: Bromocriptine; Clinical Trials as Topic; Depression, Chemical; Ergolines; Female; Humans; Lactation; Pregnancy; Prolactin | 1975 |
Single dose cabergoline versus bromocriptine in inhibition of puerperal lactation: randomised, double blind, multicentre study. European Multicentre Study Group for Cabergoline in Lactation Inhibition.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agents; Double-Blind Method; Drug Administration Schedule; Ergolines; Female; Humans; Lactation; Pregnancy; Prospective Studies | 1991 |
Cabergoline versus bromocriptine in suppression of lactation after cesarean delivery.
Topics: Administration, Oral; Adult; Bromocriptine; Cabergoline; Cesarean Section; Ergolines; Female; Humans; Lactation; Postpartum Period; Prolactin; Single-Blind Method | 1991 |
The effects of lisuride, terguride and bromocriptine on intraocular pressure (IOP).
Topics: Adult; Bromocriptine; Double-Blind Method; Ergolines; Humans; Intraocular Pressure; Lisuride; Random Allocation | 1989 |
Pergolide and bromocriptine for the treatment of patients with hyperprolactinemia.
Topics: Adult; Blood Pressure; Bromocriptine; Dopamine Antagonists; Ergolines; Female; Follicle Stimulating Hormone; Humans; Hyperprolactinemia; Luteinizing Hormone; Pergolide; Prolactin; Prospective Studies; Random Allocation; Time Factors | 1986 |
Terguride--a new dopamine agonist drug: a comparison of its neuroendocrine and side effect profile with bromocriptine.
Topics: Adult; Blood Pressure; Bromocriptine; Double-Blind Method; Drug Evaluation; Ergolines; Follicle Stimulating Hormone; Growth Hormone; Humans; Hydrocortisone; Lisuride; Male; Prolactin; Pulse; Random Allocation; Thyrotropin | 1988 |
Prolactin-lowering effect of acute and once weekly repetitive oral administration of cabergoline at two dose levels in hyperprolactinemic patients.
Topics: Adolescent; Adult; Amenorrhea; Bromocriptine; Cabergoline; Clinical Trials as Topic; Ergolines; Female; Humans; Hyperprolactinemia; Kinetics; Male; Middle Aged; Prolactin | 1988 |
Metergoline as an inhibitor of prolactin release.
Topics: Bromocriptine; Double-Blind Method; Ergolines; Female; Humans; Lactation; Metergoline; Pregnancy; Prolactin; Random Allocation; Sucking Behavior; Time Factors | 1987 |
Dopamine agonists in the treatment of hyperprolactinemia. Comparison between bromocriptine and lisuride.
Topics: Bromocriptine; Dopamine; Ergolines; Female; Humans; Lisuride; Male; Prolactin | 1986 |
Parkinson's disease: a comparison of mesulergine and bromocriptine.
Topics: Adult; Aged; Bromocriptine; Clinical Trials as Topic; Ergolines; Female; Humans; Male; Middle Aged; Movement; Nervous System; Parkinson Disease | 1985 |
Treatment of human hyperprolactinaemia with a new dopamine agonist: CU 32085 (mesulergin).
Topics: Administration, Oral; Adolescent; Adult; Aged; Bromocriptine; Clinical Trials as Topic; Ergolines; Female; Gonads; Humans; Hyperprolactinemia; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Receptors, Dopamine; Tomography, X-Ray Computed | 1985 |
Mesulergine and bromocriptine in long-term treatment of advanced parkinsonism.
Topics: Adult; Aged; Blood Pressure; Bromocriptine; Drug Administration Schedule; Ergolines; Female; Heart Rate; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors | 1985 |
Adjuvant treatment of Parkinson's disease with dopamine agonists: open trial with bromocriptine and CU 32-085.
Topics: Aged; Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine | 1982 |
Comparison of dopamine agonists in the treatment of hyperprolactinemic syndromes: a multicenter study.
Topics: Adolescent; Adult; Aged; Amenorrhea; Bromocriptine; Clinical Trials as Topic; Dopamine; Ergolines; Female; Galactorrhea; Humans; Middle Aged; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Random Allocation | 1983 |
Lisuride treatment in Parkinson's disease: clinical and pharmacokinetic studies.
Topics: Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Parkinson Disease | 1983 |
Comparison of pergolide and bromocriptine therapy in parkinsonism.
Topics: Aged; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide | 1983 |
Metergoline as an alternative to bromocriptine in amenorrhoea.
Topics: Adult; Amenorrhea; Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Ergolines; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menstruation; Metergoline; Ovulation; Progesterone; Prolactin; Random Allocation; Time Factors | 1984 |
Pergolide in late-stage Parkinson disease.
Topics: Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Sleep Wake Disorders | 1982 |
Effects of lisuride and bromocriptine on inhibition of lactation and on serum prolactin levels: comparative double-blind study.
Topics: Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Ergolines; Female; Humans; Lactation; Lisuride; Pregnancy; Prolactin | 1981 |
[Our experience in the inhibition of lactation (Controlled clinical study with bromocriptine, methergoline and pyridoxine)].
Topics: Adult; Bromocriptine; Clinical Trials as Topic; Ergolines; Female; Humans; Lactation; Metergoline; Pregnancy; Prolactin; Pyridoxine | 1980 |
Assessment of hypokinesia in Parkinsonism.
Topics: Adult; Aged; Bromocriptine; Clinical Trials as Topic; Ergolines; Humans; Levodopa; Lisuride; Male; Middle Aged; Motor Activity; Movement; Parkinson Disease; Placebos; Posture; Time Factors | 1981 |
Lisuride versus bromocriptine treatment in Parkinson disease: a double-blind study.
Topics: Adult; Aged; Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Parkinson Disease; Random Allocation | 1982 |
Metergoline versus bromocriptine in the prevention of puerperal lactation. A double-blind clinical trial.
Topics: Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Ergolines; Female; Humans; Lactation; Metergoline; Postpartum Period; Pregnancy | 1982 |
[Hyperprolactinemic amenorrhea:treatment with cabergoline versus bromocriptine. Results of a national multicenter randomized double-blind study].
Topics: Adolescent; Adult; Amenorrhea; Bromocriptine; Cabergoline; Dopamine Agonists; Double-Blind Method; Ergolines; Female; France; Humans; Hyperprolactinemia; Middle Aged; Prolactin; Prospective Studies | 1995 |
A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group.
Topics: Adolescent; Adult; Amenorrhea; Bromocriptine; Cabergoline; Dopamine Agents; Double-Blind Method; Ergolines; Female; Humans; Hyperprolactinemia; Middle Aged; Prolactin | 1994 |
Effects of the dopamine agonist cabergoline in patients with prolactinoma intolerant or resistant to bromocriptine.
Topics: Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Ergolines; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Pregnancy; Prolactinoma | 1996 |
Double-blind comparison of cabergoline and bromocriptine in Parkinson's disease patients with motor fluctuations.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Bromocriptine; Cabergoline; Double-Blind Method; Ergolines; Female; Humans; Male; Middle Aged; Movement Disorders; Parkinson Disease | 1996 |
Cabergoline for hyperprolactinemia.
Topics: Abnormalities, Drug-Induced; Bromocriptine; Cabergoline; Costs and Cost Analysis; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Ergolines; Female; Humans; Intestinal Absorption; Prolactin | 1997 |
Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males.
Topics: Adult; Aminoquinolines; Biomarkers; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Bone Remodeling; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Humans; Hyperprolactinemia; Male; Middle Aged; Prospective Studies | 1998 |
Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: a comparison with bromocriptine.
Topics: Adult; Bromocriptine; Cabergoline; Cohort Studies; Dopamine Agonists; Ergolines; Follow-Up Studies; Hormones; Humans; Hyperprolactinemia; Libido; Male; Penile Erection; Prolactin; Semen; Time Factors | 1998 |
[Treatment of hyperprolactinemic amenorrhea with cabergoline].
Topics: Adolescent; Adult; Amenorrhea; Bromocriptine; Cabergoline; Dopamine Agonists; Double-Blind Method; Drug Tolerance; Ergolines; Female; Humans; Hyperprolactinemia; Prolactin; Treatment Outcome | 1997 |
Study of the change of prolactin and progesterone during dopaminergic agonist treatments in pseudopregnant bitches.
Topics: Animals; Bromocriptine; Cabergoline; Dog Diseases; Dogs; Dopamine Agonists; Ergolines; Female; Placebos; Progesterone; Prolactin; Pseudopregnancy | 2001 |
Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients.
Topics: Adult; Antineoplastic Agents, Hormonal; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Treatment Outcome | 2001 |
Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy.
Topics: Adenoma; Adolescent; Adult; Aged; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance; Ergolines; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Hypopituitarism; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Radioimmunoassay; Retrospective Studies | 2001 |
Circulating nitric oxide changes throughout the menstrual cycle in healthy women and women affected by pathological hyperprolactinemia on dopamine agonist therapy.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Estradiol; Female; Humans; Hyperprolactinemia; Luteal Phase; Menstrual Cycle; Nitric Oxide; Ovulation; Pituitary Neoplasms; Progesterone; Prolactinoma; Reference Values | 2002 |
Coat colour changes associated with cabergoline administration in bitches.
Topics: Animals; Bromocriptine; Cabergoline; Dog Diseases; Dogs; Dopamine Agonists; Ergolines; Estrous Cycle; Female; Hair Color; Melanocyte-Stimulating Hormones; Pedigree; Pigmentation; Pseudopregnancy | 2003 |
Medical therapy of macroprolactinomas in males: I. Prevalence of hypopituitarism at diagnosis. II. Proportion of cases exhibiting recovery of pituitary function.
Topics: Adrenocorticotropic Hormone; Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Follicle Stimulating Hormone; Humans; Hypopituitarism; Luteinizing Hormone; Male; Middle Aged; Pergolide; Pituitary Function Tests; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Testosterone; Thyrotropin | 2002 |
Usefulness of switching to cabergoline from other dopamine agonists in patients with advanced Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Cabergoline; Ergolines; Humans; Parkinson Disease; Pergolide; Prospective Studies; Treatment Outcome | 2004 |
[Comparative evaluation of effectiveness of treatment of hyperprolactinemia].
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Administration Schedule; Ergolines; Female; Humans; Hyperprolactinemia; Ovulation; Pituitary Neoplasms; Treatment Outcome | 2007 |
Quality of life in women with microprolactinoma treated with dopamine agonists.
Topics: Adult; Antineoplastic Agents; Brazil; Bromocriptine; Cabergoline; Case-Control Studies; Cross-Sectional Studies; Dopamine Agonists; Ergolines; Female; Health Status Indicators; Humans; Hyperprolactinemia; Middle Aged; Multivariate Analysis; Pituitary Neoplasms; Prolactin; Prolactinoma; Quality of Life; Reproducibility of Results; Surveys and Questionnaires; Treatment Outcome | 2008 |
Overnight switching from ergot-derived dopamine agonists to pramipexole in patients with Parkinson's disease: an open preliminary trial in Japan.
Topics: Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Ergolines; Humans; Japan; Outcome Assessment, Health Care; Parkinson Disease; Pergolide; Pramipexole; Severity of Illness Index; Time Factors; Treatment Outcome | 2009 |
Cabergoline versus bromocriptine for symptomatic treatment of premenstrual mastalgia: a randomised, open-label study.
Topics: Adult; Analysis of Variance; Breast; Bromocriptine; Cabergoline; Drug Administration Schedule; Ergolines; Female; Hormone Antagonists; Humans; Middle Aged; Pain; Pain Measurement; Premenstrual Syndrome; Prolactin; Quality of Life; Severity of Illness Index; Treatment Outcome | 2010 |
A comparison of bromocriptine & cabergoline on fertility outcome of hyperprolactinemic infertile women undergoing intrauterine insemination.
Topics: Adult; Bromocriptine; Cabergoline; Ergolines; Female; Humans; Hyperprolactinemia; Infertility, Female; Insemination, Artificial | 2010 |
Evaluation of the efficacy of pramipexole for treating levodopa-induced dyskinesia in patients with Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dyskinesia, Drug-Induced; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3 | 2013 |
Different effects of cabergoline and bromocriptine on metabolic and cardiovascular risk factors in patients with elevated prolactin levels.
Topics: Adult; Blood Glucose; Bromocriptine; Cabergoline; Cardiovascular Diseases; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Insulin Resistance; Insulin-Like Growth Factor I; Lipids; Middle Aged; Prolactin; Risk Factors | 2015 |
523 other study(ies) available for bromocriptine and ergoline
| Article | Year |
|---|---|
Prolactin, bromocriptine and dopaminergic neurotransmission.
Topics: Bromocriptine; Dopamine; Endocrine System Diseases; Ergolines; Humans; Prolactin; Prolactin Release-Inhibiting Factors; Receptors, Drug; Synaptic Transmission | 1976 |
Correlation of behavioural inhibition or excitation produced by bromocriptine with changes in brain catecholamine turnover.
Topics: Animals; Behavior, Animal; Brain; Bromocriptine; Catecholamines; Ergolines; Male; Methyltyrosines; Motor Activity; Rats; Stimulation, Chemical; Sympathetic Nervous System; Time Factors | 1976 |
Bromocriptine in treating mania.
Topics: Adrenergic Agonists; Bipolar Disorder; Bromocriptine; Ergolines; Female; Humans; Male; Prolactin; Receptors, Dopamine | 1977 |
The interactions of bromocriptine and lergotrile with dopamine and alpha-adrenergic receptors.
Topics: Acetonitriles; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Apomorphine; Binding Sites; Brain; Bromocriptine; Butaclamol; Cattle; Cerebral Cortex; Corpus Striatum; Dihydroergotoxine; Dopamine; Ergolines; Haloperidol; In Vitro Techniques; Osmolar Concentration; Rats; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Synaptosomes; Tyrosine 3-Monooxygenase | 1977 |
The roles of presynaptic function and hepatic drug metabolism in the hypothermic actions of two novel dopaminergic agonists.
Topics: Acetonitriles; Animals; Body Temperature; Bromocriptine; Dopamine; Ergolines; In Vitro Techniques; Liver; Male; Proadifen; Pyridines; Rats; Synapses; Time Factors | 1977 |
The pathophysiology of hyperprolactinemic states and the role of newer ergot compounds in their treatment.
Topics: Acetonitriles; Amenorrhea; Bromocriptine; Dopamine; Ergolines; Ergot Alkaloids; Female; Galactorrhea; Humans; Levodopa; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactin Release-Inhibiting Factors | 1978 |
Dopaminephilic properties of ergot alkaloids.
Topics: Acetonitriles; Animals; Bromocriptine; Corpus Striatum; Ergolines; Ergot Alkaloids; Haplorhini; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine; Spiperone; Substantia Nigra; Synaptosomes; Tremor; Tyrosine 3-Monooxygenase | 1978 |
Mental disturbances during bromocriptine and lergotrile treatment of Parkinson's disease.
Topics: Aged; Bromocriptine; Confusion; Depression; Ergolines; Female; Hallucinations; Humans; Male; Mental Disorders; Middle Aged; Neurocognitive Disorders; Parkinson Disease; Schizophrenia, Paranoid | 1978 |
Selective affinities of bromocriptine and lergotrile for rat limbic dopamine binding sites [proceedings].
Topics: Animals; Bromocriptine; Ergolines; Limbic System; Male; Rats; Receptors, Dopamine | 1978 |
Ergot derivatives for Parkinsonism.
Topics: Bromocriptine; Ergolines; Humans; Parkinson Disease; Pyridines | 1978 |
The effects of dopamine, bromocriptine, lergotrile and metoclopramide on prolactin release from continuously perfused columns of isolated rat pituitary cells.
Topics: Animals; Bromocriptine; Dopamine; Ergolines; Female; In Vitro Techniques; Metoclopramide; Perfusion; Pituitary Gland, Anterior; Prolactin; Rats | 1979 |
Lergotrile in Parkinson disease: further studies.
Topics: Aged; Bromocriptine; Chemical Phenomena; Chemistry; Dopa Decarboxylase; Ergolines; Humans; Levodopa; Middle Aged; Parkinson Disease | 1979 |
Central dopamine agonistic activity and microsomal biotransformation of lisuride, lergotrile and bromocriptine.
Topics: Animals; Biotransformation; Body Temperature; Brain; Bromocriptine; Dopamine; Ergolines; Homovanillic Acid; Lisuride; Male; Microsomes; Rats | 1979 |
Hypothermic action of lisuride in rats and differences to bromocriptine in the antagonistic effect of neuroleptics.
Topics: Animals; Antipsychotic Agents; Body Temperature; Bromocriptine; Cold Temperature; Depression, Chemical; Ergolines; Female; Haloperidol; Lisuride; Rats; Sulpiride; Time Factors | 1979 |
Rotational behaviour in rats with unilateral striatal kainic acid lesions: a behavioural model for studies on intact dopamine receptors.
Topics: Animals; Apomorphine; Behavior; Bromocriptine; Corpus Striatum; Denervation; Dominance, Cerebral; Efferent Pathways; Ergolines; Humans; Hydroxydopamines; Kainic Acid; Male; Pyrrolidines; Rats; Receptors, Dopamine; Stereotyped Behavior; Substantia Nigra | 1979 |
Improvement of brain tissue oxygenation during cerebrovascular insufficiency by interfering with the catecholaminergic system.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Apomorphine; Blood Volume; Brain; Bromocriptine; Cats; Cerebrovascular Disorders; Ergolines; Oxygen; Phenoxybenzamine | 1979 |
Regulation of striatal acetylcholine concentration by D2-dopamine receptors.
Topics: Acetylcholine; Animals; Bromocriptine; Corpus Striatum; Ergolines; Male; Metoclopramide; Molindone; Neurons; Rats; Receptors, Dopamine | 1979 |
Letter: Prolactin, levodopa, and migraine.
Topics: Bromocriptine; Ergolines; Humans; Levodopa; Migraine Disorders; Prolactin | 1975 |
Letter: Bromocritine and serum-growth-hormone levels in diabetes mellitus.
Topics: Adult; Bromocriptine; Diabetes Mellitus, Type 1; Ergolines; Growth Hormone; Humans; Male; Physical Exertion; Rest | 1975 |
Letter: Growth-hormone response to bromocriptine in parkinsonism.
Topics: Bromocriptine; Ergolines; Growth Hormone; Humans; Parkinson Disease | 1976 |
Letter: Bromocriptine and growth hormone.
Topics: Adult; Breast Neoplasms; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Middle Aged | 1976 |
Hyperprolactinaemia and luteal insufficiency.
Topics: Adult; Amenorrhea; Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Luteal Phase; Menstruation; Ovulation; Pregnancy; Prolactin; Syndrome; Time Factors | 1976 |
Letter: Bromocriptine in acromegaly.
Topics: Acromegaly; Bromocriptine; Ergolines; Evaluation Studies as Topic; Humans | 1976 |
Letter: Digital vasospasm with bromocriptine.
Topics: Acromegaly; Bromocriptine; Cold Temperature; Ergolines; Fingers; Humans; Vasoconstrictor Agents | 1976 |
Bromocriptine treatment of secondary amenorrhoea.
Topics: Adolescent; Adult; Amenorrhea; Bromocriptine; Drug Evaluation; Ergolines; Female; Follow-Up Studies; Galactorrhea; Humans; Menstruation; Ovulation; Pregnancy; Prolactin; Puerperal Disorders | 1976 |
Letter: Bromocriptine and hypertension.
Topics: Acromegaly; Adult; Blood Pressure; Bromocriptine; Drug Therapy, Combination; Ergolines; Humans; Hydralazine; Hypertension; Male; Propranolol | 1976 |
Letter: Bromocriptine regimen for restoration of ovulatory function.
Topics: Bromocriptine; Chiari-Frommel Syndrome; Ergolines; Female; Humans; Infertility, Female; Ovulation; Pregnancy | 1976 |
Letter: Bromocriptine and secondary amenorrhoea.
Topics: Amenorrhea; Bromocriptine; Ergolines; Female; Humans; Ovulation; Prolactin | 1976 |
Letter: Bromocriptine and secondary amenorrhoea.
Topics: Amenorrhea; Bromocriptine; Ergolines; Female; Humans; Prolactin | 1976 |
Bromocriptine in Nelson's syndrome and Cushing's disease.
Topics: Adrenalectomy; Adrenocorticotropic Hormone; Adult; Bromocriptine; Cushing Syndrome; Ergolines; Female; Humans; Male; Postoperative Complications; Prolactin; Syndrome | 1976 |
Acrocyanosis treated with bromocriptine.
Topics: Adolescent; Bromocriptine; Cyanosis; Ergolines; Female; Foot; Hand; Humans | 1976 |
Gastrointestinal bleeding in patients on bromocriptine.
Topics: Acromegaly; Adult; Aged; Bromocriptine; Ergolines; Female; Humans; Male; Middle Aged; Peptic Ulcer; Peptic Ulcer Hemorrhage | 1976 |
Gastrointestinal bleeding in patients on bromocriptine.
Topics: Acromegaly; Bromocriptine; Ergolines; Humans; Peptic Ulcer; Peptic Ulcer Hemorrhage | 1976 |
Aldosterone and prolactin.
Topics: Aldosterone; Bromocriptine; Ergolines; Humans; Nephrectomy; Potassium; Prolactin; Renal Dialysis | 1976 |
Hypotension and bromocriptine.
Topics: Acromegaly; Aged; Bromocriptine; Ergolines; Humans; Hypotension; Male | 1976 |
Bromocriptine and plasma-aldosterone.
Topics: Adult; Aldosterone; Bromocriptine; Ergolines; Female; Humans; Hyperaldosteronism; Male; Prolactin | 1976 |
Bromocriptine for male infertility.
Topics: Bromocriptine; Cell Count; Ergolines; Follicle Stimulating Hormone; Humans; Infertility, Male; Luteinizing Hormone; Male; Prolactin; Semen; Spermatozoa; Testosterone | 1977 |
Bromocriptine and gastric acid output.
Topics: Adolescent; Adult; Bromocriptine; Ergolines; Gastric Acidity Determination; Gastric Juice; Humans; Male; Stimulation, Chemical | 1977 |
Bromocriptine for induction of ovulation in normoprolactinaemic post-pill anovulation.
Topics: Adolescent; Adult; Amenorrhea; Anovulation; Bromocriptine; Contraceptives, Oral; Drug Evaluation; Ergolines; Female; Follow-Up Studies; Humans; Menstruation Disturbances; Oligomenorrhea; Prolactin | 1977 |
[Bromocriptine (CB 154) in the treatment of prostatic adenoma].
Topics: Bromocriptine; Ergolines; Humans; Male; Prostatic Hyperplasia | 1977 |
Bromocriptine, gastric acid output, and gastrin secretion.
Topics: Administration, Oral; Adult; Animals; Bromocriptine; Cats; Ergolines; Female; Gastric Juice; Gastrins; Humans; Male; Middle Aged; Pentagastrin; Placebos; Stimulation, Chemical | 1977 |
Impact of new diagnostic methods on the differential diagnosis and treatment of secondary amenorrhoea.
Topics: Amenorrhea; Bromocriptine; Contraceptives, Oral; Diagnosis, Differential; Ergolines; Female; Galactorrhea; Humans; Lactation Disorders; Pituitary Function Tests; Pituitary Neoplasms; Pneumoencephalography; Pregnancy; Prolactin; Tomography; Tomography, X-Ray Computed | 1977 |
Bromocriptine inhibits prolactin and growth-hormone release by human pituitary tumours in culture.
Topics: Adenoma; Bromocriptine; Culture Techniques; Ergolines; Growth Hormone; Humans; Pituitary Neoplasms; Prolactin | 1977 |
Cervical incompetence and premature delivery after bromocriptine therapy for infertility.
Topics: Adult; Bromocriptine; Ergolines; Female; Humans; Infertility, Female; Obstetric Labor, Premature; Pregnancy; Uterine Cervical Incompetence | 1977 |
Hyperprolactinaemia and antihypertensive effect of bromocriptine in essential hypertension. Identification of abnormal central dopamine control.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Bromocriptine; Dopamine; Ergolines; Humans; Hypertension; Male; Prolactin; Sodium | 1977 |
Fainting and bromocriptine: Danger when motoring.
Topics: Accidents, Traffic; Adult; Bromocriptine; Ergolines; Female; Humans; Infertility, Female; Syncope | 1977 |
Shock syndrome after bromocriptine.
Topics: Anaphylaxis; Bromocriptine; Ergolines; Female; Humans; Middle Aged; Syndrome | 1977 |
Cervical incompetence and premature delivery after bromocriptine therapy for infertility.
Topics: Bromocriptine; Ergolines; Female; Humans; Infertility, Female; Obstetric Labor, Premature; Pregnancy; Prolactin; Risk; Uterine Cervical Incompetence | 1977 |
Dopamine disorder in duodenal ulceration.
Topics: Animals; Anti-Ulcer Agents; Apomorphine; Bromocriptine; Chemical Phenomena; Chemistry; Cysteamine; Dopamine; Drug Synergism; Duodenal Ulcer; Ergolines; Female; Gastric Juice; Haloperidol; Pimozide; Rats; Receptors, Dopamine | 1979 |
Blockade of photically induced epilepsy by 'dopamine agonist' ergot alkaloids.
Topics: Allyl Compounds; Animals; Bromocriptine; Dopamine; Electroencephalography; Epilepsy; Ergolines; Ergonovine; Ergot Alkaloids; Haplorhini; Lysergic Acid Diethylamide; Papio; Photic Stimulation | 1978 |
Bromocriptine, dihydroergotoxine, methysergide, d-LSD, CF25--397, and 29--712: effects on the metabolism of the biogenic amines in the brain of the rat.
Topics: Animals; Biogenic Amines; Brain; Bromocriptine; Dihydroergotoxine; Dopamine; Ergolines; Lysergic Acid Diethylamide; Male; Methysergide; Nitriles; Pyridines; Rats; Receptors, Drug; Reserpine; Serotonin | 1978 |
Lisuride hydrogen maleate: evidence for a long lasting dopaminergic activity in humans.
Topics: Acromegaly; Adult; Bromocriptine; Dose-Response Relationship, Drug; Ergolines; Female; Growth Hormone; Humans; Lisuride; Male; Middle Aged; Pimozide; Placebos; Prolactin; Thyrotropin-Releasing Hormone | 1978 |
Altered growth hormone and prolactin responses to dopaminergic stimulation in Huntington's chorea.
Topics: Adult; Aged; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Huntington Disease; Kinetics; Male; Middle Aged; Prolactin | 1977 |
Metabolic studies with bromocriptine in patients with idiopathic parkinsonism and Huntington's chorea.
Topics: Bromocriptine; Ergolines; Growth Hormone; Homovanillic Acid; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Parkinson Disease; Prolactin | 1976 |
Metabolic effects of 2-bromo ergocryptine-methane-sulphonate (CB 154) in the rat.
Topics: Animals; Bromocriptine; Calcium; Creatinine; Ergolines; Male; Mesylates; Potassium; Rats; Sodium | 1975 |
Hormonally induced renal neoplasia in the male Syrian hamster and the inhibitory effect of 2-bromo-alpha-ergocryptine methanesulfonate.
Topics: Animals; Body Weight; Bromocriptine; Cell Count; Cricetinae; Diethylstilbestrol; Ergolines; Growth Hormone; Hyperplasia; Kidney Neoplasms; Kidney Tubules, Proximal; Male; Mesylates; Organ Size; Pituitary Gland; Pituitary Neoplasms; Prolactin; Testis | 1975 |
The effect of prolactin and CB154 on in vivo lipogenesis and enzyme patterns in the Japanese quail, Coturnix coturnix japonica and of photositmulation on enzyme patterns in the white-throated sparrow, Zonotrichia albicollis.
Topics: Alanine Transaminase; Animals; ATP Citrate (pro-S)-Lyase; Birds; Body Weight; Bromocriptine; Coturnix; Ergolines; Fructose-Bisphosphatase; Glucose; Glucosephosphate Dehydrogenase; Hexokinase; Lipids; Liver; Malate Dehydrogenase; Male; Mitochondria, Liver; Organ Size; Phosphogluconate Dehydrogenase; Prolactin; Proteins; Quail | 1976 |
Effects of growth hormone release-inhibiting hormone and bromocryptine (CB 154) in states of abnormal pituitary-adrenal function.
Topics: Adrenal Gland Diseases; Adrenocorticotropic Hormone; Adult; Bromocriptine; Ergolines; Female; Humans; Hydrocortisone; Male; Middle Aged; Pituitary Diseases; Somatostatin | 1976 |
Long-term treatment of acromegaly with bromocryptine: postprandial HGH levels and response to TRH and glucose administration.
Topics: Acromegaly; Adrenocorticotropic Hormone; Adult; Aged; Bromocriptine; Diet; Ergolines; Female; Follicle Stimulating Hormone; Glucose; Glucose Tolerance Test; Growth Hormone; Humans; Luteinizing Hormone; Male; Middle Aged; Thyrotropin; Thyrotropin-Releasing Hormone; Time Factors; Vasopressins | 1976 |
Effects of bromocriptine on central dopaminergic receptors.
Topics: Adenylyl Cyclases; Animals; Bromocriptine; Corpus Striatum; Cyclic AMP; Dopamine Antagonists; Enzyme Activation; Ergolines; Male; Rats; Receptors, Drug | 1976 |
Effect of bromocriptine in pituitary-dependent Cushing's syndrome.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Bromocriptine; Cushing Syndrome; Ergolines; Female; Humans; Hydrocortisone; Male; Middle Aged | 1976 |
Bromocriptine for Cushing's disease.
Topics: Adrenocorticotropic Hormone; Adult; Bromocriptine; Cushing Syndrome; Dexamethasone; Ergolines; Humans; Hydrocortisone; Male | 1977 |
Lack of effect of prolactin inhibition by alpha-bromoergocriptine (CB 154) on plasma aldosterone in anephric and non-nephrectomized patients on regular haemodialysis.
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Bromocriptine; Depression, Chemical; Ergolines; Female; Humans; Hydrocortisone; Kidney Failure, Chronic; Male; Middle Aged; Potassium; Prolactin; Renal Dialysis; Renin | 1977 |
Pre- and postsynaptic action of bromocriptine: its pharmacological effects on shcizophrenia and neurological diseases.
Topics: Animals; Bromocriptine; Cyclic AMP; Ergolines; Female; Humans; Huntington Disease; Male; Middle Aged; Motor Activity; Nervous System Diseases; Parkinson Disease; Rats; Schizophrenia; Stereotyped Behavior; Synapses | 1977 |
Considerations on the preneoplastic lesions of the mammary gland.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Breast; Breast Neoplasms; Bromocriptine; Cell Transformation, Neoplastic; Cells, Cultured; Ergolines; Female; Humans; Hyperplasia; Mammary Neoplasms, Experimental; Mammary Tumor Virus, Mouse; Mice; Neoplasm Transplantation; Precancerous Conditions; Transplantation, Heterologous; Urethane | 1977 |
Bromocriptine and lisuride stimulate the accumulation of cyclic AMP in intact slices but not in homogenates of rat neostriatum.
Topics: Animals; Bromocriptine; Corpus Striatum; Cyclic AMP; Dopamine Antagonists; Ergolines; Fluphenazine; In Vitro Techniques; Lisuride; Male; Rats | 1979 |
[Dynamics of hormonal modifications induced by bromocryptin during hyperprolactinemia].
Topics: Adolescent; Adult; Amenorrhea; Bromocriptine; Erectile Dysfunction; Ergolines; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Humans; Luteinizing Hormone; Male; Pituitary Gland; Prolactin; Secretory Rate; Testosterone; Time Factors | 1977 |
Treatment of functional amenorrhea-galactorrhea with 2-bromoergocryptine.
Topics: Adult; Amenorrhea; Bromocriptine; Ergolines; Evaluation Studies as Topic; Female; Galactorrhea; Gonadotropin-Releasing Hormone; Humans; Lactation Disorders; Pituitary Gland; Pregnancy; Prolactin | 1977 |
Hypogonadism, galactorrhoea and hyper-prolactinaemia: Evaluation of pituitary gonadotrophins reserve before and under bromocriptine.
Topics: Adolescent; Adult; Bromocriptine; Ergolines; Female; Follicle Stimulating Hormone; Galactorrhea; Humans; Hypogonadism; Lactation Disorders; Luteinizing Hormone; Male; Pituitary Hormone-Releasing Hormones; Pregnancy; Prolactin | 1977 |
Effect of prolactin inhibitory agents on the ectopic anterior pituitary and the mammary gland in rats.
Topics: Animals; Bromocriptine; DNA; Ergolines; Estradiol; Female; Histocytochemistry; Hypophysectomy; Immunoenzyme Techniques; Maleates; Mammary Glands, Animal; Organ Size; Pituitary Gland; Pituitary Gland, Anterior; Progesterone; Prolactin; Rats; Transplantation, Autologous | 1977 |
Gonadotropic responsiveness to clomiphene, LRH, estradiol, and bromocriptine in galactorrheic women.
Topics: Bromocriptine; Clomiphene; Depression, Chemical; Drug Administration Schedule; Ergolines; Estradiol; Feedback; Female; Follicle Stimulating Hormone; Galactorrhea; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Humans; Hypothalamus; Lactation Disorders; Luteinizing Hormone; Pregnancy; Progesterone; Prolactin | 1977 |
Metabolic and clinical studies on patients with acromegaly treated with bromocriptine over 22 months.
Topics: Acromegaly; Adult; Aged; Bromocriptine; Diabetes Mellitus; Ergolines; Female; Growth Hormone; Humans; Male; Middle Aged; Pimozide; Thyrotropin-Releasing Hormone | 1977 |
Clinical response to CB-154 and the pituitary response to thyrotropin-releasing hormone-gonadotropin-releasing hormone in patients with galactorrhea-amenorrhea.
Topics: Adult; Amenorrhea; Bromocriptine; Ergolines; Female; Follicle Stimulating Hormone; Galactorrhea; Humans; Lactation Disorders; Luteinizing Hormone; Pituitary Gland; Pituitary Hormone-Releasing Hormones; Pregnancy; Prolactin; Thyrotropin-Releasing Hormone | 1977 |
Prolactin response to TRH during inhibition of puerperal lactation with ergolinic drugs.
Topics: Bromocriptine; Ergolines; Female; Humans; Lactation; Metergoline; Pregnancy; Prolactin; Thyrotropin-Releasing Hormone; Time Factors | 1977 |
Long-term treatment with 2-Br-alpha-ergocryptine in acromegaly.
Topics: Acromegaly; Adult; Blood Glucose; Bromocriptine; Calcium; Drug Evaluation; Ergolines; Female; Glycosuria; Growth Hormone; Humans; Hydroxyproline; Insulin; Insulin Secretion; Male; Middle Aged; Phosphates; Phosphorus; Prolactin; Thyrotropin-Releasing Hormone; Time Factors | 1977 |
Feasibility of suppressing and reinitiating lactation in women with premature infants.
Topics: Adult; Bromocriptine; Ergolines; Female; Humans; Infant, Newborn; Lactation; Postpartum Period; Pregnancy; Prolactin; Thyrotropin-Releasing Hormone | 1977 |
Bromocriptine and TRH-induced growth hormone release in anorexia nervosa.
Topics: Adolescent; Adult; Anorexia Nervosa; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Stimulation, Chemical; Thyrotropin-Releasing Hormone | 1977 |
[Bromocryptin effect on growth hormone and prolactin secretion after administration of thyrotropin-releasing hormone in patients with primary hypothyroidism and acromegaly (author's transl)].
Topics: Acromegaly; Adult; Aged; Bromocriptine; Ergolines; Growth Hormone; Humans; Hypothyroidism; Middle Aged; Prolactin; Thyrotropin-Releasing Hormone | 1977 |
Effects of glucocorticoids on casein gene expression in the rabbit.
Topics: Animals; Bromocriptine; Caseins; DNA Replication; Ergolines; Female; Galactosyltransferases; Hydrocortisone; Kinetics; Lactose Synthase; Mammary Glands, Animal; Nucleic Acid Hybridization; Polyribosomes; Prolactin; Protein Biosynthesis; Pseudopregnancy; Rabbits; RNA, Messenger; Transcription, Genetic | 1977 |
Effect of bromoergocriptine on TRH-induced growth hormone and prolactin release in acromegalic patients.
Topics: Acromegaly; Adult; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Kinetics; Male; Middle Aged; Prolactin; Radioimmunoassay; Thyrotropin-Releasing Hormone | 1977 |
Effect of bromocryptine on the secretion of thyrotropic hormone (TSH), prolactin (Pr), human growth hormone (HGH), thyroxine (T4) and triiodothyroxine (T3) in hypothyroidism.
Topics: Adult; Aged; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Hypothyroidism; Middle Aged; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Triiodothyronine | 1977 |
The effect of 2-bromo-alpha-ergocryptine and 2-chloro-alpha-methylergoline-8beta-acetonitrile (lergotrile mesylate) on the prolactin secretion of the ewe.
Topics: Acetonitriles; Animals; Bromocriptine; Ergolines; Female; Lactation; Pituitary Gland, Anterior; Pregnancy; Prolactin; Secretory Rate; Sheep; Thyrotropin-Releasing Hormone | 1977 |
[The new lactation inhibitors].
Topics: Adult; Bromocriptine; Ergolines; Female; Humans; Lactation; Metergoline; Pregnancy | 1979 |
Interaction of sulfpride and ergot derivatives on rat brain DOPAC concentration and prolactin secretion in vivo.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Bromocriptine; Corpus Striatum; Ergolines; Male; Metergoline; Nucleus Accumbens; Phenylacetates; Prolactin; Rats; Sulpiride | 1979 |
Specific radioimmunoassay of ergot peptide alkaloids in plasma.
Topics: Bromocriptine; Cross Reactions; Dihydroergotamine; Ergolines; Ergotamine; Humans; Radioimmunoassay; Structure-Activity Relationship | 1979 |
Restoration of the prolactin response to sulpiride by metergoline administration in hyperprolactinemic patients.
Topics: Adenoma; Adult; Amenorrhea; Bromocriptine; Dopamine; Ergolines; Female; Humans; Metergoline; Pituitary Gland; Pituitary Neoplasms; Prolactin; Sulpiride | 1979 |
[Antiprolactin therapy in the treatment of benign lesions of the breast. Comparison of bromocryptine and methergoline].
Topics: Adult; Breast Diseases; Bromocriptine; Ergolines; Female; Fibrocystic Breast Disease; Humans; Metergoline; Middle Aged; Prolactin | 1979 |
The effect of L-dopa and lergotrile mesylate on the interaction of fluphenazine decanoate and amphetamine-induced stereotypy and mortality.
Topics: Acetonitriles; Amphetamine; Animals; Behavior; Bromocriptine; Dopamine Antagonists; Drug Interactions; Ergolines; Fluphenazine; Humans; Levodopa; Male; Rats; Stereotyped Behavior | 1977 |
A comparison of apomorphine, bromocriptine and Sandoz CM 29-712 (6-methyl-8a-cyanomethyl-ergoline-l) in four different turning models in the rat [proceedings].
Topics: Animals; Apomorphine; Behavior; Bromocriptine; Ergolines; Humans; Nitriles; Rats; Stereotyped Behavior | 1978 |
Neurochemical and neuropharmacological investigations with four ergot derivatives: bromocriptine, dihydroergotoxine, CF 25-397 and CM 29-712.
Topics: Animals; Behavior, Animal; Brain; Bromocriptine; Catecholamines; Chemical Phenomena; Chemistry; Dihydroergotoxine; Electroencephalography; Ergolines; Humans; Locomotion; Male; Mice; Morphine; Movement Disorders; Rabbits; Rats; Receptors, Dopamine; Reserpine; Sleep; Stereotyped Behavior | 1978 |
The effect of levodopa, lergotrile, and bromocriptine on brain iron, manganese, and copper.
Topics: Acetonitriles; Animals; Brain Chemistry; Bromocriptine; Copper; Ergolines; Guinea Pigs; Iron; Levodopa; Male; Manganese; Metals | 1978 |
Prolactin secretion inhibition by a new 8alpha-amino-ergoline, CH 29-171.
Topics: Animals; Bromocriptine; Dose-Response Relationship, Drug; Embryo Implantation; Ergolines; Female; Lactation; Methyltyrosines; Pregnancy; Prolactin; Rats; Reserpine; Secretory Rate | 1978 |
Transient bitemporal hemianopsia during pregnancy after treatment of galactorrhea-amenorrhea syndrome with bromocriptine.
Topics: Adult; Amenorrhea; Bromocriptine; Ergolines; Estradiol; Female; Follicle Stimulating Hormone; Galactorrhea; Hemianopsia; Humans; Lactation Disorders; Luteinizing Hormone; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin; Syndrome; Visual Fields | 1977 |
Sleep-related growth hormone release following 2-bromo-alpha-ergocriptine treatment in acromegalic patients.
Topics: Acromegaly; Adult; Bromocriptine; Circadian Rhythm; Electroencephalography; Ergolines; Female; Growth Hormone; Humans; Male; Middle Aged; Sleep; Wakefulness | 1977 |
Bromocryptine therapy in cases of amenorrhea-galactorrhea.
Topics: Adult; Amenorrhea; Bromocriptine; Ergolines; Female; Follicle Stimulating Hormone; Galactorrhea; Humans; Hypothyroidism; Lactation Disorders; Luteinizing Hormone; Pituitary Neoplasms; Pregnancy; Prolactin; Thyrotropin | 1977 |
[Dopaminergic blockage using pimozide and dopaminergic stimulation using bromocryptin. Effect on secretion of somatotropin].
Topics: Acromegaly; Adult; Aged; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Male; Middle Aged; Pimozide; Receptors, Dopamine; Stimulation, Chemical | 1977 |
Hormonal changes induced by bromocriptine (CB-154) at the early stage of treatment.
Topics: Adult; Amenorrhea; Bromocriptine; Ergolines; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hyperpituitarism; Luteinizing Hormone; Pituitary Hormones, Anterior; Prolactin | 1977 |
Successful use of bromocriptine in the treatment of a patient with chronic portasystemic encephalopathy.
Topics: Bromocriptine; Cerebrovascular Circulation; Chronic Disease; Ergolines; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Middle Aged; Oxygen Consumption | 1977 |
Serum prolactin levels and the value of bromocriptine in the treatment of anovulatory infertility.
Topics: Adult; Anovulation; Bromocriptine; Ergolines; Female; Humans; Infertility, Female; Prolactin | 1977 |
Central dopaminergic and noradrenergic components of bromocryptine-induced locomotor activity in mice [proceedings].
Topics: Animals; Bromocriptine; Dopamine; Ergolines; Mice; Motor Activity; Norepinephrine; Stimulation, Chemical | 1977 |
The inhibitory effect of dopamine agonists on LH release in women.
Topics: Amenorrhea; Bromocriptine; Ergolines; Female; Follicle Stimulating Hormone; Humans; Levodopa; Luteinizing Hormone; Prolactin | 1977 |
Tumor formation in preneoplastic mammary nodule lines in mice treated with nafoxidine, testosterone, and 2-bromo-alpha-ergocryptine.
Topics: Animals; Bromocriptine; Ergolines; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nafoxidine; Neoplasm Transplantation; Ovary; Precancerous Conditions; Pyrrolidines; Receptors, Androgen; Receptors, Estrogen; Testosterone; Transplantation, Isogeneic | 1977 |
Suppression of mammary tumorigenesis in C3H/He mice by ovariectomy or treatment with 2-bromo-alpha-ergocryptine: a comparison.
Topics: Adrenal Glands; Animals; Bromocriptine; Castration; Ergolines; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Precancerous Conditions; Prolactin | 1977 |
Bromocriptine treatment of acromegaly.
Topics: Acromegaly; Adult; Bromocriptine; Dose-Response Relationship, Drug; Drug Evaluation; Ergolines; Female; Glucose Tolerance Test; Growth Hormone; Humans; Male; Middle Aged; Pituitary Neoplasms | 1977 |
17beta-oestradiol and Enovid mammary tumorigenesis in C3H/HeJ female mice: counteraction by concurrent 2-bromo-alpha-ergocryptine.
Topics: Animals; Bromocriptine; Contraceptives, Oral; Contraceptives, Oral, Combined; Ergolines; Estradiol; Estrogen Antagonists; Female; Mammary Neoplasms, Experimental; Mestranol; Mice; Norethynodrel | 1977 |
Bromocriptine--fact or expensive fancy.
Topics: Bromocriptine; Costs and Cost Analysis; Endocrine System Diseases; Ergolines; Female; Humans; United Kingdom | 1977 |
Long-term treatment of acromegaly with bromocriptine.
Topics: Acromegaly; Adolescent; Adult; Aged; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Male; Middle Aged; Time Factors | 1977 |
Bromocriptine for severe mastalgia.
Topics: Adult; Breast Diseases; Bromocriptine; Ergolines; Female; Humans; Pain | 1977 |
Indirect evidences of prolactin involvement in precocious puberty induced by hypothalamic lesions in female rats.
Topics: Animals; Body Weight; Bromocriptine; Ergolines; Female; Hypothalamus; Lactation; Milk; Pregnancy; Prolactin; Rats; Secretory Rate; Sexual Maturation | 1977 |
Bromocriptine for severe mastalgia.
Topics: Breast Diseases; Bromocriptine; Ergolines; Female; Humans; Premenstrual Syndrome; Research Design | 1977 |
Interaction between bromocriptine and levodopa. Biochemical basis for an improved treatment for parkinsonism.
Topics: Animals; Brain; Bromocriptine; Carbidopa; Dopamine; Drug Interactions; Ergolines; gamma-Aminobutyric Acid; Hydroxyindoleacetic Acid; Levodopa; Male; Parkinson Disease; Rats; Serotonin | 1977 |
Bromocriptin and methylergometrine: pharmacological approach of the mechanism of their central effects.
Topics: Animals; Behavior, Animal; Body Temperature; Bromocriptine; Catalepsy; Drug Interactions; Ergolines; Ergotamines; Humans; Male; Mice; Motor Activity; Prochlorperazine; Reserpine; Social Environment; Stereotyped Behavior | 1977 |
[Bromocriptine (Parlodel). A prolactin inhibiting dopamine receptor agonist].
Topics: Amenorrhea; Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Lactation; Pregnancy | 1977 |
Effect of prolactin and bromocriptine on growth of transplanted hormone-dependent mouse mammary tumours.
Topics: Animals; Bromocriptine; Castration; Ergolines; Estrone; Female; Mammary Neoplasms, Experimental; Mice; Neoplasm Transplantation; Progesterone; Prolactin; Transplantation, Homologous | 1977 |
Growth hormone, insulin, and prolactin secretion in anorexia nervosa and obesity during bromocriptine treatment.
Topics: Adolescent; Adult; Anorexia Nervosa; Bromocriptine; Ergolines; Female; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Insulin Secretion; Obesity; Prolactin | 1977 |
Differential effects of three dopamine agonists: apomorphine, bromocriptine and lergotrile.
Topics: Acetonitriles; Animals; Apomorphine; Brain; Bromocriptine; Dopamine; Ergolines; Humans; Male; Methyltyrosines; Rats; Stereotyped Behavior | 1977 |
[Preliminary results of treatment of hormone-dependent metastatic carcinoma of the breast with the bromocriptin-medroxyprogesterone acetate combination].
Topics: Adult; Aged; Breast Neoplasms; Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Ergolines; Female; Humans; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis; Receptors, Estrogen | 1977 |
Visual abnormalities in a pregnancy following bromocriptin medication.
Topics: Adult; Amenorrhea; Bromocriptine; Cesarean Section; Ergolines; Female; Follicle Stimulating Hormone; Humans; Infertility, Female; Luteinizing Hormone; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin; Sella Turcica; Thyrotropin; Tomography, X-Ray; Vision Disorders; Visual Acuity; Visual Fields | 1977 |
Use of brom-ergocryptine in treating amenorrhea/galactorrhea.
Topics: Adult; Amenorrhea; Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Lactation Disorders; Pregnancy; Prolactin | 1977 |
Bromocriptine in encephalopathy.
Topics: Bromocriptine; Chronic Disease; Ergolines; Hepatic Encephalopathy; Humans | 1977 |
Treatment of Parkinson's disease with bromocriptine.
Topics: Bromocriptine; Ergolines; Humans; Levodopa; Parkinson Disease | 1977 |
[Amenorrhea and bromocryptine].
Topics: Amenorrhea; Bromocriptine; Ergolines; Female; Humans; Pituitary Neoplasms; Prolactin | 1977 |
Bromocriptine--a versatile remedy.
Topics: Acromegaly; Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Lactation Disorders; Parkinson Disease; Pregnancy | 1977 |
Bromocriptine: a rather specific stimulant of dopamine receptors regulating dopamine metabolism.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Brain; Bromocriptine; Dopamine; Drug Interactions; Ergolines; Mice; Motor Activity; Pimozide; Receptors, Dopamine; Stimulation, Chemical | 1977 |
A study of the effects of bromocriptine on serum prolactin, follicle stimulating hormone and luteinizing hormone and on ovarian responsiveness to exogenous gonadotrophins in anovulatory women.
Topics: Adult; Anovulation; Bromocriptine; Ergolines; Estrogens; Female; Follicle Stimulating Hormone; Gonadotropins, Pituitary; Humans; Luteinizing Hormone; Ovary; Prolactin | 1977 |
Effect of 2-bromo-alpha-ergocryptine (CB 154) on plasma prolactin, LH and testosterone levels, accessory reproductive glands and spermatogenesis in lambs during puberty.
Topics: Animals; Bromocriptine; Epididymis; Ergolines; Fructose; Luteinizing Hormone; Male; Organ Size; Prolactin; Seminal Vesicles; Sexual Maturation; Sheep; Spermatogenesis; Testis; Testosterone | 1977 |
[Drug therapy of acromegaly].
Topics: Acromegaly; Adult; Bromocriptine; Ergolines; Female; Humans; Male; Middle Aged | 1977 |
Changes in pituitary hormones serum levels in bromocryptine-treated parkinsonian patients.
Topics: Aged; Bromocriptine; Ergolines; Female; Gonadotropins, Pituitary; Growth Hormone; Humans; Male; Middle Aged; Parkinson Disease; Pituitary Hormones, Anterior; Thyrotropin | 1977 |
[Bromoergocryptine in the treatment of nonpuerperal galactorrhea].
Topics: Adult; Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Lactation Disorders; Pregnancy | 1977 |
Stimulating action of sulpiride and pimozide on prolactin release. Effect on bromocriptine, L-dopa and metergoline administration.
Topics: Adolescent; Adult; Bromocriptine; Ergolines; Female; Humans; Levodopa; Male; Metergoline; Pimozide; Prolactin; Sulpiride | 1977 |
Dopamine agonists and audiogenic seizures: the relationship between protection against seizures and changes in monoamine metabolism.
Topics: Acoustic Stimulation; Animals; Apomorphine; Biogenic Amines; Brain; Bromocriptine; Dopamine; Ergolines; Ergonovine; Female; Lysergic Acid Diethylamide; Male; Mice; Mice, Inbred DBA; Quipazine; Seizures | 1978 |
Evaluation of the central effects of ergot alkaloids by means of electroencephalography.
Topics: Animals; Behavior, Animal; Brain; Bromocriptine; Dihydroergotoxine; Electroencephalography; Ergolines; Ergot Alkaloids; Ergotamine; Mice; Rabbits; Rats; Receptors, Dopamine | 1978 |
Role of ergot derivatives in the treatment of parkinsonism.
Topics: Acetonitriles; Animals; Bromocriptine; Disease Models, Animal; Ergolines; Humans; Liver; Parkinson Disease; Pyridines; Structure-Activity Relationship | 1978 |
Comparison between lergotrile and bromocriptine in parkinsonism.
Topics: Acetonitriles; Adult; Aged; Bromocriptine; Carbidopa; Chemical Phenomena; Chemistry; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine | 1978 |
Mechanisms underlying the prolactin-lowering effect of meterogoline in the rat.
Topics: Animals; Bromocriptine; Ergolines; Female; Male; Metergoline; Pituitary Gland, Anterior; Prolactin; Quipazine; Radioimmunoassay; Rats; Reserpine; Time Factors | 1978 |
The influence of 2 br-alpha-ergocryptine (CB-154) and apomorphine on induced prolactin secretion in the crab eating monkey (Macaca fascicularis).
Topics: Animals; Apomorphine; Bromocriptine; Castration; Ergolines; Female; Humans; Macaca fascicularis; Ovary; Perphenazine; Prolactin; Radioimmunoassay; Thyrotropin-Releasing Hormone; Time Factors | 1975 |
Prolactin and thyrotropin responses to thyrotropin-releasing hormone in patients with secondary amenorrhea: the effect of bromocriptine.
Topics: Adult; Amenorrhea; Bromocriptine; Contraceptives, Oral; Ergolines; Female; Humans; Pituitary Gland; Pregnancy; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone; Time Factors | 1976 |
Neuropharmacological investigations with two ergot alkaloids, Hydergine and bromocriptine.
Topics: Activity Cycles; Animals; Behavior, Animal; Bromocriptine; Dihydroergotoxine; Ergolines; Ergoloid Mesylates; Humans; Mice; Morphine; Rats; Stereotyped Behavior | 1976 |
Inhibition of prolactin release by metergoline administration in man.
Topics: Adult; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Kinetics; Male; Metergoline; Prolactin; Time Factors | 1977 |
Treatment of parkinsonism.
Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Carbidopa; Dopamine; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine | 1977 |
Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea.
Topics: Adult; Amenorrhea; Bromocriptine; Ergolines; Estradiol; Female; Follicle Stimulating Hormone; Galactorrhea; Humans; Lactation Disorders; Luteinizing Hormone; Middle Aged; Pregnancy; Prolactin | 1976 |
Effects of 2-bromo-alpha-ergocryptine and pimozide on growth hormone secretion in man.
Topics: Adolescent; Adult; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Menstruation; Pimozide; Time Factors | 1976 |
Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.
Topics: Amphetamine; Animals; Apomorphine; Bromocriptine; Drug Interactions; Ergolines; Humans; Hydroxydopamines; Levodopa; Male; Mice; Motor Activity; Rats; Receptors, Drug; Reserpine; Stereotyped Behavior; Substantia Nigra | 1976 |
Galactorrhea-amenorrhea syndromes: etiology and treatment.
Topics: Adenoma; Amenorrhea; Bromocriptine; Chiari-Frommel Syndrome; Ergolines; Female; Galactorrhea; Humans; Lactation Disorders; Pituitary Function Tests; Pituitary Neoplasms; Pregnancy; Recurrence; Syndrome | 1976 |
Studies with bromocriptine. Part 1. "On-off" phenomena.
Topics: Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1976 |
Serum growth hormone response to bromocriptine during a glucose tolerance test in acromegaly.
Topics: Acromegaly; Adult; Blood Glucose; Bromocriptine; Ergolines; Ergot Alkaloids; Female; Glucose Tolerance Test; Growth Hormone; Humans; Male; Middle Aged | 1976 |
Editorial: The many faces of bromocriptine.
Topics: Acromegaly; Bromocriptine; Ergolines; Female; Humans; Hypogonadism; Lactation; Lactation Disorders; Male; Parkinson Disease; Pregnancy | 1976 |
Inhibition of lactation in rabbits by 2-Br-alpha-Ergokryptine-mesilate (CB154).
Topics: Animals; Animals, Newborn; Body Weight; Bromocriptine; Depression, Chemical; Dose-Response Relationship, Drug; Ergolines; Female; Intestinal Absorption; Lactation; Milk; Milk Ejection; Pregnancy; Prolactin; Rabbits; Species Specificity | 1976 |
Prolactin and testosterone: independent circulating levels in hyperprolactinemic and normoprolactinemic amenorrhea. The effect of prolactin suppression by bromocriptine.
Topics: Adult; Amenorrhea; Bromocriptine; Depression, Chemical; Ergolines; Female; Humans; Prolactin; Testosterone | 1976 |
Inhibitory effect of an ergoline derivative, methergoline, on growth hormone and prolactin levels in acromegalic patients.
Topics: Acromegaly; Adult; Aged; Bromocriptine; Cyproheptadine; Ergolines; Female; Growth Hormone; Humans; Male; Metergoline; Middle Aged; Phentolamine; Pituitary Gland; Prolactin; Serotonin Antagonists | 1976 |
Bromocriptine increases plasma estradiol-17 beta concentration in amenorrhea patients with normal serum prolactin.
Topics: Amenorrhea; Bromocriptine; Ergolines; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Prolactin | 1976 |
Proceedings: Effects of treatment with ovine prolactin and bromocriptine upon growth and exchangeable calcium in mice.
Topics: Animals; Bromocriptine; Calcium; Ergolines; Growth; Mice; Prolactin | 1976 |
Letter: Bromocriptine and breast cancer.
Topics: Breast Neoplasms; Bromocriptine; Ergolines; Female; Humans | 1976 |
Letter: Platelet and coagulation studies in patients treated with bromocriptine.
Topics: Blood Coagulation; Bromocriptine; Ergolines; Female; Fibrinolysis; Humans; Male; Parkinson Disease; Platelet Aggregation | 1976 |
Bromocriptine in the treatment of the hyperprolactinaemia-hypogonadism syndromes.
Topics: Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Hypogonadism; Male; Pituitary Neoplasms; Pregnancy; Prolactin | 1976 |
Successful treatment of acromegaly with bromocriptine.
Topics: Acromegaly; Bromocriptine; Ergolines; Female; Glucose Tolerance Test; Growth Hormone; Humans; Hydroxyproline; Male | 1976 |
Letter: Bromergocryptine and the galactorrhea-amenorrhea syndrome.
Topics: Amenorrhea; Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Lactation Disorders; Pregnancy | 1976 |
Effect of 2 br-alpha-ergocryptin (CB 154) on serum prolactin and the clinical picture in a case of progressive gigantomastia in pregnancy.
Topics: Adult; Breast Diseases; Bromocriptine; Carbamazepine; Diazepam; Epilepsy, Temporal Lobe; Ergolines; Female; Humans; Mephenytoin; Phenobarbital; Pregnancy; Pregnancy Complications; Prolactin | 1976 |
Proceedings: Growth, prolactin and growth hormone in lambs treated with CB154.
Topics: Animals; Bromocriptine; Ergolines; Growth Hormone; Prolactin; Sheep | 1976 |
Bromocriptine in migraine.
Topics: Adult; Bromocriptine; Drug Evaluation; Ergolines; Female; Humans; Menstruation; Middle Aged; Migraine Disorders; Premenstrual Syndrome | 1976 |
The effect of 2-bromo-alpha-ergocryptine (CB154) administration of the hormone levels, organ weights, prostatic morphology and zinc concentrations in the male rat.
Topics: Adenylyl Cyclases; Adrenal Glands; Animals; Bromocriptine; Culture Techniques; Ergolines; Female; Luteinizing Hormone; Male; Organ Size; Prolactin; Prostate; Rats; Testis; Testosterone; Zinc | 1976 |
Comparison of reflex effects of levodopa and bromocriptine in Parkinsonism.
Topics: Bromocriptine; Ergolines; Humans; Levodopa; Parkinson Disease; Reflex | 1976 |
[Fall of the growth hormone levels in acromegalics after bromocryptin (author's transl)].
Topics: Acromegaly; Adolescent; Adult; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Male; Middle Aged | 1976 |
Infertility due to hyperprolactinemia and its treatment with ergocryptine.
Topics: Bromocriptine; Ergolines; Female; Humans; Infertility, Female; Prolactin | 1976 |
A comparison of the effects of CB-154 and lergotrile mesylate on prolactin and growth hormone secretion in mice.
Topics: Acetonitriles; Animals; Body Weight; Bromocriptine; Dose-Response Relationship, Drug; Ergolines; Female; Growth Hormone; Mice; Mice, Inbred C57BL; Organ Size; Pituitary Gland; Prolactin | 1976 |
Restoration of fertility in prolactin induced premature menopause.
Topics: Adult; Bromocriptine; Ergolines; Female; Humans; Infertility, Female; Menopause, Premature; Prolactin | 1976 |
Treatment of parkinson's disease with bromocriptine.
Topics: Aged; Bromocriptine; Delusions; Dopa Decarboxylase; Drug Evaluation; Ergolines; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Parkinson Disease | 1976 |
Developments in the treatment of parkinsonism.
Topics: Antiparkinson Agents; Bromocriptine; Drug Synergism; Ergolines; Humans; Parkinson Disease | 1976 |
Induction of menstruation with bromocryptine in patients with euprolactinemic amenorrhea.
Topics: Adult; Amenorrhea; Bromocriptine; Ergolines; Female; Humans; Menstruation; Ovulation; Prolactin | 1976 |
The influence of the prolactin inhibitor bromocriptin (CB 154) on human luteal function in vivo.
Topics: Adult; Bromocriptine; Corpus Luteum; Ergolines; Female; Humans; Menstruation; Progesterone; Prolactin; Time Factors | 1976 |
Growth hormone and prolactin release in acromegalic patients following metergoline administration.
Topics: Acromegaly; Adult; Animals; Bromocriptine; Ergolines; Growth Hormone; Humans; Levodopa; Male; Metergoline; Middle Aged; Prolactin; Serotonin; Serotonin Antagonists | 1976 |
Effects of pituitary graft and 2-bromo-alpha-ergocryptine on mammary DNA synthesis in mice in relation to mammary tumorigenesis.
Topics: Animals; Bromocriptine; DNA; Ergolines; Estrus; Female; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Pituitary Gland; Pituitary Gland, Anterior; Pregnancy; Prolactin; Transplantation, Isogeneic | 1976 |
Interaction of estrogen and prolactin in spontaneous mammary tumorigenesis of the mouse.
Topics: Animals; Bromocriptine; Drug Synergism; Ergolines; Estradiol; Estrogens; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Ovary; Pregnancy; Progesterone Congeners; Prolactin | 1976 |
[Neuroendocrine aspects of Parkinson's disease. Therapeutic/effect of a prolactin inhibitor].
Topics: Aged; Bromocriptine; Drug Evaluation; Ergolines; Female; Humans; Middle Aged; Parkinson Disease; Prolactin | 1976 |
Treatment of fibrocystic disease of the breast with a prolactin inhibitor: 2-Br-alpha-ergocryptine (CB-154).
Topics: Adolescent; Adult; Breast Diseases; Bromocriptine; Ergolines; Female; Humans; Middle Aged; Prolactin | 1976 |
Bromocriptine:dopamine-receptor agonist.
Topics: Acromegaly; Aged; Bromocriptine; Ergolines; Female; Humans; Infertility, Female; Parkinson Disease; Pituitary Neoplasms; Receptors, Dopamine | 1976 |
Lack of effect of acute prolactin suppression on renal water sodium and potassium excretion during sleep.
Topics: Adult; Body Water; Bromocriptine; Circadian Rhythm; Ergolines; Female; Humans; Male; Potassium; Prolactin; Sleep; Sodium; Urine; Wakefulness | 1976 |
Ovarian refractoriness to gonadotropins in cases of inappropriate lactation: restoration of ovarian function with bromocryptine.
Topics: Amenorrhea; Bromocriptine; Ergolines; Female; Fertility; Galactorrhea; Gonadotropins, Pituitary; Humans; Lactation Disorders; Menotropins; Ovary; Ovulation; Pregnancy; Prolactin; Thyrotropin | 1976 |
Pregnancy following bromocryptine therapy for the amenorrhoea-galactorrhoea syndrome due to a pituitary tumour.
Topics: Adenoma, Chromophobe; Adult; Amenorrhea; Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Lactation Disorders; Pituitary Neoplasms; Pregnancy; Syndrome | 1976 |
Bromocriptine potentiation of gastric acid secretion in cats.
Topics: Animals; Bromocriptine; Cats; Ergolines; Female; Gastric Juice; Male; Pentagastrin; Vagotomy | 1976 |
Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa.
Topics: Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Evaluation; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Ergolines; Female; Follow-Up Studies; Growth Hormone; Humans; Levodopa; Male; Metoclopramide; Middle Aged; Parkinson Disease; Receptors, Dopamine | 1976 |
Effect of prolactin and the anit-prolactin bromocriptin on the testosterone uptake and metabolism in androgen-sensitive and insensitive canine organs.
Topics: Animals; Bromocriptine; Castration; Dogs; Ergolines; Kidney; Liver; Male; Muscles; Penis; Prolactin; Prostate; Testosterone; Urethra | 1976 |
[Effect of 2-bromo-alpha-ergocryptine on the response of the hypothalamo-hypophyseal-adrenal system to insulin hypoglycemia in man].
Topics: Adolescent; Adrenal Glands; Adult; Animals; Bromocriptine; Dogs; Ergolines; Female; Humans; Hydrocortisone; Hypoglycemia; Hypothalamo-Hypophyseal System; Insulin; Male; Rats; Receptors, Dopamine | 1976 |
[Endocrine effects of bromocryptin in patients with Parkinsonism].
Topics: Aged; Bromocriptine; Ergolines; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Pituitary Hormones | 1976 |
[Modifications of the incretory pituitary response of prolactin to sulpiride after treatment with bromocryptin].
Topics: Adult; Bromocriptine; Ergolines; Female; Humans; Male; Pituitary Gland; Prolactin; Sulpiride | 1976 |
Current concepts in drug therapy. (21) Bromocriptine "Parlodel" (Sandoz).
Topics: Bromocriptine; Ergolines; Female; Humans; Male | 1976 |
Bromocriptine in the treatment of advanced breast cancer.
Topics: Breast Neoplasms; Bromocriptine; Drug Evaluation; Ergolines; Female; Growth Hormone; Humans; Hypophysectomy; Prolactin | 1976 |
[Medicamentous ablactation post partum. Comparative study between bromocryptin (Parlodel) and methallenoestrol (Vallestril) as well as 2 combination variants of both preparations].
Topics: Bromocriptine; Drug Combinations; Drug Synergism; Ergolines; Estrogens, Non-Steroidal; Female; Humans; Lactation; Naphthalenes; Pregnancy; Prolactin | 1976 |
[Treatment of Parkinson's disease with bromocriptine].
Topics: Aged; Bromocriptine; Drug Evaluation; Ergolines; Female; Humans; Male; Middle Aged; Parkinson Disease | 1976 |
Bromocriptine in refractory post partum lactation.
Topics: Adult; Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Lactation Disorders; Pregnancy | 1976 |
Clinical studies with bromocriptine in idiopathic parkinsonism.
Topics: Bromocriptine; Drug Evaluation; Ergolines; Humans; Parkinson Disease | 1976 |
A study of the effect of bromocriptine on serum oestradiol, prolactin, and follicle stimulating hormone levels in puerperal women.
Topics: Bromocriptine; Ergolines; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Pituitary Gland; Postpartum Period; Pregnancy; Prolactin; Radioimmunoassay | 1975 |
[Use of bromoergocryptine in physiological inhibition of lactation].
Topics: Administration, Oral; Bromocriptine; Drug Evaluation; Ergolines; Female; Humans; Infant, Newborn; Lactation; Postpartum Period; Pregnancy; Pregnancy Complications | 1975 |
Treatment of acromegaly with bromocryptine.
Topics: Acromegaly; Adult; Aged; Blood Glucose; Bromocriptine; Ergolines; Fasting; Female; Growth Hormone; Humans; Male; Middle Aged; Time Factors | 1975 |
Effects of oestrogen and bromocryptine on in vivo secretion and mitosis in prolactin cells.
Topics: Animals; Body Weight; Bromocriptine; Depression, Chemical; Diethylstilbestrol; Ergolines; Growth Hormone; Male; Mitosis; Organ Size; Pituitary Gland; Pituitary Gland, Anterior; Prolactin; Rats; Stimulation, Chemical | 1975 |
Hypothermic action of bromocriptine.
Topics: Amphetamine; Animals; Apomorphine; Body Temperature Regulation; Brain; Bromocriptine; Cold Temperature; Colon; Dopamine Antagonists; Dose-Response Relationship, Drug; Environment, Controlled; Ergolines; Hypothermia; Male; Pimozide; Rats | 1975 |
Letter: Prolactin, bromocriptine, and haemostasis.
Topics: Animals; Blood Coagulation; Bromocriptine; Ergolines; Guinea Pigs; Mice; Prolactin; Rats | 1975 |
[Therapy of acromegaly using bromocriptine].
Topics: Acromegaly; Administration, Oral; Blood Glucose; Bromocriptine; Diabetes Complications; Diabetes Mellitus; Ergolines; Female; Growth Hormone; Humans; Male; Sweating; Time Factors | 1975 |
Dopaminergic control of growth hormone secretion in normal and acromegalic subjects.
Topics: Acromegaly; Amantadine; Bromocriptine; Ergolines; Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Levodopa; Phentolamine; Pituitary Gland; Propranolol | 1975 |
Serum prolactin levels of rats under continuous estrogen stimulation and 2 Br-alpha-ergocryptine (CB-154) injection.
Topics: Animals; Body Weight; Bromocriptine; Castration; Depression, Chemical; Ergolines; Estradiol; Female; Injections, Subcutaneous; Organ Size; Organophosphorus Compounds; Ovary; Polymers; Prolactin; Rats; Stimulation, Chemical; Tartrates; Time Factors; Vaginal Smears | 1975 |
[Two cases of amenorrhea-galactorrhea with sterility treated with CB 154 (2 bromo-alpha-ergocryptine): ovulation and pregnancy].
Topics: Adult; Amenorrhea; Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Infertility, Female; Lactation Disorders; Ovulation; Pregnancy | 1975 |
The acute effect of 2-bromo-a-ergocryptine (CB-154) on anterior pituitary hormones and free fatty acids in man.
Topics: Blood Glucose; Bromocriptine; Ergolines; Fatty Acids, Nonesterified; Female; Follicle Stimulating Hormone; Growth Hormone; Humans; Hydrocortisone; Lipid Mobilization; Luteinizing Hormone; Male; Pituitary Hormones, Anterior; Prolactin | 1975 |
The influence of prolactin and CB154 on electrolyte concentration of amniotic fluid in the rat.
Topics: Amniotic Fluid; Animals; Bromocriptine; Ergolines; Female; Potassium; Prolactin; Rats; Sheep; Sodium | 1975 |
Metaclopramide and prolactin secretion in man: effects of pretreatment with L-dopa and 2-bromo-alpha-ergocryptine (CB-154).
Topics: Adult; Bromocriptine; Ergolines; Female; Humans; Hypothalamus; Levodopa; Male; Metoclopramide; Pituitary Gland; Prolactin | 1975 |
Amenorrhea and galactorrhea: results of therapy with 2-Brom-alpha-ergocryptine (CB-154).
Topics: Adult; Amenorrhea; Breast Feeding; Bromocriptine; Ergolines; Female; Follicle Stimulating Hormone; Galactorrhea; Humans; Lactation; Lactation Disorders; Luteinizing Hormone; Pregnancy; Progesterone; Prolactin; Radioimmunoassay | 1975 |
[Successful treatment of galactorrhea, anemorrhea and infertility with a new ergot alkaloid (2-Br-alpha-ergocryptine)].
Topics: Adult; Amenorrhea; Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Infertility; Lactation; Lactation Disorders; Male; Pregnancy; Prolactin | 1975 |
Editorial: Galactorrhea-amenorrhea, brom-ergocryptine, and the dopamine receptor.
Topics: Amenorrhea; Brain; Bromocriptine; Depression, Chemical; Dopamine; Ergolines; Female; Galactorrhea; Humans; Lactation Disorders; Male; Pregnancy; Prolactin; Receptors, Drug; Syndrome | 1975 |
Effect of CB-154 (2 Br-a-ergocryptine) on serum follicle stimulating hormone, luteinzing hormone and prolactin in women with the amenorrhoea-galactorrhoea syndrome.
Topics: Adult; Amenorrhea; Bromocriptine; Depression, Chemical; Ergolines; Ergot Alkaloids; Female; Follicle Stimulating Hormone; Galactorrhea; Humans; Lactation Disorders; Luteinizing Hormone; Ovulation; Pregnancy; Prolactin; Stimulation, Chemical; Time Factors | 1975 |
Treatment of galactorrhea-amenorrhea syndrome with 2-Br-alpha-ergocryptin (CB 154). Clinical response and pattern of pituitary and steriod hormones before and during therapy.
Topics: Adult; Amenorrhea; Bromocriptine; Contraceptives, Oral; Ergolines; Estrogens; Female; Follicle Stimulating Hormone; Galactorrhea; Humans; Hypophysectomy; Lactation Disorders; Luteinizing Hormone; Pregnancy; Progesterone; Prolactin; Psychotropic Drugs; Radioimmunoassay; Syndrome | 1975 |
Bromocriptine treatment of female infertility: report of 13 pregnancies.
Topics: Adult; Bromocriptine; Ergolines; Female; Humans; Infertility, Female; Pituitary Irradiation; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin; Vision Disorders; Visual Fields | 1975 |
[Hyperprolactinemic amenorrhea and sterility treated with bromocriptine].
Topics: Adult; Amenorrhea; Bromocriptine; Ergolines; Female; Humans; Infertility, Female; Prolactin | 1975 |
Proceedings: Effects of prolactin and bromocriptine on the response to Moloney sarcoma virus in mice.
Topics: Animals; Bromocriptine; Ergolines; Mice; Mice, Inbred BALB C; Moloney murine leukemia virus; Neoplasms, Experimental; Prolactin; Rhabdomyosarcoma | 1975 |
Proceedings: Effects of bromocriptine and prolactin on thymus growth and thymus uptake of tritiated thymidine in mice of the Swiss and Bar Harbor 129 strains.
Topics: Animals; Bromocriptine; Ergolines; Mice; Mice, Inbred Strains; Muscular Dystrophy, Animal; Prolactin; Thymidine; Thymus Gland | 1975 |
Proceedings: Bromocriptine therapy of acromegaly.
Topics: Acromegaly; Bromocriptine; Ergolines; Humans | 1975 |
Pharmacological characterization of CB 154.
Topics: Animals; Binding Sites; Bromocriptine; Depression, Chemical; Ergolines; Female; Male; Prolactin; Rats | 1975 |
[A patient with primary amenorrhea].
Topics: Amenorrhea; Bromocriptine; Ergolines; Female; Gonadotropins; Humans; Prolactin | 1975 |
Effect of five dopaminergic drugs on plasma growth hormone levels in acromegalic subjects.
Topics: Acromegaly; Adult; Aged; Amantadine; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Levodopa; Male; Memantine; Middle Aged; Piperazines; Piribedil | 1975 |
Luteal 20alpha-hydroxy steroid dehydrogenase and the formation of delta4-3-oxo steroids in the rat after weaning or treatment with 2-bromo-alpha-ergocryptine during lactation.
Topics: Adrenalectomy; Animals; Bromocriptine; Corpus Luteum; Ergolines; Female; Hydroxysteroid Dehydrogenases; Ketosteroids; Lactation; Ovary; Pregnancy; Prolactin; Rats; Time Factors; Weaning | 1975 |
Editorial: Bromocriptine--a changing scene.
Topics: Acromegaly; Bromocriptine; Ergolines; Female; Humans; Lactation; Male; Pregnancy; Prolactin | 1975 |
Effects of bromocriptine on milk secretion in the rabbit.
Topics: Animals; Bromocriptine; Ergolines; Female; Lactation; Pregnancy; Prolactin; Rabbits; Time Factors | 1975 |
Successful treatment of mastodynia with the prolactin inhibitor bromocryptine (CB 154).
Topics: Adult; Breast Diseases; Bromocriptine; Ergolines; Female; Humans; Middle Aged; Pain; Premenstrual Syndrome; Prolactin | 1975 |
Inhibition by dopamine agonists of dopamine accumulation following gamma-hydroxybutyrate treatment.
Topics: Animals; Apomorphine; Brain; Bromocriptine; Codeine; Depression, Chemical; Dopamine; Ergolines; Haloperidol; Hydroxybutyrates; Male; Naphthols; Piribedil; Rats | 1975 |
["Use of bromocriptin (CB 154) in the treatment of puerperal and pathological lactation" (author's transl)].
Topics: Adult; Bromocriptine; Ergolines; Female; Humans; Lactation Disorders; Pregnancy; Prolactin | 1976 |
Letter: CB-154.
Topics: Adenoma; Adult; Bromocriptine; Ergolines; Female; Humans; Infertility, Female; Pituitary Neoplasms | 1976 |
Proceedings: Renal interactions of prolactin and bromocriptine.
Topics: Animals; Bromocriptine; Ergolines; Kidney; Male; Prolactin; Rats | 1976 |
[The "problem" of stopping loctation prevention and suppression with CB 154 (author's transl)].
Topics: Adult; Bromocriptine; Ergolines; Female; Humans; Lactation; Nausea; Parity; Pregnancy; Vomiting; Weaning | 1976 |
Effect of bromocriptine on plasma growth hormone and glucose tolerance in chronic renal failure.
Topics: Blood Glucose; Bromocriptine; Ergolines; Glucose; Growth Hormone; Humans; Kidney Failure, Chronic | 1976 |
[Letter: Efficacy of bromocriptine in 2 cases of levodopa-resistant parkinsonism].
Topics: Aged; Bromocriptine; Drug Evaluation; Ergolines; Female; Humans; Male; Middle Aged; Parkinson Disease | 1976 |
Letter: Treatment of mania with bromocriptine.
Topics: Bipolar Disorder; Bromocriptine; Ergolines; Humans; Prolactin | 1976 |
Further observations on postpartum ovarian refractoriness: effect of gonadal stimulation in women receiving bromocryptine.
Topics: Bromocriptine; Ergolines; Estradiol; Estrogens; Female; Humans; Menotropins; Ovary; Postpartum Period; Pregnancy; Prolactin | 1976 |
Failure to demonstrate transfer of milk prolactin into blood of milk-fed rats and calves.
Topics: Absorption; Animals; Animals, Newborn; Bromocriptine; Cattle; Colostrum; Ergolines; Female; Lactation; Male; Milk; Pregnancy; Prolactin; Rats; Species Specificity | 1976 |
Coagulation studies in patients treated with bromocriptine.
Topics: Blood Coagulation; Blood Coagulation Tests; Bromocriptine; Ergolines; Female; Humans; Male | 1976 |
Prophylaxis of early preneoplastic lesions of the mammary gland.
Topics: Animals; Bromocriptine; Ergolines; Female; Hyperplasia; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Metergoline; Mice; Mice, Inbred C3H; Parity; Precancerous Conditions; Prolactin | 1976 |
Bromocriptine - an important advance.
Topics: Acromegaly; Bromocriptine; Depression, Chemical; Ergolines; Female; Humans; Lactation; Parkinson Disease; Pregnancy; Prolactin | 1976 |
Dopamine receptor subtypes colocalize in rat striatonigral neurons.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antisense Elements (Genetics); Base Sequence; Blotting, Southern; Bromocriptine; DNA; Ergolines; Evoked Potentials; Microscopy, Fluorescence; Molecular Sequence Data; Neostriatum; Neurons; Oligodeoxyribonucleotides; Quinpirole; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; RNA Probes; RNA, Messenger; Sodium Channels; Substantia Nigra | 1992 |
Dopamine stimulates growth hormone release from the pituitary of goldfish, Carassius auratus, through the dopamine D1 receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Bromocriptine; Domperidone; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Ergolines; Goldfish; Gonadotropin-Releasing Hormone; Growth Hormone; Pituitary Gland; Quinpirole; Radioimmunoassay; Receptors, Dopamine | 1992 |
Pleuropulmonary changes during treatment of Parkinson's disease with a long-acting ergot derivative, cabergoline.
Topics: Bromocriptine; Cabergoline; Dopamine Agents; Ergolines; Humans; Lung Diseases; Male; Middle Aged; Parkinson Disease; Pleural Effusion | 1992 |
Antidepressant-like effects of dopamine agonists in an animal model of depression.
Topics: Animals; Arousal; Brain; Bromocriptine; Depressive Disorder; Disease Models, Animal; Dopamine Agents; Dose-Response Relationship, Drug; Drinking; Ergolines; Helplessness, Learned; Male; Motivation; Quinpirole; Rats; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Taste | 1992 |
Opposite influences of dopaminergic receptor subtypes on penile erection.
Topics: Animals; Apomorphine; Bromocriptine; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Ergolines; Male; Parasympatholytics; Parasympathomimetics; Penile Erection; Quinpirole; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1992 |
Effect of mesulergine on prolactin secretion and dopamine D2 receptors-adaptive changes in diethylstilbestrol-induced hyperplasia of the rat anterior pituitary.
Topics: Animals; Antiparkinson Agents; Bromocriptine; Diethylstilbestrol; Dose-Response Relationship, Drug; Ergolines; Female; Hyperplasia; Hyperprolactinemia; Pergolide; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Wistar; Receptors, Dopamine D2; Spiperone; Time Factors; Tritium | 1992 |
The effect of mesulergine on prolactin secretion and anterior pituitary cells morphology in diethylstilboestrol-treated female Wistar rats.
Topics: Animals; Antiparkinson Agents; Bromocriptine; Cell Division; Diethylstilbestrol; Drug Interactions; Ergolines; Female; Hyperprolactinemia; Immunohistochemistry; Pergolide; Pituitary Gland, Anterior; Prolactin; Rats | 1992 |
Cabergoline in the long-term therapy of hyperprolactinemic disorders.
Topics: Adolescent; Adult; Aged; Bromocriptine; Cabergoline; Drug Resistance; Ergolines; Female; Humans; Hyperprolactinemia; Male; Menstruation Disturbances; Middle Aged; Ovulation; Pituitary Neoplasms; Prolactinoma | 1992 |
Differential effects of dopamine agonists upon stimulated limbic and striatal dopamine release: in vivo voltammetric data.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Bromocriptine; Corpus Striatum; Dopamine; Dopamine Agents; Electrochemistry; Electrophysiology; Ergolines; In Vitro Techniques; Limbic System; Male; Microelectrodes; Nucleus Accumbens; Pergolide; Piperidines; Quinpirole; Rats; Rats, Inbred Strains; Stereotaxic Techniques | 1991 |
Dopamine receptors mediating inhibition of the cyclic adenosine monophosphate generating system in the rat renal cortex.
Topics: Animals; Benzazepines; Bromocriptine; Cyclic AMP; Dopamine; Dopamine Agents; Ergolines; In Vitro Techniques; Kidney Cortex; Male; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1991 |
Absence of postsynaptic DA2 dopamine receptors in the dog renal vasculature.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Bromocriptine; Dogs; Dopamine; Dopamine Agents; Ergolines; Fenoldopam; Histamine Antagonists; Male; Quinpirole; Receptors, Dopamine; Renal Circulation; Sympatholytics; Synapses; Vasodilation | 1991 |
Pharmacological characterization of dopamine receptors in parasympathetic innervation of rat heart.
Topics: Acetylcholine; Animals; Apomorphine; Bradycardia; Bromocriptine; Decerebrate State; Dopamine Agents; Electric Stimulation; Ergolines; Heart; Heart Rate; Male; Pergolide; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Vagus Nerve | 1991 |
Role of genotype and dopamine receptors in behaviour of inbred mice in a forced swimming test.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analysis of Variance; Animals; Behavior, Animal; Benzazepines; Bromocriptine; Depression; Dopamine Agents; Ergolines; Genotype; Mice; Mice, Inbred Strains; Quinpirole; Receptors, Dopamine; Sulpiride; Swimming | 1991 |
Evaluation of dopamine receptor involvement in rat feeding behaviour.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Appetite Depressants; Bromocriptine; Dopamine Agents; Dose-Response Relationship, Drug; Ergolines; Feeding Behavior; Male; Quinpirole; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Reserpine; Serotonin Antagonists | 1991 |
Different effects of direct and indirect dopamine receptor agonists on immobility time in reserpine-treated mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Bromocriptine; Bupropion; Dopamine Agents; Dopamine Antagonists; Ergolines; Injections, Subcutaneous; Male; Mice; Motor Activity; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Reserpine; Sulpiride; Swimming | 1991 |
Differential effects of dopamine agonists on locomotion in intact and reserpine-treated mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; Animals; Apomorphine; Benzazepines; Bromocriptine; Dopamine Agents; Dose-Response Relationship, Drug; Ergolines; Male; Methyltyrosines; Mice; Motor Activity; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Reserpine; Sulpiride; Tyrosine 3-Monooxygenase | 1991 |
Effect of AT II on the exploratory behaviour of rats. Interactions with elymoclavine and bromocryptine.
Topics: Angiotensin II; Animals; Behavior, Animal; Bromocriptine; Ergolines; Exploratory Behavior; Male; Motor Activity; Rats; Rats, Inbred Strains | 1991 |
Differential ability of selective and non-selective dopamine agonists to induce climbing in the rat indicates the involvement of both D-1 and D-2 receptors in this behaviour.
Topics: Amphetamine; Animals; Apomorphine; Benzazepines; Bromocriptine; Clonidine; Dopamine Agents; Ergolines; Female; Levodopa; Motor Activity; Pergolide; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Sulpiride | 1990 |
Age-related changes of dopamine sensitive cyclic AMP generation in the rat frontal cortex.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aging; Animals; Apomorphine; Benzazepines; Bromocriptine; Cyclic AMP; Dopamine; Dopamine Agents; Dopamine Antagonists; Ergolines; Fenoldopam; Frontal Lobe; Male; Quinpirole; Rats; Rats, Inbred Strains | 1990 |
Alpha-2 adrenergic activity of bromocriptine and quinpirole in chicken pineal gland. Effects on melatonin synthesis and [3H]rauwolscine binding.
Topics: Animals; Arylamine N-Acetyltransferase; Binding Sites; Bromocriptine; Chickens; Clonidine; Dopamine Agents; Ergolines; Male; Melatonin; Membranes; Pineal Gland; Quinpirole; Receptors, Adrenergic, alpha; Retina; Tritium; Yohimbine | 1990 |
In vivo interaction of cabergoline with rat brain dopamine receptors labelled with [3H]N-n-propylnorapomorphine.
Topics: Administration, Oral; Animals; Apomorphine; Brain Chemistry; Bromocriptine; Cabergoline; Dopamine Agents; Dose-Response Relationship, Drug; Ergolines; Female; In Vitro Techniques; Injections, Intravenous; Kinetics; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1990 |
New perspectives in medical management of hyperprolactinemia.
Topics: Adenoma; Bromocriptine; Cabergoline; Delayed-Action Preparations; Empty Sella Syndrome; Ergolines; Female; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms | 1990 |
[Hyperprolactinemia syndrome in men].
Topics: Adult; Bromocriptine; Ergolines; Humans; Hyperprolactinemia; Infertility, Male; Lisuride; Male; Middle Aged; Oligospermia; Prolactin; Syndrome | 1990 |
Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
Topics: Adenylyl Cyclases; Animals; Benzazepines; Bromocriptine; Butaclamol; Corpus Striatum; Dopamine; Enzyme Activation; Ergolines; Guanine Nucleotides; Norepinephrine; Potassium; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sodium; Spiperone; Sulpiride | 1985 |
Duodenal ulcer induced by MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine).
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amylases; Animals; Bicarbonates; Bromocriptine; Dose-Response Relationship, Drug; Duodenal Ulcer; Duodenum; Ergolines; Female; Gastric Acid; Gastric Emptying; Gastrointestinal Motility; Monoamine Oxidase Inhibitors; Pancreas; Pyridines; Rats; Rats, Inbred Strains; Trypsin | 1985 |
D-2 dopaminergic agonists and adenosine 3',5'-monophosphate directly regulate the synthesis of alpha-melanocyte-stimulating hormone-like peptides by cultured rat melanotrophs.
Topics: 1-Methyl-3-isobutylxanthine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 8-Bromo Cyclic Adenosine Monophosphate; Animals; Benzamides; Benzazepines; Bromocriptine; Cells, Cultured; Chemical Precipitation; Cholera Toxin; Chromatography, High Pressure Liquid; Colforsin; Cyclic AMP; Dopamine; Ergolines; Immunologic Techniques; Melanocyte-Stimulating Hormones; Pituitary Gland; Pro-Opiomelanocortin; Quinpirole; Rats; Receptors, Dopamine; Spiperone | 1986 |
Hypothalamic D2 receptors mediate the preferential release of somatostatin-28 in response to dopaminergic stimulation.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Bromocriptine; Butaclamol; Domperidone; Dopamine; Ergolines; Hypothalamus; Male; Metoclopramide; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Somatostatin; Somatostatin-28 | 1986 |
Effectiveness and tolerability of long term treatment with cabergoline, a new long-lasting ergoline derivative, in hyperprolactinemic patients.
Topics: Adenoma; Adult; Amenorrhea; Bromocriptine; Cabergoline; Dopamine Agents; Ergolines; Female; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactin | 1989 |
[Effectiveness of lysenyl-forte treatment in acromegaly and hyperprolactinemia syndrome].
Topics: Acromegaly; Adolescent; Adult; Aged; Aged, 80 and over; Bromocriptine; Drug Evaluation; Ergolines; Female; Humans; Hyperprolactinemia; Lisuride; Male; Middle Aged; Syndrome | 1989 |
Effect of pentobarbitone sodium and bromocriptine on follicular oestradiol production in the rat.
Topics: Animals; Bromocriptine; Chorionic Gonadotropin; Diestrus; Ergolines; Estradiol; Female; Luteinizing Hormone; Ovarian Follicle; Pentobarbital; Proestrus; Prolactin; Rats; Rats, Inbred Strains | 1989 |
Dopamine D2 agonist-induced behavioural depression is reversed by dopamine D1 agonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Bromocriptine; Dose-Response Relationship, Drug; Ergolines; Indoles; Male; Mice; Motor Activity; Phenanthridines; Quinpirole; Receptors, Dopamine | 1989 |
Differential action of bromocriptine on nigrostriatal versus mesolimbic dopaminergic neurons.
Topics: 4-Butyrolactone; Animals; Apomorphine; Bromocriptine; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Ergolines; Limbic System; Male; Nucleus Accumbens; Olfactory Bulb; Prolactin; Rats; Time Factors | 1987 |
Climbing and stereotyped behaviours in mice require the stimulation of D-1 dopamine receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Apomorphine; Appetite Depressants; Behavior, Animal; Benzazepines; Bromocriptine; Ergolines; Male; Mice; Mice, Inbred Strains; Piribedil; Quinpirole; Receptors, Dopamine; Stereotyped Behavior | 1988 |
D2 dopamine receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in rat striatum.
Topics: Adenylyl Cyclases; Animals; Benzazepines; Bromocriptine; Butyrophenones; Colforsin; Corpus Striatum; Ergolines; In Vitro Techniques; Male; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Spiperone | 1985 |
Excitation by dopamine D-2 receptor agonists, bromocriptine and LY 171555, in caudate nucleus neurons activated by nigral stimulation.
Topics: Animals; Benzazepines; Bromocriptine; Cats; Caudate Nucleus; Domperidone; Electric Stimulation; Ergolines; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D2; Substantia Nigra | 1986 |
Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release.
Topics: Acetylcholine; alpha-Methyltyrosine; Animals; Apomorphine; Bromocriptine; Cocaine; Corpus Striatum; Dopamine; Electric Stimulation; Ergolines; Haloperidol; In Vitro Techniques; Methyltyrosines; Neurotransmitter Uptake Inhibitors; Nomifensine; Quinpirole; Rabbits; Receptors, Dopamine; Reserpine | 1986 |
Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Bromocriptine; Ergolines; Male; Motor Activity; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Rotation | 1986 |
Striatal cholinergic function reflects differences in D-2 dopaminergic receptor activation.
Topics: Acetylcholine; Animals; Bromocriptine; Corpus Striatum; Ergolines; Female; Lisuride; Pimozide; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Sulpiride | 1987 |
Dopaminergic agents selectively alter the post-translational processing of beta-endorphin in the intermediate pituitary of the rat.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; beta-Endorphin; Bromocriptine; Domperidone; Dopamine Antagonists; Ergolines; Haloperidol; Male; Pituitary Gland; Protein Processing, Post-Translational; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1987 |
The dopamine D2 receptor agonists, quinpirole and bromocriptine produce conditioned place preferences.
Topics: Animals; Bromocriptine; Conditioning, Psychological; Dose-Response Relationship, Drug; Ergolines; Male; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Reference Values | 1988 |
Dopaminergic modulation of hippocampal noradrenaline release. Evidence for alpha 2-antagonistic effects of some dopamine receptor agonists and antagonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Bromocriptine; Cocaine; Dopamine; Electric Stimulation; Ergolines; Hippocampus; In Vitro Techniques; Norepinephrine; Quinpirole; Rabbits; Receptors, Adrenergic, alpha; Receptors, Dopamine; Serotonin; Yohimbine | 1985 |
The medical treatment of the hypersecreting pituitary gland.
Topics: Adenoma; Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Bromocriptine; Cyproheptadine; Ergolines; Female; Humans; Male; Middle Aged; Pergolide; Pituitary Gland; Pituitary Neoplasms; Prolactin; Valproic Acid | 1985 |
Variability and selectivity of anterior pituitary response to dopamine agonists throughout the normal menstrual cycle.
Topics: Bromocriptine; Dopamine; Dopamine Antagonists; Ergolines; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menstrual Cycle; Pergolide; Pituitary Gland, Anterior; Pituitary Hormone-Releasing Hormones; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone | 1986 |
Dopaminergic inhibition of tyrosinase activity in hair follicular melanocytes of the mouse.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aging; Animals; Benzazepines; Bromocriptine; Catechol Oxidase; Depression, Chemical; Dopamine; Ergolines; Female; Hair; Haloperidol; Male; Melanocytes; Mice; Mice, Inbred C3H; Monophenol Monooxygenase; Quinpirole; Skin; Spiperone; Sulpiride | 1986 |
Dopamine agonists as primary treatment in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Disability Evaluation; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Lisuride; Long-Term Care; Parkinson Disease; Pergolide; Receptors, Dopamine | 1987 |
Puerperal lactation, gonadotropin release and estradiol release: effects of metergoline and bromocriptine.
Topics: Adult; Bromocriptine; Ergolines; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Lactation; Luteinizing Hormone; Metergoline; Ovulation; Postpartum Period; Pregnancy; Prolactin | 1987 |
Effects of 8-OH-DPAT, lisuride and some ergot-related compounds on the acoustic startle response in the rat.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Bromocriptine; Ergolines; Lisuride; Male; Metergoline; Methiothepin; Naphthalenes; Pergolide; Quinpirole; Rats; Rats, Inbred Strains; Reflex, Startle; Tetrahydronaphthalenes | 1985 |
Pleuropulmonary disease during bromocriptine treatment of Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Ergolines; Humans; Lung Diseases; Male; Middle Aged; Parkinson Disease; Pleural Diseases; Radiography | 1988 |
Prolactin stimulation tests: different response patterns after bromocriptine, lisuride, and metergoline treatment of puerperal women.
Topics: Adult; Bromocriptine; Ergolines; Female; Humans; Lisuride; Metergoline; Metoclopramide; Postpartum Period; Pregnancy; Prolactin | 1988 |
Inhibitory effect of cabergoline on the development of estrogen-induced prolactin-secreting adenomas of the pituitary.
Topics: Adenoma; Animals; Antineoplastic Agents; Body Weight; Bromocriptine; Cabergoline; DNA, Neoplasm; Ergolines; Estrogens; Female; Mitosis; Pituitary Neoplasms; Prolactin; Rats | 1988 |
Depletion of catecholamines reveals inhibitory effects of bromocryptine and lysuride on neostriatal neurones recorded intracellularly in vitro.
Topics: Animals; Bromocriptine; Catecholamines; Corpus Striatum; Electrodes; Ergolines; In Vitro Techniques; Lisuride; Male; Membrane Potentials; Neurons; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reserpine; Substantia Nigra | 1988 |
On the mode of action of six putative dopamine receptor agonists on suppression of exploratory behaviour in rats.
Topics: Animals; Bromocriptine; Ergolines; Exploratory Behavior; Habituation, Psychophysiologic; Male; Motor Activity; Piperidines; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1987 |
Synthesis and dopaminergic activity of trans-6-methyl-7a,8,9,10,11,11a-hexahydro-7H-pyrrolo[3,2,1-gh]- 4,7-phenanthroline and trans-1,2,3,4,4a,5,6,10b-octahydro-4,7-phenanthroline derivatives.
Topics: Animals; Bromocriptine; Ergolines; Male; Phenanthrolines; Prolactin; Pyrroles; Rats; Receptors, Dopamine; Structure-Activity Relationship | 1986 |
Effect of clonidine, quipazine, and LY 53857 on the prolactin-suppressant action of bromocriptine in rats.
Topics: Animals; Bromocriptine; Clonidine; Drug Interactions; Ergolines; Male; Pituitary Gland, Anterior; Prolactin; Quinolines; Quipazine; Rats; Rats, Inbred Strains; Serotonin Antagonists | 1986 |
Dystonia-Parkinson syndrome: differential effects of levodopa and dopamine agonists.
Topics: Adult; Bromocriptine; Carbidopa; Dystonia; Ergolines; Humans; Levodopa; Meige Syndrome; Middle Aged; Parkinson Disease; Pergolide; Torticollis | 1986 |
Animal model of depression: imipramine, bromocriptine and lisuride alleviate motor depression.
Topics: Adjustment Disorders; Animals; Bromocriptine; Disease Models, Animal; Ergolines; Female; Imipramine; Lisuride; Male; Motor Activity; Rats; Rats, Inbred Strains | 1986 |
Discordant responses of prolactinoma to two different dopamine agonists.
Topics: Adult; Bromocriptine; Drug Resistance; Ergolines; Female; Humans; Pergolide; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1986 |
Long-lasting prolactin-lowering effect of cabergoline, a new dopamine agonist, in hyperprolactinemic patients.
Topics: Adult; Aged; Blood Pressure; Bromocriptine; Cabergoline; Ergolines; Female; Growth Hormone; Humans; Hyperprolactinemia; Male; Middle Aged; Time Factors | 1986 |
Ultrastructural morphometry of prolactin secreting adenomas treated with dopamine agonists.
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Cell Nucleolus; Cell Nucleus; Dopamine; Endoplasmic Reticulum; Ergolines; Ergot Alkaloids; Exocytosis; Female; Humans; Lisuride; Male; Mitochondria; Organoids; Pituitary Neoplasms; Prolactin | 1986 |
[Somnambulism as a result of dopaminomimetics?].
Topics: Adult; Bromocriptine; Ergolines; Female; Humans; Lisuride; Somnambulism | 1986 |
Behavioral effects of long-term neuroleptic treatment in Cebus monkeys.
Topics: Animals; Apomorphine; Behavior, Animal; Bromocriptine; Cebus; Dextroamphetamine; Dopamine; Ergolines; Haloperidol; Humans; Mastication; Pergolide; Receptors, Dopamine; Stereotyped Behavior | 1985 |
Intolerance of bromocriptine: is metergoline a satisfactory alternative?
Topics: Bromocriptine; Drug Hypersensitivity; Ergolines; Female; Humans; Male; Menstruation; Metergoline; Prolactin | 1985 |
Management of prolactinomas. A reappraisal.
Topics: Adenoma; Bromocriptine; Ergolines; Female; Humans; Lisuride; Metergoline; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Radiotherapy Dosage; Radiotherapy, High-Energy; Time Factors | 1985 |
[Dopaminergic agonists in Parkinson disease].
Topics: Aged; Bromocriptine; Dopamine; Ergolines; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Piribedil | 1986 |
Prolactin cell carcinoma of the pituitary. Clinicopathologic, immunohistochemical, and ultrastructural study of a case with cranial and extracranial metastases.
Topics: Biological Assay; Brain Neoplasms; Bromocriptine; Combined Modality Therapy; Ergolines; Female; Histocytochemistry; Hormones; Humans; Microscopy, Electron; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Pergolide; Pituitary Neoplasms; Prolactin | 1985 |
Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Ergolines; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Nausea; Outcome and Process Assessment, Health Care; Parkinson Disease; Pergolide; Time Factors | 1985 |
Three-year observation of mesulergine (CU 32-085) in advanced and newly treated parkinsonism.
Topics: Adult; Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1985 |
Low doses of dopamine agonists in the long-term treatment of macroprolactinomas.
Topics: Adenoma; Adult; Aged; Bromocriptine; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Radiography; Receptors, Dopamine | 1985 |
The effect of dopamine agonist therapy on large functionless pituitary tumours.
Topics: Adenoma, Chromophobe; Adult; Bromocriptine; Dopamine; Ergolines; Female; Humans; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactin; Prospective Studies | 1985 |
Effect of the new ergot derivative terguride on plasma PRL and GH levels in patients with pathological hyperprolactinemia or acromegaly.
Topics: Acromegaly; Adolescent; Adult; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Lisuride; Male; Middle Aged; Prolactin; Time Factors | 1985 |
[Hyperprolactinemia and prolactinomas. Results of surgical and drug therapy].
Topics: Adolescent; Adult; Aged; Bromocriptine; Dopamine; Drug Therapy, Combination; Ergolines; Female; Humans; Hyperprolactinemia; Lisuride; Male; Middle Aged; Paraneoplastic Endocrine Syndromes; Prolactin | 1985 |
Antitumor activity of FCE 21336, a new prolactin lowering drug, on the MXT mouse mammary carcinoma.
Topics: Animals; Antineoplastic Agents; Bromocriptine; Cabergoline; Dose-Response Relationship, Drug; Ergolines; Female; Mammary Neoplasms, Experimental; Mice; Prolactin | 1985 |
Dopamine agonists in hyperprolactinemia.
Topics: Bromocriptine; Ergolines; Humans; Hyperprolactinemia; Pergolide | 1985 |
[Oral lisuride in Parkinson's disease].
Topics: Adult; Aged; Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Ergolines; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease | 1985 |
[Results of different types of treatment in prolactin adenoma].
Topics: Adenoma; Bromocriptine; Ergolines; Female; Humans; Male; Metergoline; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin | 1985 |
Treatment of parkinsonism with bromocriptine.
Topics: Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Parkinson Disease | 1974 |
Effects of inhibitors of pituitary prolactin release on testicular cholesterol stores, seminal vesicles weight, fertility, and lactation in mice.
Topics: Animals; Bromocriptine; Cholesterol; Depression, Chemical; Ergolines; Female; Fertility; Lactation; Male; Mice; Organ Size; Pregnancy; Prolactin; Seminal Vesicles; Testis | 1974 |
Dopamine agonists and Parkinson's disease.
Topics: Antiparkinson Agents; Apomorphine; Brain; Bromocriptine; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Neurons; Parkinson Disease; Pergolide; Piribedil; Receptors, Dopamine | 1984 |
Clinical course and outcome of pregnancy in twenty-five patients with pituitary microadenomas.
Topics: Adenoma; Adult; Amenorrhea; Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Infant, Newborn; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin | 1980 |
Cross tolerance between two dopaminergic ergot derivatives--bromocriptine and lergotrile.
Topics: Aged; Blood Pressure; Bromocriptine; Drug Tolerance; Ergolines; Heart Rate; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1980 |
Inhibition of apomorphine-, bromocriptine- and lergotrile-induced circling behaviour in rats by subsequent haloperidol administration.
Topics: Animals; Apomorphine; Behavior; Bromocriptine; Clozapine; Ergolines; Haloperidol; Humans; Male; Rats; Stereotyped Behavior; Time Factors | 1980 |
Bromocriptine and CF 25-397 in the treatment of tardive dyskinesia.
Topics: Adult; Antipsychotic Agents; Bromocriptine; Double-Blind Method; Dyskinesia, Drug-Induced; Ergolines; Female; Humans; Male; Pyridines | 1980 |
Reinstatement of estrous cycles in middle-aged spontaneously persistent estrous rats: importance of circulating prolactin and the resulting facilitative action of progesterone.
Topics: Aging; Animals; Bromocriptine; Ergolines; Estrus; Female; Luteinizing Hormone; Pregnancy; Progesterone; Prolactin; Pseudopregnancy; Rats | 1980 |
Neuropharmacology of synthetic ergot derivatives in man.
Topics: Animals; Brain; Bromocriptine; Ergolines; Ergot Alkaloids; Humans; Peripheral Nerves; Prolactin; Receptors, Neurotransmitter | 1980 |
Progress in the pharmacotherapy of Parkinsonism.
Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Dopamine Antagonists; Ergolines; Humans; Monoamine Oxidase Inhibitors; Parkinson Disease; Receptors, Dopamine | 1980 |
Psychiatric effects of bromocriptine and lergotrile in Parkinsonian patients.
Topics: Aged; Bromocriptine; Cognition Disorders; Confusion; Dose-Response Relationship, Drug; Electroencephalography; Ergolines; Female; Humans; Male; Mental Disorders; Middle Aged; Parkinson Disease; Personality Disorders; Psychoses, Substance-Induced; Schizophrenia | 1980 |
Central monoamine synapses as sites of action for ergot drugs.
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Behavior, Animal; Binding, Competitive; Brain; Bromocriptine; Catecholamines; Ergolines; Ergot Alkaloids; Male; Mice; Rats; Receptors, Neurotransmitter | 1980 |
Anorectic effect of lisuride and other ergot derivatives in the rat.
Topics: Animals; Apomorphine; Appetite Depressants; Bromocriptine; Dose-Response Relationship, Drug; Eating; Ergolines; Ergot Alkaloids; Haloperidol; Humans; Lisuride; Male; Motor Activity; Pimozide; Rats; Receptors, Dopamine; Stereotyped Behavior; Time Factors | 1980 |
Differential behavioral and biochemical effects of four dopaminergic agonists.
Topics: Animals; Apomorphine; Behavior, Animal; Brain Chemistry; Bromocriptine; Dopamine; Ergolines; Haloperidol; Male; Methyltyrosines; Mice; Motor Skills; Piribedil | 1980 |
Inhibition of neurotransmitter receptor binding by ergot derivatives.
Topics: Adrenergic alpha-Antagonists; Animals; Brain; Bromocriptine; Dioxanes; Ergolines; Ergot Alkaloids; gamma-Aminobutyric Acid; Lysergic Acid Diethylamide; Male; Metergoline; Organ Specificity; Quinuclidinyl Benzilate; Rats; Receptors, Neurotransmitter; Serotonin; Spiperone; Structure-Activity Relationship; Synapses | 1981 |
Lisuride and cerebral electrical activity in the rabbit.
Topics: Animals; Antipsychotic Agents; Behavior; Brain; Bromocriptine; Electroencephalography; Ergolines; Lisuride; Rabbits | 1981 |
Physiologic disposition of pergolide.
Topics: Adult; Animals; Bromocriptine; Chromatography, High Pressure Liquid; Ergolines; Feces; Humans; Male; Middle Aged; Pergolide | 1981 |
Treatment of hyperprolactinaemia with pergolide mesylate: acute effects and preliminary evaluation of long-term treatment.
Topics: Administration, Oral; Adult; Bromocriptine; Depression, Chemical; Ergolines; Female; Follicle Stimulating Hormone; Growth Hormone; Humans; Luteinizing Hormone; Male; Pergolide; Prolactin; Time Factors | 1981 |
Bromocriptine enhances guanylate cyclase activity.
Topics: Animals; Bromocriptine; Dopamine; Dose-Response Relationship, Drug; Ergolines; Female; Guanylate Cyclase; Kinetics; Ovary; Pituitary Gland; Rats; Rats, Inbred Strains | 1981 |
Akinetic mutism from hypothalamic damage: successful treatment with dopamine agonists.
Topics: Adult; Akinetic Mutism; Bromocriptine; Carbidopa; Ergolines; Humans; Hypothalamic Neoplasms; Hypothalamus; Levodopa; Male; Methylphenidate; Postoperative Complications | 1981 |
Low CSF GABA in Parkinsonian patients who respond poorly to therapy or suffer from the "on-off" phenomenon.
Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Ergolines; Female; gamma-Aminobutyric Acid; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prognosis; Radioligand Assay | 1982 |
Stereotyped responses of rats to two 2-halogenoergolines: 2-bromo-alpha-ergocryptine and lergotrile.
Topics: Animals; Apomorphine; Bromocriptine; Drug Interactions; Ergolines; Fenclonine; Haloperidol; Humans; Male; Methyldopa; Methyltyrosines; Rats; Stereotyped Behavior; Stimulation, Chemical | 1982 |
Pergolide-induced circling in rats with 6-hydroxydopamine lesions in the nigrostriatal pathway.
Topics: Animals; Behavior, Animal; Brain Diseases; Bromocriptine; Ergolines; Female; Hydroxydopamines; Oxidopamine; Parkinson Disease; Pergolide; Rats; Rats, Inbred Strains | 1982 |
Effects of three dopamine agonists on cage climbing behavior.
Topics: Animals; Behavior, Animal; Bromocriptine; Ergolines; Male; Mice; Mice, Inbred Strains; Motor Activity; Pergolide | 1983 |
Somatostatin depletion of the gut and pancreas induced by cysteamine is not prevented by vagotomy or by dopamine agonists.
Topics: Animals; Bromocriptine; Cysteamine; Duodenum; Ergolines; Female; Hypothalamus; Pancreas; Rats; Rats, Inbred Strains; Somatostatin; Stomach; Vagotomy | 1983 |
Effects of agonists and antagonists of D1 and D2 dopamine receptors on self-stimulation of the medial prefrontal cortex in the rat.
Topics: Animals; Apomorphine; Bromocriptine; Cerebral Cortex; Dose-Response Relationship, Drug; Ergolines; Functional Laterality; Male; Pimozide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Self Stimulation; Spiperone; Sulpiride; Synaptic Transmission | 1983 |
Action of apomorphine, bromocriptine and lergotrile on gamma-aminobutyric acid and acetylcholine release in nucleus accumbens and corpus striatum.
Topics: Acetylcholine; Afferent Pathways; Animals; Apomorphine; Bromocriptine; Bucladesine; Corpus Striatum; Culture Techniques; Dose-Response Relationship, Drug; Ergolines; gamma-Aminobutyric Acid; Male; Molindone; Muridae; Nucleus Accumbens; Receptors, Dopamine; Septal Nuclei; Sulpiride; Synaptic Transmission | 1983 |
Cardiovascular effects of bromocriptine and lergotrile in renal and spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Bromocriptine; Ergolines; Heart Rate; Hypertension; Hypertension, Renal; Male; Rats; Rats, Inbred Strains | 1983 |
Ocular hypotensive action of ergoline derivatives in rabbits: effects of sympathectomy and domperidone pretreatment.
Topics: Administration, Topical; Animals; Bromocriptine; Domperidone; Ergolines; Eye; Ganglia, Sympathetic; Intraocular Pressure; Male; Pergolide; Rabbits; Sympathectomy | 1984 |
Dopamine analog-induced hyperglycemia in rats: involvement of the adrenal medulla and the endocrine pancreas.
Topics: Adrenal Medulla; Animals; Apomorphine; Blood Glucose; Bromocriptine; Dextroamphetamine; Dihydroxyphenylalanine; Dopamine; Ergolines; Indans; Insulin; Islets of Langerhans; Male; Pergolide; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Dopamine; Tetrahydronaphthalenes | 1984 |
Mouse locomotor activity: an in vivo test for dopamine autoreceptor activation.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Bromocriptine; Ergolines; Female; Methods; Mice; Motor Activity; Receptors, Dopamine; Sulpiride | 1984 |
Effect of dopamine agonist withdrawal after long-term therapy in prolactinomas. Studies with high-definition computerised tomography.
Topics: Adult; Aged; Bromocriptine; Dopamine; Ergolines; Female; Humans; Male; Middle Aged; Pergolide; Pituitary Function Tests; Pituitary Neoplasms; Pregnancy; Prolactin; Sella Turcica; Tomography, X-Ray Computed | 1984 |
Hypotensive action and alpha-adrenolytic properties of a new dopaminergic agonist, CU 32-085, in the rat.
Topics: Adrenergic alpha-Antagonists; Anesthesia; Animals; Antihypertensive Agents; Antiparkinson Agents; Blood Pressure; Bromocriptine; Clonidine; Epinephrine; Ergolines; Female; Heart Rate; Hemodynamics; Male; Methoxamine; Norepinephrine; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1984 |
Urinary excretion of free catecholamines in long-term treatment with dopaminergic agonists.
Topics: Acromegaly; Adult; Aged; Blood Pressure; Bromocriptine; Dopamine; Epinephrine; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Norepinephrine; Somatostatin | 1984 |
Therapeutic experience with the new dopamine agonist CU 32-085 in advanced Parkinson's disease.
Topics: Adult; Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Carboxy-Lyases; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parasympatholytics; Parkinson Disease | 1983 |
Non-opiate beta-endorphin fragments and dopamine--VI. Behavioural analysis of the interaction between gamma-type endorphins and dopaminergic systems in the nucleus accumbens of rats.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; beta-Endorphin; Bromocriptine; Dopamine; Endorphins; Ergolines; Fluphenazine; gamma-Endorphin; Haloperidol; Male; Motor Activity; Nucleus Accumbens; Rats; Rats, Inbred Strains; Septal Nuclei; Sulpiride | 1984 |
Dopamine agonists in Parkinson's disease.
Topics: Bromocriptine; Dopamine; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1984 |
[Follow-up of the effect of prolactin-lowering substances].
Topics: Adult; Amenorrhea; Bromocriptine; Ergolines; Female; Humans; Hyperprolactinemia; Infertility, Female; Lisuride; Menstruation; Prolactin | 1981 |
Evaluation and treatment of hyperprolactinaemia in women of childbearing age.
Topics: Adenoma; Adult; Amenorrhea; Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Hyperprolactinemia; Lisuride; Pituitary Neoplasms; Pregnancy; Prolactin | 1981 |
Neurochemical effects of some ergot derivatives: a basis for their antiparkinson actions.
Topics: Acetylcholine; Adenylyl Cyclases; Animals; Antiparkinson Agents; Brain; Bromocriptine; Cerebral Cortex; Corpus Striatum; Cyclic AMP; Dopamine; Ergolines; In Vitro Techniques; Kinetics; Male; Nitriles; Norepinephrine; Rats | 1981 |
Dopamine agonists in the treatment of Parkinson's disease.
Topics: Blood Pressure; Bromocriptine; Disability Evaluation; Domperidone; Dopamine; Ergolines; Follow-Up Studies; Humans; Levodopa; Parkinson Disease; Pleural Effusion; Receptors, Neurotransmitter; Time Factors | 1983 |
Hormonal regulation of testicular LH/hCG receptors in rat.
Topics: Animals; Bromocriptine; Chorionic Gonadotropin; Ergolines; Estradiol; Gonadotropins, Equine; Hormones; Male; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, LH; Testis; Testosterone | 1983 |
Effect of dopaminergic drugs on hypothalamic and pituitary immunoreactive beta-endorphin concentrations in the rat.
Topics: Animals; beta-Endorphin; beta-Lipotropin; Bromocriptine; Endorphins; Ergolines; Hypothalamus; Lisuride; Male; Pituitary Gland; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1983 |
In vitro selectivity of lisuride and other ergot derivatives for alpha 1- and alpha 2-adrenoceptors.
Topics: Animals; Bromocriptine; Clonidine; Dose-Response Relationship, Drug; Ergolines; Ergot Alkaloids; Guinea Pigs; Ileum; In Vitro Techniques; Lisuride; Muscle Contraction; Receptors, Adrenergic, alpha; Spleen | 1984 |
Mesulergine, a new dopamine agonist: effects on anterior pituitary function and kinetics.
Topics: Absorption; Adult; Analysis of Variance; Biological Availability; Bromocriptine; Ergolines; Humans; Male; Pituitary Gland, Anterior; Pituitary Hormone-Releasing Hormones; Prolactin; Radioimmunoassay | 1984 |
Autoreceptors mediate the inhibition of dopamine synthesis by bromocriptine and lisuride in rats.
Topics: 4-Butyrolactone; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Brain Chemistry; Bromocriptine; Dihydroxyphenylalanine; Dopamine; Dose-Response Relationship, Drug; Ergolines; Lisuride; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sulpiride; Time Factors | 1983 |
Long-term monolayer culture of human anterior pituitary cells: functional validation of a method.
Topics: Bromocriptine; Cells, Cultured; Ergolines; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Methods; Pergolide; Pituitary Gland, Anterior; Prolactin; Thyrotropin-Releasing Hormone; Time Factors | 1984 |
Psychotic reactions during treatment of pituitary tumours with dopamine agonists.
Topics: Acromegaly; Adenoma; Adult; Bromocriptine; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Psychoses, Substance-Induced | 1984 |
On some central effects of elymoclavine.
Topics: Animals; Bromocriptine; Catalepsy; Central Nervous System; Corpus Striatum; Ergolines; Exploratory Behavior; Haloperidol; Humans; Hydroxydopamines; Mice; Oxidopamine; Pimozide; Rats; Receptors, Dopamine; Seizures; Stereotyped Behavior; Sympathetic Nervous System | 1984 |
[Bromocriptine and methergoline in the inhibition of puerperal lactation].
Topics: Adolescent; Adult; Bromocriptine; Depression, Chemical; Drug Evaluation; Ergolines; Estradiol; Female; Humans; Lactation; Metergoline; Postpartum Period; Pregnancy; Prolactin; Time Factors | 1984 |
Enhancement of the cyclic motor activity of the ovine small intestine by lysergic acid derivatives. Mechanism and significance.
Topics: Action Potentials; Animals; Bromocriptine; Duodenum; Ergolines; Gastrointestinal Motility; Intestine, Small; Lysergic Acid; Methylergonovine; Methysergide; Periodicity; Pyloric Antrum; Serotonin; Serotonin Antagonists; Sheep; Vagotomy | 1984 |
Mechanism of action and tolerance of mesulergine.
Topics: Adenoma; Administration, Oral; Adult; Animals; Blood Pressure; Bromocriptine; Cells, Cultured; Dopamine Antagonists; Drug Evaluation; Ergolines; Female; Humans; Hypotension; Male; Menstruation; Middle Aged; Nausea; Pituitary Neoplasms; Prolactin; Radioimmunoassay; Random Allocation; Rats | 1984 |
Bromocriptine and lisuride in dystonias.
Topics: Bromocriptine; Dystonia; Ergolines; Humans; Lisuride | 1984 |
Pergolide versus bromocriptine.
Topics: Bromocriptine; Ergolines; Humans; Parkinson Disease; Pergolide | 1984 |
Metergoline and bromocriptine in the management of tumoral and idiopathic hyperprolactinemia.
Topics: Adenoma; Adult; Amenorrhea; Anovulation; Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Metergoline; Middle Aged; Pituitary Neoplasms; Pregnancy; Prolactin | 1983 |
A comparison of the potencies of various dopamine receptor agonists in models for pre- and postsynaptic receptor activity.
Topics: 3,4-Dihydroxyphenylacetic Acid; 4-Butyrolactone; Animals; Behavior, Animal; Bromocriptine; Dopamine; Ergolines; Homovanillic Acid; Models, Neurological; Motor Activity; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1983 |
Treatment of Parkinson's disease with 8-alpha-amino-ergoline, CU 32-085.
Topics: Activities of Daily Living; Adult; Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Ergolines; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Psychomotor Performance; Receptors, Dopamine | 1983 |
Therapeutic results with a new ergoline derivate (8-alpha-amino-ergoline, CU 32-085) in parkinsonian patients.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1984 |
Bromocriptine and lisuride in Parkinson's disease.
Topics: Adult; Aged; Bromocriptine; Carboxy-Lyases; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease | 1984 |
Serum prolactin and ovarian function after discontinuation of drug treatment for hyperprolactinaemia: a study with bromocriptine and metergoline.
Topics: Adenoma; Amenorrhea; Bromocriptine; Ergolines; Female; Humans; Metergoline; Ovulation; Pituitary Neoplasms; Progesterone; Prolactin; Prospective Studies; Recurrence | 1984 |
Dopaminergic treatment of acromegaly: different effects on hormone secretion and tumor size.
Topics: Acromegaly; Adenoma; Adult; Aged; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Lisuride; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1984 |
Hyperprolactinemic primary amenorrhea: case report with successful prolactin-lowering treatment and review of the literature.
Topics: Adult; Amenorrhea; Bromocriptine; Ergolines; Female; Follicle Stimulating Hormone; Galactorrhea; Humans; Lactation Disorders; Luteinizing Hormone; Metergoline; Pregnancy; Progesterone; Prolactin; Sulpiride; Thyrotropin-Releasing Hormone | 1980 |
Influence of prolactin and growth hormone on rat mammary tumors induced by N-nitrosomethylurea.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bromocriptine; Ergolines; Female; Growth Hormone; Hypophysectomy; Male; Mammary Neoplasms, Experimental; Methylnitrosourea; Nitrosourea Compounds; Pergolide; Prolactin; Rats | 1982 |
Binding of antiparkinsonian ergot derivatives to the dopamine receptor.
Topics: Animals; Antiparkinson Agents; Apomorphine; Bromocriptine; Caudate Nucleus; Ergolines; Lisuride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone | 1981 |
Effect of bromocriptine and metergoline in the treatment of hyperprolactinaemic states.
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Ergolines; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Metergoline; Middle Aged; Pituitary Neoplasms; Pregnancy; Progesterone; Prolactin; Testosterone | 1982 |
Growth hormone and changes in the secretion of thyrotropic hormone after thyrotropin-releasing hormone (TRH): ineffectiveness of dopaminergic stimulation.
Topics: Acromegaly; Adult; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Lisuride; Male; Middle Aged; Receptors, Dopamine; Thyrotropin; Thyrotropin-Releasing Hormone; Triiodothyronine | 1982 |
Bromocriptine and lisuride in Parkinson disease.
Topics: Aged; Bromocriptine; Carbidopa; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Lisuride; Middle Aged; Parkinson Disease | 1983 |
Progressive supranuclear palsy: clinical features and response to treatment in 16 patients.
Topics: Aged; Bromocriptine; Bulbar Palsy, Progressive; Ergolines; Female; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease; Pergolide | 1983 |
Comparative efficacy of pergolide and bromocriptine in patients with advanced Parkinson's disease.
Topics: Aged; Bromocriptine; Disability Evaluation; Drug Evaluation; Ergolines; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Time Factors | 1983 |
Dopa dose-dependent sexual deviation.
Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Ergolines; Humans; Male; Middle Aged; Paraphilic Disorders; Parkinson Disease; Pergolide | 1983 |
Bromocriptine--lisuride cross tolerance.
Topics: Aged; Bromocriptine; Drug Tolerance; Ergolines; Humans; Lisuride; Male; Middle Aged; Parkinson Disease | 1983 |
Dopaminergic inhibition of prolactin synthesis and prolactin messenger RNA accumulation in cultured pituitary cells.
Topics: Animals; Bromocriptine; DNA; Dopamine; Epinephrine; Ergolines; Female; Kinetics; Norepinephrine; Nucleic Acid Hybridization; Pituitary Gland; Prolactin; Protein Biosynthesis; Rats; RNA, Messenger | 1980 |
Ergot drugs suppress plasma prolactin and lactation but not aggression in parturient mice.
Topics: Aggression; Animals; Body Weight; Bromocriptine; Ergolines; Ergot Alkaloids; Female; Humans; Lactation; Male; Mice; Pregnancy; Prolactin; Sucking Behavior | 1980 |
Bromocriptine and alpha-ergocryptine do not inhibit oxytocin secretion in the lactating rat.
Topics: Animals; Bromocriptine; Ergolines; Female; Lactation; Oxytocin; Pregnancy; Prolactin; Rats; Secretory Rate | 1981 |
The effect of ergocornine, bromocriptine, D-6-methyl-8-ergolinylacetamide and D-6-propyl-8-ergolinylacetamide on the prolactin secretion in goats. Comparison of potency and duration of effect.
Topics: Animals; Bromocriptine; Dose-Response Relationship, Drug; Ergolines; Female; Goats; Lactation; Pregnancy; Prolactin; Time Factors | 1982 |
Ergot drugs suppress plasma levels of prolactin (PRL) but not growth hormone (GH), luteinizing hormone (LH) or corticosterone (CORT) in parturient mice.
Topics: Animals; Bromocriptine; Corticosterone; Ergolines; Female; Growth Hormone; Labor, Obstetric; Lactation; Luteinizing Hormone; Mice; Pregnancy; Prolactin | 1982 |
Possible involvement of dopamine in the release of prolactin-like hormone from bullfrog pituitary gland.
Topics: Animals; Bromocriptine; Dopamine; Ergolines; Metamorphosis, Biological; Organ Culture Techniques; Pimozide; Pituitary Gland, Anterior; Prolactin; Rana catesbeiana; Tail | 1980 |
Long-term treatment of acromegaly with lisuride: differences of effect on growth hormone and somatomedin.
Topics: Acromegaly; Adult; Alkaline Phosphatase; Blood Glucose; Bone and Bones; Bromocriptine; Ergolines; Female; Glucose Tolerance Test; Growth Hormone; Humans; Hydroxyproline; Insulin; Isoenzymes; Lisuride; Male; Somatomedins | 1981 |
Metergoline as a lactation inhibitor.
Topics: Bromocriptine; Dose-Response Relationship, Drug; Ergolines; Female; Humans; Lactation; Metergoline; Postpartum Period; Pregnancy; Prolactin; Time Factors | 1982 |
Effect of haloperidol pre- and post-treatment on the ability of pergolide and bromocriptine to antagonize the gamma-butyrolactone-induced increase in brain dopamine in rats.
Topics: 4-Butyrolactone; Animals; Brain Chemistry; Bromocriptine; Dopamine; Ergolines; Furans; Haloperidol; Pergolide; Rats; Rats, Inbred Strains | 1982 |
Effects of pergolide and bromocriptine on male rat sexual behavior.
Topics: Animals; Bromocriptine; Ergolines; Male; Pergolide; Rats; Sexual Behavior, Animal | 1982 |
Locomotor hypokinesia in the reserpine-treated rat: drug effects from the corpus striatum and nucleus accumbens.
Topics: Animals; Antiparkinson Agents; Apomorphine; Bromocriptine; Corpus Striatum; Ergolines; Locomotion; Male; Motor Activity; Nucleus Accumbens; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reserpine; Septal Nuclei | 1982 |
Pergolide, a potent long-acting dopamine-receptor agonist.
Topics: Adult; Blood Pressure; Bromocriptine; Circadian Rhythm; Dose-Response Relationship, Drug; Ergolines; Ergot Alkaloids; Growth Hormone; Hormones; Humans; Male; Middle Aged; Myocardial Contraction; Pergolide; Perphenazine; Prolactin; Receptors, Dopamine; Time Factors | 1980 |
Lisuride in parkinsonism.
Topics: Adult; Aged; Bromocriptine; Double-Blind Method; Ergolines; Humans; Lisuride; Middle Aged; Movement; Parkinson Disease; Placebos; Reaction Time; Receptors, Serotonin; Sleep | 1981 |
[Comparative clinical evaluation of the effectiveness of methergoline and bromocriptine in inhibiting puerperal lactation].
Topics: Adult; Bromocriptine; Ergolines; Female; Humans; Lactation; Metergoline; Pregnancy | 1980 |
Treatment of hyperprolactinemic states with different drugs: a study with bromocriptine, metergoline, and lisuride.
Topics: Adenoma; Adolescent; Adult; Amenorrhea; Bromocriptine; Erectile Dysfunction; Ergolines; Female; Galactorrhea; Humans; Lisuride; Male; Metergoline; Middle Aged; Ovarian Function Tests; Pituitary Neoplasms; Pregnancy; Prolactin; Visual Fields | 1982 |
Beneficial effects of lisuride in Meige disease.
Topics: Apomorphine; Bromocriptine; Ergolines; Female; Humans; Lisuride; Lymphedema; Male; Middle Aged | 1982 |
[Experience obtained from prolactin-inhibiting therapy for functional sterility (author's transl)].
Topics: Amenorrhea; Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Infertility, Female; Lisuride; Oligomenorrhea; Pregnancy; Prolactin | 1980 |
Two new dopamine agonists that are long acting in vivo but short acting in vitro.
Topics: Animals; Bromocriptine; Dose-Response Relationship, Drug; Ergolines; In Vitro Techniques; Male; Pergolide; Prolactin; Rats; Secretory Rate; Time Factors | 1980 |
The effects of lisuride and some other dopaminergic agonists on receptor binding in human brain.
Topics: Brain; Bromocriptine; Ergolines; Humans; Kinetics; Lisuride; Receptors, Dopamine; Spiperone | 1981 |
Characterization of normal and supersensitive dopamine receptors: effects of ergot drugs and neuropeptides.
Topics: Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Brain; Bromocriptine; Caudate Nucleus; Corpus Striatum; Ergolines; Kinetics; Organ Specificity; Pergolide; Putamen; Rats; Receptors, Dopamine | 1981 |
On the stereochemistry of dopaminergic ergoline derivatives.
Topics: Apomorphine; Bromocriptine; Dopamine; Ergolines; Molecular Conformation; Stereoisomerism | 1981 |
Size reduction of macroprolactinomas by bromocriptine or lisuride treatment.
Topics: Adolescent; Adult; Bromocriptine; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1981 |
[Inhibition of puerperal lactation with bromocriptine and methergoline. Clinical evaluation].
Topics: Adolescent; Adult; Bromocriptine; Ergolines; Female; Humans; Lactation; Metergoline; Pregnancy | 1980 |
Lactation-inhibiting and prolactin-lowering effect of lisuride and bromocriptine: a comparative study.
Topics: Bromocriptine; Double-Blind Method; Ergolines; Female; Humans; Lactation; Lisuride; Postpartum Period; Pregnancy; Prolactin | 1981 |
Lisuride in the treatment of Parkinsonism.
Topics: Administration, Oral; Aged; Bromocriptine; Drug Therapy, Combination; Ergolines; Humans; Injections, Intravenous; Levodopa; Lisuride; Middle Aged; Parkinson Disease | 1980 |
Effect of octreotide on circulating IGF-I chromatographic profile: evidence for an inhibitory action on the formation of the 150-kDa ternary complex.
Topics: Acromegaly; Adult; Bromocriptine; Cabergoline; Carrier Proteins; Ergolines; Growth Hormone; Humans; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Middle Aged; Octreotide | 1995 |
In vivo effect of cabergoline, a dopamine agonist, on estrogen-induced rat pituitary tumors.
Topics: Animals; Antineoplastic Agents; Bromocriptine; Cabergoline; Cytoplasmic Granules; Dopamine Agonists; Endoplasmic Reticulum; Ergolines; Estradiol; Female; Microscopy, Electron; Organ Size; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred F344 | 1995 |
Suggestive evidence for a DA D3 receptor-mediated increase in the release of oxytocin in the male rat.
Topics: Animals; Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Male; Oxytocin; Prolactin; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Sex Factors; Tetrahydronaphthalenes | 1995 |
Effect of cabergoline, a dopamine agonist, on estrogen-induced rat pituitary tumors: in vitro culture studies.
Topics: Animals; Antineoplastic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Estradiol; Female; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred F344; Tumor Cells, Cultured | 1995 |
X-ray crystal structure and conformational analysis of N-(3-dimethylaminopropyl)-N-(ethylaminocarbonyl)-6-(2-propenyl)er goline -8 beta-carboxamide (Cabergoline): comparison with bromocriptine and lisuride and a hypothesis for its high dopaminergic activi
Topics: Bromocriptine; Cabergoline; Crystallography, X-Ray; Dopamine Agonists; Ergolines; Lisuride; Molecular Conformation; Structure-Activity Relationship | 1995 |
Possible sites of dopaminergic inhibition of gonadotropin release from the pituitary of a teleost fish, tilapia.
Topics: Animals; Apomorphine; Arachidonic Acid; Bromocriptine; Calcimycin; Calcium; Cells, Cultured; Colforsin; Cyclic AMP; Diglycerides; Dopamine; Dopamine Agonists; Ergolines; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Ionomycin; Pituitary Gland; Quinpirole; Signal Transduction; Tilapia | 1995 |
Drenching sweats as an off phenomenon in Parkinson's disease: treatment and relation to plasma levodopa profile.
Topics: Aged; Bromocriptine; Cabergoline; Chorea; Dopamine Agonists; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Monitoring, Physiologic; Parkinson Disease; Pergolide; Sweating | 1995 |
Lack of cross-sensitization between the locomotor-activating effects of bromocriptine and those of cocaine or heroin.
Topics: Animals; Bromocriptine; Cocaine; Cues; Dopamine Agonists; Environment; Ergolines; Heroin; Male; Motor Activity; Quinpirole; Rats; Receptors, Dopamine D2 | 1993 |
Involvement of D1 dopamine receptor mechanism in ischemia-induced impairment of CA1 presynaptic fiber spikes in rat hippocampal slices.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Analysis of Variance; Animals; Benzazepines; Brain Ischemia; Bromocriptine; Dopamine Agonists; Ergolines; Hippocampus; In Vitro Techniques; Male; Nerve Fibers; Presynaptic Terminals; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D1; Sulpiride | 1994 |
Opposing roles for D-1 and D-2 dopamine receptors in the regulation of lower esophageal sphincter motility in the rat.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Bromocriptine; Dihydroergotoxine; Dopamine; Dopamine Agents; Ergolines; Esophagogastric Junction; Fenoldopam; In Vitro Techniques; Male; Peristalsis; Phentolamine; Prazosin; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1994 |
Cabergoline treated hyperprolactinaemia results in pregnancy in a bromocriptine intolerant patient after seventeen years of infertility.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agents; Ergolines; Female; Humans; Hyperprolactinemia; Infertility, Female; Pregnancy | 1994 |
Progress in the management of hyperprolactinemia.
Topics: Amenorrhea; Bromocriptine; Cabergoline; Dopamine Agents; Ergolines; Female; Humans; Hyperprolactinemia | 1994 |
Comparative analysis of the behaviors evoked by bromocriptine and quinpirole (LY 171555) in adult cats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Bromocriptine; Cats; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Ergolines; Female; Male; Quinpirole; Receptors, Dopamine D2 | 1994 |
Structural elucidation of two novel ergot alkaloid impurities in alpha-ergokryptine and bromokryptine.
Topics: Bromocriptine; Chromatography, High Pressure Liquid; Drug Contamination; Ergolines; Ergot Alkaloids; Magnetic Resonance Spectroscopy; Molecular Structure | 1994 |
High affinity of ergopeptides for cytochromes P450 3A. Importance of their peptide moiety for P450 recognition and hydroxylation of bromocriptine.
Topics: Animals; Bromocriptine; Cytochrome P-450 CYP2E1; Cytochrome P-450 Enzyme System; Dexamethasone; Dihydroergotamine; Ergolines; Humans; Hydroxylation; Isoenzymes; Lysergic Acid; Microsomes, Liver; Mixed Function Oxygenases; NADP; Oxidation-Reduction; Peptides; Rats; Recombinant Proteins; Saccharomyces cerevisiae; Substrate Specificity | 1994 |
Regulation of striatal aromatic L-amino acid decarboxylase: effects of blockade or activation of dopamine receptors.
Topics: Animals; Antipsychotic Agents; Aromatic-L-Amino-Acid Decarboxylases; Benzazepines; Bromocriptine; Corpus Striatum; Cycloheximide; Dextroamphetamine; Dopamine D2 Receptor Antagonists; Drug Interactions; Ergolines; Flupenthixol; Male; Pimozide; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Remoxipride; Stereoisomerism | 1993 |
Depression of the monosynaptic reflex by apomorphine or bromocriptine is not mediated by D1/D2 receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzamides; Bromocriptine; Decerebrate State; Depression, Chemical; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Ergolines; Male; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Reflex, Monosynaptic; Sulpiride; Synaptic Transmission | 1993 |
Rapid identification of ergot derivatives by 1H-NMR spectroscopy.
Topics: Bromocriptine; Ergolines; Ergotamine; Magnetic Resonance Spectroscopy; Reference Standards; Stereoisomerism | 1994 |
Mass spectrometry as an aid to the identification of ergots and dihydroergots: comparison of hard and soft ionization techniques.
Topics: Bromocriptine; Ergolines; Ergotamine; Ergotamines; Molecular Weight; Spectrometry, Mass, Fast Atom Bombardment | 1994 |
Vaginal cabergoline in the treatment of hyperprolactinemic patients intolerant to oral dopaminergics.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Vagina | 1996 |
Differential effects of three dopamine receptor agonists in MPTP-treated monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Macaca fascicularis; Parkinson Disease, Secondary; Pergolide | 1995 |
Effects of selective serotonin and dopamine agonists on plasma levels of glucose, insulin and glucagon in the rat.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Blood Glucose; Bromocriptine; Buspirone; Dopamine Agonists; Ergolines; Glucagon; Insulin; Male; Quinpirole; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Tetrahydronaphthalenes | 1996 |
Effects of dopamine agonists and antagonists on cocaine-induced operant responding for a cocaine-associated stimulus.
Topics: Animals; Benzazepines; Bromocriptine; Cocaine; Conditioning, Operant; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Ergolines; Male; Raclopride; Rats; Rats, Wistar; Reinforcement, Psychology; Salicylamides; Self Administration | 1996 |
Dopamine receptor affinities in vitro and stereotypic activities in vivo of cabergoline in rats.
Topics: Animals; Benzazepines; Binding, Competitive; Bromocriptine; Cabergoline; Dopamine Agonists; Dopamine Antagonists; Ergolines; In Vitro Techniques; Male; Pergolide; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior | 1996 |
Effect of different dopaminergic agents in the treatment of acromegaly.
Topics: Acromegaly; Adult; Aminoquinolines; Bromocriptine; Cabergoline; Delayed-Action Preparations; Dopamine Agonists; Ergolines; Female; Human Growth Hormone; Humans; Male; Middle Aged; Prolactin | 1997 |
Late development of resistance to bromocriptine in a patient with macroprolactinoma.
Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Ergolines; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma | 1998 |
Therapeutic effects of dopamine D1/D2 receptor agonists on detrusor hyperreflexia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys.
Topics: Animals; Bromocriptine; Dopamine Agonists; Ergolines; Macaca fascicularis; Male; MPTP Poisoning; Parkinson Disease, Secondary; Pergolide; Receptors, Dopamine D1; Receptors, Dopamine D2; Reflex; Triazoles; Urinary Bladder; Urination | 1998 |
Pharmacological effects of BAM-1120, a novel ergoline derivative, on central dopaminergic functions in rats.
Topics: Animals; Bromocriptine; Dopamine; Dopamine Agents; Dopamine Agonists; Ergolines; Estradiol; Female; Hyperprolactinemia; Lisuride; Male; Rats; Rats, Wistar; Reserpine; Rotation; Stereotyped Behavior; Sympathectomy, Chemical; Sympatholytics | 1998 |
New hyperprolactinemia and anovulation model in common marmoset (Callithrix jacchus) and effect of cabergoline.
Topics: Animals; Anovulation; Bromocriptine; Cabergoline; Callithrix; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Ergolines; Estradiol; Female; Hyperprolactinemia; Menstrual Cycle; Progesterone; Prolactin; Sulpiride; Time Factors | 1999 |
Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients.
Topics: Adenoma; Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance; Drug Tolerance; Ergolines; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Pituitary Neoplasms; Pregnancy; Retrospective Studies; Sex Characteristics | 1999 |
Ergocryptine and other ergot alkaloids stimulate the release of [3H]dopamine from rat striatal synaptosomes.
Topics: Animals; Bromocriptine; Corpus Striatum; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Ergonovine; Ergotamine; Male; Rats; Rats, Sprague-Dawley; Synaptosomes | 1999 |
Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization.
Topics: Adolescent; Adult; Aminoquinolines; Analysis of Variance; Biomarkers; Bone Density; Bone Remodeling; Bromocriptine; Cabergoline; Case-Control Studies; Collagen; Collagen Type I; Dopamine Agonists; Ergolines; Female; Femur Neck; Humans; Longitudinal Studies; Lumbar Vertebrae; Male; Middle Aged; Osteocalcin; Osteoporosis; Peptides; Pituitary Neoplasms; Prolactinoma; Regression Analysis | 2000 |
Comparative effects of repeated administration of dopamine agonists on circling behavior in rats.
Topics: Animals; Benzothiazoles; Brain; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Administration Schedule; Ergolines; Indoles; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Pergolide; Pramipexole; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Dopamine D1; Receptors, Dopamine D2; Thiazoles | 2000 |
Use of the dopamine agonists bromocriptine and cabergoline in the management of risperidone-induced hyperprolactinemia in patients with psychotic disorders.
Topics: Adult; Antipsychotic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Hypogonadism; Male; Middle Aged; Prolactin; Psychotic Disorders; Risperidone | 2000 |
Treatment versus no treatment of transient hyperprolactinemia in patients undergoing intracytoplasmic sperm injection programs.
Topics: Adult; Bromocriptine; Cabergoline; Chorionic Gonadotropin; Dopamine Agonists; Embryo Transfer; Ergolines; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Hyperprolactinemia; Luteolytic Agents; Oocytes; Prolactin; Retrospective Studies; Sperm Injections, Intracytoplasmic; Treatment Outcome; Triptorelin Pamoate | 2000 |
Pituitary adenomas in childhood and adolescence. Clinical analysis of 10 cases.
Topics: Acromegaly; Adenoma; Adolescent; Amenorrhea; Bromocriptine; Cabergoline; Child; Ergolines; Female; Headache; Human Growth Hormone; Humans; Male; Neoplasm Recurrence, Local; Octreotide; Pituitary Neoplasms; Prolactinoma; Puberty, Delayed; Radiotherapy; Treatment Outcome; Vision Disorders; Visual Fields | 2001 |
Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method.
Topics: Adult; Bromocriptine; Cabergoline; Cohort Studies; Ergolines; Female; Fertility; Headache; Humans; Magnetic Resonance Imaging; Medical Records; Menstruation; Menstruation Disturbances; Middle Aged; Pituitary Gland; Polyethylene Glycols; Prolactin; Tomography, X-Ray Computed | 2001 |
Efficacy and tolerability of dopamine agonists in a parkinsonian population.
Topics: Age of Onset; Aged; Aging; Benzothiazoles; Bromocriptine; Dopamine Agonists; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Drug Tolerance; Ergolines; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Retrospective Studies; Thiazoles; Treatment Outcome | 2001 |
Cabergoline and hyperprolactinaemia: new preparation. Better than bromocriptine.
Topics: Bromocriptine; Clinical Trials as Topic; Dopamine Agonists; Ergolines; Female; France; Humans; Hyperprolactinemia; Menstruation Disturbances; Treatment Outcome | 2000 |
Successful treatment of a large macroprolactinoma with cabergoline during pregnancy.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma | 2001 |
The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma.
Topics: Adult; Anastrozole; Aromatase Inhibitors; Bromocriptine; Cabergoline; Dopamine Agonists; Enzyme Inhibitors; Ergolines; Hormone Replacement Therapy; Humans; Magnetic Resonance Imaging; Male; Nitriles; Pituitary Neoplasms; Prolactin; Prolactinoma; Sexual Dysfunction, Physiological; Testosterone; Treatment Outcome; Triazoles | 2002 |
Prolactinomas, dopamine agonists and headache: two case reports.
Topics: Adult; Amenorrhea; Anti-Inflammatory Agents, Non-Steroidal; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Headache; Humans; Indomethacin; Magnetic Resonance Imaging; Pituitary Neoplasms; Prolactin; Prolactinoma; Radiography | 2003 |
Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cultured mouse astrocytes.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Astrocytes; Blotting, Northern; Brain-Derived Neurotrophic Factor; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Ergolines; Glial Cell Line-Derived Neurotrophic Factor; Mice; Mice, Inbred ICR; Nerve Growth Factor; Nerve Growth Factors; Pergolide; Receptors, Dopamine D1; Receptors, Dopamine D2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors | 2003 |
[Clinical and therapeutic aspects of prolactinoma in men].
Topics: Adolescent; Adult; Age of Onset; Biomarkers; Bromocriptine; Cabergoline; Chi-Square Distribution; Dopamine Agonists; Ergolines; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Pituitary Neoplasms; Prolactin; Prolactinoma; Statistics, Nonparametric; Treatment Outcome | 2003 |
Prolactinoma presenting as painful postganglionic Horner syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain; Bromocriptine; Cabergoline; Carotid Arteries; Dopamine Agonists; Ergolines; Horner Syndrome; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Migraine Disorders; Neoplasm Recurrence, Local; p-Hydroxyamphetamine; Pituitary Neoplasms; Prolactin; Prolactinoma; Remission Induction | 2004 |
Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Domperidone; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Feasibility Studies; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Therapeutic Equivalency; Thiazoles | 2004 |
Cardiopulmonary complications of ergot-derivative dopamine agonists.
Topics: Antipsychotic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Heart Valve Diseases; Humans; Hyperprolactinemia; Pergolide; Pulmonary Fibrosis; Risperidone | 2004 |
Valvular heart disease and fibrotic reactions may be related to ergot dopamine agonists, but non-ergot agonists may also not be spared.
Topics: Aortic Valve; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Fibrosis; Heart Valve Diseases; Humans; Parkinson Disease; Pergolide | 2004 |
Nelson's syndrome: complete remission with cabergoline but not with bromocriptine or cyproheptadine treatment.
Topics: Adenoma; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Bromocriptine; Cabergoline; Cyproheptadine; Dopamine Agonists; Ergolines; Female; Hormone Replacement Therapy; Humans; Magnetic Resonance Imaging; Nelson Syndrome; Pituitary Neoplasms | 2004 |
Dopamine agonist treatment before and after the birth reduces prolactin concentration but does not impair paternal responsiveness in Djungarian hamsters, Phodopus campbelli.
Topics: Animals; Bromocriptine; Cabergoline; Cricetinae; Dopamine Agonists; Ergolines; Female; Male; Parturition; Paternal Behavior; Phodopus; Pregnancy; Prolactin; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2005 |
Effectiveness of adding dopamine agonist therapy to long-acting somatostatin analogues in the management of acromegaly.
Topics: Acromegaly; Adult; Aged; Aged, 80 and over; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Prolactin; Retrospective Studies; Somatostatin | 2005 |
The clinical characteristics of headache in patients with pituitary tumours.
Topics: Adenoma; Adult; Aminoquinolines; Antineoplastic Agents, Hormonal; Bromocriptine; Cabergoline; Disability Evaluation; Dopamine Agonists; Ergolines; Female; Headache; Humans; Male; Migraine Disorders; Octreotide; Peptides, Cyclic; Pituitary Neoplasms; Severity of Illness Index; Somatostatin; Time Factors | 2005 |
The use of high-dose daily cabergoline in an adolescent patient with macroprolactinoma.
Topics: Bromocriptine; Cabergoline; Child; Dopamine Agonists; Ergolines; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactinoma; Treatment Outcome | 2005 |
Long-term remission following withdrawal of dopamine agonist therapy in subjects with microprolactinomas.
Topics: Adolescent; Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2005 |
Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists.
Topics: Adult; Aged; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance; Ergolines; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma; Remission Induction; Retrospective Studies; Treatment Outcome | 2005 |
Potential for long-term remission of microprolactinoma after withdrawal of dopamine-agonist therapy.
Topics: Adolescent; Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma | 2006 |
Clinical presentation and response to therapy in patients with massive prolactin hypersecretion.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Testosterone | 2007 |
Growth hormone excess with onset in adolescence: clinical appearance and long-term treatment outcome.
Topics: Adolescent; Adult; Antineoplastic Agents, Hormonal; Body Height; Body Mass Index; Bromocriptine; Cabergoline; Combined Modality Therapy; Ergolines; Female; Growth Hormone; Growth Hormone-Secreting Pituitary Adenoma; Headache; Hormone Antagonists; Humans; Insulin Resistance; Insulin-Like Growth Factor I; Male; Menstruation Disturbances; Octreotide; Peptides, Cyclic; Pituitary Neoplasms; Retrospective Studies; Somatostatin; Treatment Outcome | 2007 |
Prolactin and autoimmune diseases in humans.
Topics: Aminoquinolines; Animals; Arthritis, Rheumatoid; Autoimmune Diseases; Bromocriptine; Cabergoline; Cyclosporine; Dopamine Agonists; Double-Blind Method; Drug Therapy, Combination; Ergolines; Female; Humans; Hyperprolactinemia; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Mice; Mice, Knockout; Penicillamine; Prednisone; Prolactin; Rats; Receptors, Prolactin | 2007 |
Dopaminergic treatment of nonfunctioning pituitary adenomas.
Topics: Adenoma; Bromocriptine; Cabergoline; Dopamine Agents; Dopamine Agonists; Ergolines; Humans; Pituitary Neoplasms; Prolactin | 2007 |
Remarkable effects of cabergoline in a patient with huge prolactinoma resistant to high-dose bromocriptine: case report.
Topics: Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Ergolines; Humans; Male; Pituitary Neoplasms; Prolactinoma; Treatment Outcome | 2008 |
The frequency of cardiac valvular regurgitation in Parkinson's disease.
Topics: Aged; Aortic Valve Insufficiency; Azepines; Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Male; Mitral Valve Insufficiency; Parkinson Disease; Pergolide; Pramipexole; Prevalence | 2008 |
Clinical profile and long term follow up of children and adolescents with prolactinomas.
Topics: Adolescent; Amenorrhea; Bromocriptine; Cabergoline; Child; Dopamine Agonists; Ergolines; Female; Galactorrhea; Humans; Male; Pregnancy; Prolactin; Prolactinoma; Retrospective Studies; Treatment Outcome; Young Adult | 2009 |
High risk factors for valvular heart disease from dopamine agonists in patients with Parkinson's disease.
Topics: Age Factors; Aged; Benzothiazoles; Bromocriptine; Cabergoline; Case-Control Studies; Dopamine Agonists; Echocardiography; Ergolines; Female; Heart Valve Diseases; Humans; Hypertension; Male; Parkinson Disease; Pergolide; Pramipexole; Risk Factors | 2009 |
Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonists.
Topics: Aged; Aged, 80 and over; Apomorphine; Benzothiazoles; Bromocriptine; Cabergoline; Databases, Factual; Dopamine Agonists; Endomyocardial Fibrosis; Ergolines; Female; Fibrosis; Heart Valve Diseases; Humans; Indoles; Male; Middle Aged; Pergolide; Pericarditis; Pleural Diseases; Pramipexole; Pulmonary Fibrosis; Retroperitoneal Fibrosis; Tetrahydronaphthalenes; Thiophenes; United States | 2009 |
Dopamine agonists and hyperprolactinaemia.
Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Heart Valve Diseases; Humans; Hyperprolactinemia | 2009 |
Dopamine agonists, Dopplers and doubt: cabergoline-associated cardiac valvulopathy.
Topics: Antiparkinson Agents; Bromocriptine; Cabergoline; Case-Control Studies; Cross-Sectional Studies; Dopamine Agonists; Ergolines; Female; Heart Valve Diseases; Humans; Hyperprolactinemia; Male; Parkinson Disease; Pergolide; Prolactin; Serotonin 5-HT2 Receptor Agonists; Ultrasonography | 2009 |
Non-surgical management of cystic prolactinomas.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Follow-Up Studies; Gadolinium; Hormones; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Young Adult | 2009 |
Comparative efficacy of bromocriptine, cabergoline and thyroxine in inducing oestrus in bitches.
Topics: Animals; Bromocriptine; Cabergoline; Dogs; Ergolines; Estrous Cycle; Female; Fertilization; Hormone Antagonists; Litter Size; Progesterone; Prolactin; Thyroxine | 2010 |
Management of prolactinomas in Brazil: an electronic survey.
Topics: Brazil; Bromocriptine; Cabergoline; Data Collection; Dopamine Agonists; Ergolines; Female; Humans; Pregnancy; Prolactinoma | 2010 |
Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas.
Topics: Adult; Birth Weight; Bromocriptine; Cabergoline; Cohort Studies; Dopamine Agonists; Drug Resistance; Ergolines; Female; Humans; Hyperprolactinemia; Infertility, Female; Magnetic Resonance Imaging; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Progesterone; Prolactin; Prolactinoma | 2010 |
Comparison of cabergoline and bromocriptine in patients with asymptomatic incidental hyperprolactinemia undergoing ICSI-ET.
Topics: Adult; Bromocriptine; Cabergoline; Databases, Factual; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Infertility, Female; Pregnancy; Pregnancy Rate; Retrospective Studies; Sperm Injections, Intracytoplasmic; Treatment Outcome | 2010 |
BMI and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonists.
Topics: Adult; Aftercare; Aged; Blood Glucose; Body Composition; Body Mass Index; Body Weight; Bromocriptine; Cabergoline; Cholesterol, HDL; Cholesterol, LDL; Dopamine Agonists; Ergolines; Female; Humans; Insulin; Insulin Resistance; Leptin; Male; Metabolic Syndrome; Metabolome; Middle Aged; Obesity; Prevalence; Prolactinoma; Waist Circumference; Weight Gain; Young Adult | 2011 |
Effect of dopaminergic drug treatment on surgical findings in prolactinomas.
Topics: Adenoma; Adolescent; Adult; Aged; Bromocriptine; Cabergoline; Child; Dopamine Agents; Ergolines; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Young Adult | 2011 |
Disorganized schizophrenia does not deteriorate with dopamine agonists cabergoline and bromocriptine used for ablactation.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Lactation; Mastitis; Schizophrenia, Disorganized | 2011 |
Pituitary tumors: cabergoline versus bromocriptine: a meta-analysis?
Topics: Antineoplastic Agents; Bromocriptine; Cabergoline; Ergolines; Humans; Meta-Analysis as Topic; Pituitary Neoplasms; Treatment Outcome | 2011 |
Long term follow-up of patients with prolactinomas and outcome of dopamine agonist withdrawal: a single center experience.
Topics: Adolescent; Adult; Aged; Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prolactinoma; Treatment Outcome; Young Adult | 2012 |
A comparison of cabergoline and bromocriptine on the risk of valvular heart disease in patients with prolactinomas.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Echocardiography; Ergolines; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Prolactinoma | 2012 |
[Prescription of ergot derivatives for lactation inhibition in France: Current practices].
Topics: Bromocriptine; Cabergoline; Dihydroergocryptine; Dopamine Agonists; Ergolines; Ergot Alkaloids; Female; France; Humans; Lactation; Lisuride; Practice Patterns, Physicians'; Prolactin; Surveys and Questionnaires | 2012 |
No clinically significant valvular regurgitation in long-term cabergoline treatment for prolactinoma.
Topics: Adolescent; Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Cross-Sectional Studies; Echocardiography; Ergolines; Female; Humans; Male; Middle Aged; Prolactinoma; Retrospective Studies; Tricuspid Valve Insufficiency; Young Adult | 2012 |
Increased prevalence of subclinical cardiac valve fibrosis in patients with prolactinomas on long-term bromocriptine and cabergoline treatment.
Topics: Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Case-Control Studies; Dopamine Agonists; Echocardiography; Ergolines; Female; Fibrosis; Heart Valve Diseases; Heart Valves; Humans; Male; Middle Aged; Pituitary Neoplasms; Prevalence; Prolactinoma; Prospective Studies | 2012 |
[Gender effect on cardiomyopathy].
Topics: Bromocriptine; Cabergoline; Cardiomyopathies; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Cardiomyopathy, Restrictive; Dopamine Agonists; Ergolines; Evidence-Based Medicine; Female; Genetic Counseling; Humans; Phenotype; Pregnancy; Pregnancy Complications, Cardiovascular; Prognosis; Prolactin; Risk Assessment; Risk Factors; Sex Factors; Treatment Outcome | 2012 |
Optimal effective doses of cabergoline and bromocriptine and valvular leasions in men with prolactinomas.
Topics: Adult; Aged; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Pituitary Neoplasms; Prevalence; Prolactinoma; Retrospective Studies; Risk Factors; Ultrasonography; Young Adult | 2012 |
Medically treated prolactin-secreting pituitary adenomas: when should we operate?
Topics: Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Ergolines; Female; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Postmenopause; Premenopause; Prolactinoma; Prospective Studies; Retrospective Studies; Sphenoid Bone; Time Factors; Treatment Failure | 2013 |
Real-world comorbidities and treatment patterns of patients with acromegaly in two large US health plan databases.
Topics: Acromegaly; Adult; Bromocriptine; Cabergoline; Databases, Factual; Ergolines; Female; Human Growth Hormone; Humans; Male; Middle Aged; Octreotide; Peptides, Cyclic; Retrospective Studies; Somatostatin; United States | 2013 |
Short-term pharmacological suppression of the hyperprolactinemia of infertile hCG-overproducing female mice persistently restores their fertility.
Topics: Animals; Bromocriptine; Cabergoline; Chorionic Gonadotropin; Disease Models, Animal; Ergolines; Female; Fertility; Gene Expression Regulation; Humans; Hyperprolactinemia; Infertility; Mice; Mice, Transgenic; Ovulation; Phenotype; Time Factors | 2012 |
Risk of thromboembolic events in patients with prolactinomas compared with patients with nonfunctional pituitary adenomas.
Topics: Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Ergolines; Female; Humans; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Thromboembolism; Young Adult | 2013 |
Hyperprolactinemia in children: clinical features and long-term results.
Topics: Adolescent; Bromocriptine; Cabergoline; Child; Combined Modality Therapy; Ergolines; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Treatment Outcome | 2012 |
[Visual outcome in patients with macroprolactinoma treated with dopamine agonists].
Topics: Adolescent; Adult; Bromocriptine; Cabergoline; Child; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Prolactinoma; Retrospective Studies; Vision Disorders; Visual Acuity; Visual Fields; Young Adult | 2013 |
Occlusal treatment with bite splint improves dyskinesia in Parkinson's disease patient: a case report.
Topics: Activities of Daily Living; Antiparkinson Agents; Bromocriptine; Cabergoline; Clonidine; Dyskinesias; Ergolines; Female; Hand Strength; Humans; Levodopa; Middle Aged; Motor Skills; Occlusal Splints; Parkinson Disease; Posture | 2013 |
[Inhibition of lactation: end to the bromocriptin, long life to the carbergolin?].
Topics: Bromocriptine; Cabergoline; Cardiovascular Diseases; Ergolines; Female; France; Hormone Antagonists; Humans; Lactation | 2014 |
Women with prolactinomas presented at the postmenopausal period.
Topics: Aged; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Follicle Stimulating Hormone; Humans; Hyperprolactinemia; Luteinizing Hormone; Middle Aged; Pituitary Neoplasms; Postmenopause; Prolactin; Prolactinoma; Retrospective Studies; Treatment Outcome | 2014 |
Young female with acromegaloid features and pituitary macroadenoma: what is your diagnosis?
Topics: Acanthosis Nigricans; Acromegaly; Adult; Bromocriptine; Cabergoline; Diagnosis, Differential; Ergolines; Female; Gastrointestinal Diseases; Hirsutism; Human Growth Hormone; Humans; Hyperprolactinemia; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Prognathism; Prolactinoma | 2014 |
A case of iatrogenic severe mitral regurgitation.
Topics: Antineoplastic Agents; Bromocriptine; Cabergoline; Drug Therapy, Combination; Ergolines; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hormone Antagonists; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Pituitary Neoplasms; Prolactinoma; Treatment Outcome | 2013 |
Comparison of efficacy of bromocriptine and cabergoline to GnRH agonist in a rat endometriosis model.
Topics: Adult; Animals; Antineoplastic Agents; Bromocriptine; Cabergoline; Disease Models, Animal; Dopamine Agonists; Endometriosis; Endometrium; Ergolines; Female; Gonadotropin-Releasing Hormone; Humans; Laparotomy; Leuprolide; Prospective Studies; Random Allocation; Rats; Rats, Wistar; Triptorelin Pamoate | 2015 |
Retrospective comparison of cabergoline and bromocriptine effects in hyperprolactinemia: a single center experience.
Topics: Adolescent; Adult; Aged; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Young Adult | 2015 |
Treatment outcome results from the Bulgarian Acromegaly Database: adjuvant dopamine agonist therapy is efficient in less than one fifth of non-irradiated patients.
Topics: Acromegaly; Adolescent; Adult; Aged; Bromocriptine; Bulgaria; Cabergoline; Child; Databases, Factual; Dopamine Agonists; Ergolines; Female; Follow-Up Studies; Humans; Male; Middle Aged; Radiotherapy; Remission Induction; Retrospective Studies; Somatostatin | 2015 |
[Pituitary apoplexy in a pregnant woman with cystic microprolactinoma].
Topics: Adult; Bromocriptine; Cabergoline; Combined Modality Therapy; Contraindications; Dopamine Agonists; Drug Substitution; Ergolines; Female; Headache; Hormone Replacement Therapy; Humans; Hydrocortisone; Hypophysectomy; Infant, Newborn; Male; Pituitary Apoplexy; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Prolactinoma; Thyroxine; Vision Disorders | 2015 |
Different Effects of Metformin on the Hypothalamic-Pituitary-Thyroid Axis in Bromocriptine- and Cabergoline-treated Patients with Hashimoto's Thyroiditis and Glucose Metabolism Abnormalities.
Topics: Adult; Bromocriptine; Cabergoline; Ergolines; Female; Glucose Metabolism Disorders; Hashimoto Disease; Humans; Hypothalamo-Hypophyseal System; Metformin; Middle Aged; Thyroid Gland | 2015 |
Cost-Effectiveness Analysis of Microscopic and Endoscopic Transsphenoidal Surgery Versus Medical Therapy in the Management of Microprolactinoma in the United States.
Topics: Adult; Aged; Bromocriptine; Cabergoline; Cost-Benefit Analysis; Decision Support Techniques; Decision Trees; Ergolines; Female; Health Care Costs; Hormone Antagonists; Humans; Hyperprolactinemia; Life Expectancy; Male; Medicare; Microsurgery; Middle Aged; Monte Carlo Method; Neuroendoscopy; Pituitary Neoplasms; Prolactinoma; Quality-Adjusted Life Years; Sphenoid Sinus; Time Factors; Treatment Outcome; United States | 2016 |
Inhibiting the onset of lactation. Is cabergoline an alternative to bromocriptine?
Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Europe; Female; France; Humans; Lactation | 2015 |
Withdrawal of dopamine agonist therapy in prolactinomas: In which patients and when?
Topics: Adolescent; Adult; Aged; Bromocriptine; Cabergoline; Deprescriptions; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Neoplasm Recurrence, Local; Patient Selection; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Time Factors; Tumor Burden; Young Adult | 2016 |
Prolactinomas: evolution after menopause.
Topics: Adenoma; Adult; Bromocriptine; Cabergoline; Disease Progression; Dopamine Agonists; Ergolines; Female; Humans; Menopause; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Treatment Outcome; Withholding Treatment | 2016 |
Giant prolactinomas larger than 60 mm in size: a cohort of massive and aggressive prolactin-secreting pituitary adenomas.
Topics: Adolescent; Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Child; Ergolines; Female; Galactorrhea; Headache; Hormone Antagonists; Humans; Male; Middle Aged; Neurosurgical Procedures; Pituitary Neoplasms; Prolactinoma; Sexual Dysfunction, Physiological; Treatment Outcome; Tumor Burden; Vision Disorders; Young Adult | 2016 |
Treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists.
Topics: Adenoma; Adult; Aged; Bromocriptine; Cabergoline; Disease Progression; Dopamine Agonists; Ergolines; Female; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Receptors, Dopamine; Receptors, Estrogen; Treatment Outcome | 2016 |
Dopa-testotoxicosis: disruptive hypersexuality in hypogonadal men with prolactinomas treated with dopamine agonists.
Topics: Adult; Aged; Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Humans; Hypogonadism; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Sexual Dysfunction, Physiological | 2017 |
SURGICAL OUTCOMES OF PROLACTINOMAS IN RECENT ERA: RESULTS OF A HETEROGENOUS GROUP.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurosurgical Procedures; Pituitary Neoplasms; Prolactinoma; Remission Induction; Retrospective Studies; Treatment Failure; Treatment Outcome; Tumor Burden; Young Adult | 2017 |
10-year follow-up study comparing primary medical vs. surgical therapy in women with prolactinomas.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Follow-Up Studies; Humans; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Treatment Outcome; Young Adult | 2017 |
Macroprolactinomas and Nonfunctioning Pituitary Adenomas and Pregnancy Outcomes.
Topics: Adenoma; Adult; Amenorrhea; Antineoplastic Agents; Bromocriptine; Cabergoline; Case-Control Studies; Cesarean Section; Dopamine Agonists; Ergolines; Female; Galactorrhea; Humans; Incidence; Pituitary Neoplasms; Pre-Eclampsia; Preconception Care; Pregnancy; Pregnancy Complications, Neoplastic; Premature Birth; Prolactinoma; Prospective Studies; Stillbirth; United Kingdom; Vision Disorders; Young Adult | 2017 |
MRI follow-up is unnecessary in patients with macroprolactinomas and long-term normal prolactin levels on dopamine agonist treatment.
Topics: Adult; Aminoquinolines; Belgium; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Follow-Up Studies; France; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies | 2017 |
Prolactinoma management: predictors of remission and recurrence after dopamine agonists withdrawal.
Topics: Adolescent; Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Male; Middle Aged; Prolactin; Prolactinoma; Retrospective Studies; Young Adult | 2017 |
Pregnancy and Tumor Outcomes in Women with Prolactinoma.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Outcome Assessment, Health Care; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prolactinoma; Retrospective Studies; Young Adult | 2017 |
Best candidates for dopamine agonist withdrawal in patients with prolactinomas.
Topics: Adolescent; Adult; Aged; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Prolactinoma; Retrospective Studies; Young Adult | 2017 |
The efficacy of medical treatment in patients with acromegaly in clinical practice.
Topics: Acromegaly; Adenoma; Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Cohort Studies; Dopamine Agonists; Drug Resistance, Neoplasm; Ergolines; Female; Follow-Up Studies; Growth Hormone-Secreting Pituitary Adenoma; Hospitals, University; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Neoplasm Grading; Republic of Korea; Retrospective Studies; Somatostatin; Tumor Burden | 2018 |
Failure of a second temozolomide cycle in a patient with a prolactin-secreting pituitary carcinoma.
Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Bromocriptine; Cabergoline; Combined Modality Therapy; Dacarbazine; Drug Substitution; Ergolines; Fatal Outcome; Headache; Humans; Hyperprolactinemia; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactin; Prolactinoma; Proton Therapy; Temozolomide | 2017 |
Impact of menopause on outcomes in prolactinomas after dopamine agonist treatment withdrawal.
Topics: Adolescent; Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Menopause; Postmenopause; Prolactin; Prolactinoma; Retrospective Studies; Withholding Treatment; Young Adult | 2018 |
Long-term low-dose cabergoline usage: Another association with cardiac valvulopathy.
Topics: Bromocriptine; Cabergoline; Ergolines; Heart Valve Diseases; Humans; Middle Aged; Pituitary Neoplasms | 2023 |
Italian Guidelines for the Management of Prolactinomas.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Humans; Pituitary Neoplasms; Prolactin; Prolactinoma | 2023 |